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Abstract
For many years the CD45 transmembrane tyrosine phosphatase has been 
known to be an important molecule in both B and T lymphocyte receptor signalling 
events. To understand the role of this molecule in lymphocyte ontogeny and 
function I have created mice which are homozygous for a targeted mutation of exon 
12 of the Cd45 gene. These mice have B cells that are unusual in that they appear 
immature on the basis of their expression of IgM and IgD receptors and yet have 
increased expression of other markers that are associated with increasing B cell 
maturation. In addition, CD45-deficient B cells have increased expression of B7.2, 
suggesting that these cells have been activated. Following BCR stimulation in vitro 
CD45-deficient B cells have a diminished proliferation response. B-1 cell 
populations have been found to be greatly reduced in these mice suggesting that 
CD45 is also a positive regulator of B-1 receptor signalling. The use of the 3-83 
transgenic BCR demonstrates that B cells can be produced however
these cells express altered levels of IgM and IgD. Cd45'^ ' B ceUs are deleted 
normally in the presence of the negatively selecting ligand for the transgenic 
receptor and undergo both Ig heavy and light chain rearrangements normally 
suggesting that CD45 is not required for these processes. Finally Cd45''' B cells 
have a diminished but not absent Ca^  ^flux on receptor stimulation that could explain 
the abolition of some receptor mediated responses.
Cd45'^ ' mice have a severe deficiency in T cell development. Firstly there is 
a developmental block at the DN3 stage of thymocyte development, suggesting that 
CD45 plays a role in signalling from the pre-TCR. A second developmental block 
is at the DP stage in thymocyte developmental which is associated with the positive 
and negative selection events of T cell selection. Some Cd45^' T cells are able to 
migrate to the periphery albeit in greatly reduced numbers. These cells are unusual 
in that they have an activated phenotype (CD44'“/L-selectin’“). To determine the role 
of CD45 during positive selection of thymocytes both class 1 and class II transgenic
TCR receptors were used. Çd45'^ ' mice were found to display a profound block in 
the development of mature T cells expressing the transgenic TCRs suggesting an 
important role for CD45 in the positive selection of these receptors. Moreover, this 
deficiency appears to be due to altered thresholds of TCR signalling as assessed 
using bi-specific antibodies to induce positive selection events in a dose dependent 
manner. The use of a transgenic TCR to investigate T cell negative selection events 
demonstrates that Cd45'^ ' thymocytes can undergo negative selection events induced 
by the cognate ligand. However, negative selection induced by endogenous (Afrv) 
and exogenous (SEE) superantigens are deficient in Cd45'^ ' thymocytes. In addition 
Cd45'^ ' T cells are found to have a profound block in their ability to mobilise Ca^  ^in 
response to antigen receptor stimulation;
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Chapter One
INTRODUCTION
1.1 The role of the immune system
Adaptive immunity
The major function of the mammalian immune system is to protect the host 
from a diverse array of potentially pathogenic organisms by recognising and 
reacting to non-self antigens (Janeway et al,, 1996). To achieve this, the immune 
system has developed both innate and adaptive immunological responses to 
pathogens to aid their elimination.
The host’s innate immune system is its first line of defence on exposure to 
foreign antigens. These innate responses pre-exist within the host and do not 
require prior exposure to antigen. There is no alteration in the ability of the innate 
immune system to respond specifically to that antigen on subsequent encounter 
(Fearon, 1997).
Adaptive immunity differs from innate immunity in that it is induced upon 
encounter with foreign antigen and gives rise to a long-lasting protection against 
subsequent encounter with the same pathogen. Both B and T lymphocytes play a 
major role in these adaptive immunological responses. The ability of B and T cells 
to respond to pathogenic infections relies on the presence of antigen receptors on the 
surface of these cells that are capable of recognising and responding to a wide 
vaiicly of antigens. To achieve this diversity of antigen recognition every 
lymphocyte expresses an antigen receptor of unique specificity that when stimulated 
transmits a signal to the cell. Activated lymphocytes then expand clonally on
12
stimulation and differentiate into effector cells which mount responses to eliminate 
the pathogen (Janeway and Bottomly, 1994).
M ajor histocompatibility molecules
The recognition of protein antigens by B cells involves a direct binding of 
the B cell receptor (BCR) to the native protein. T cell mediated immunity, however, 
relies on the binding of the T cell receptor (TCR) to intracellularly degraded peptides 
derived from pathogens, presented on the cell surface by membrane proteins of the 
major histocompatibility (MHC) class I and class II family (Engelhard, 1994). 
These molecules are highly polymorphic cell surface glycoproteins encoded by 
genes in a single gene cluster called the H-2 locus in the mouse. MHC class I and 
n  molecules have different functions and are expressed on different cell types. 
MHC class I molecules are expressed on all nucleated cells and present peptides 
derived from intracellular antigens such as viruses. MHC class I molecules consist 
of two polypeptide chains, the a subunit and p2 -microglobulin (p2 -m) which form a 
dimer. The a  subunit is encoded by three genes in the H-2 locus namely K, D and 
L whilst the p2-m subunit is encoded in a separate locus. MHC class II molecules 
present peptides derived from extracellular antigens. MHC class II molecules 
consist of a and p subunits as dimers and are exclusively expressed on specialised 
antigen presenting cells (APCs). The MHC class II a  and p subunits are encoded in 
the H-2 locus as two pairs of genes called I-E and I-A.
Both MHC class I and II molecules are found to be very similar in their 
tertiary structure and both present peptides to T cells in a groove formed between 
subunits of their extracelluar domains (Engelhard, 1994).
B and T ceils: antigen recognition and interactions
Bone marrow derived T cell progenitors develop in the thymus into two 
distinct sub-types based on their expression, of co-regulatory molecules. T cells 
expressing the CDS co-regulatoiy molecule (CDS^ generally develop into cytotoxic
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T cells which lyse infected cells. Peptides are presented to CD8  ^ T ceUs in 
association with MHC class I molecules which activate them and cause the release 
of mediators, such as cytotoxins and cytokines, as well as the expression of surface 
molecules that lead to the death of the infected cell. T cells expressing the CD4 
co-regulatory molecule (CD4^ develop into helper cells. Peptides are presented to 
CD4^T cells in association with MHC class H molecules and when activated these 
cells aid the destruction of pathogens by stimulating other cells of the immune 
system by producing growth factors and cytokines. Once activated CD4^ T cells 
further develop into either T„1 or T„2 cells which express different cytokine profiles 
and have different functions (Murray, 1998).
Recognition of antigen by B cells leads to their activation and differentiation 
into plasma cells which produce antibody to fight infection (Rolink and Melchers, 
1996). B cell activation can either be thymus-dependent (TD) or
thymus-independent (TI), depending on the need for T cell help. TD antigens 
bound to BCRs are internalised and degraded into peptides that are presented in 
association with MHC class II molecules to CD4^ helper T cells. This presentation 
triggers the CD4^ T cells to produce cell bound and secreted effector molecules that 
synergise to elicit B cell activation. An early response of CD4^ T cells to binding 
peptide/MHC complexes is the up-regulation of a T cell surface molecule, CD40 
hgand (CD40L). CD40L binds to its receptor, CD40, a member of the Tumour 
Necrosis Factor (TNF) family that is expressed on the B cell surface (Durie et al., 
1994). This interaction causes the B cell to increase expression of the
immunoglobulin superfamily members CD80 (B7-1) and CD8 6  (B7-2) which bind 
to their ligand, CD28, present on the T cell surface (Thompson, 1995). Stimulation 
of CD28 strongly synergises with TCR stimulation and is necessary for full 
activation of the T cell. The activated CD4  ^T cell now releases cytokines such as 
IL-4, TGF-p and IFN-y which mediate the development oif these activated B cells to 
become antibody-secreting plasma cells.
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TI B ceU responses are stimulated directly by bacterial polysaccharides, 
polymeric proteins or lipopolysaccharides. Here T cell help is not required for 
plasma cell formation.
1.2 B cell development and function
The B cell receptor structure and function
B and T cell antigen receptors (BCRs and TCRs) are essential for the 
signalling events required for lymphocyte development and activation (Janeway and 
Bottomly, 1994). Although distinct in structure, the B and T cell receptors share 
many common features (Borst et al., 1996). The BCR is a cell surface 
immunoglobulin (Ig) molecule consisting of a heavy (H) and light chain (L) each of 
which have a constant region (C„ and C  ^respectively) and a variable region. The 
variable region is generated by somatic recombination events of the variable (V), 
diversity (D) and joining (J) gene segments of Ig H chains and V and J segments of 
Ig L chains which together give rise to extensive diversity of receptor specificity 
(Chen and Alt, 1993). These recombination events are initiated by the 
recombination activating gene-1 (RAG-1) and RAG-2 products (Alt et al., 1992; 
Weaver and Alt, 1997).
The BCR is part of a multi-subunit complex consisting of membrane Ig 
non-covalently associated with a disulphide-linked heterodimer of two 
transmembrane accessory proteins, CD79a (Iga) and CD79b (Igp). These 
molecules have an Ig-like extracellular domain and a short intracellular domain 
which is responsible for early downstream signalling events upon receptor 
stimulation (see later and Roth and DeFranco, 1996).
When activated, mature B cells expressing membrane bound IgM/D 
differentiate, into plasma cells that secrete antibodies. This is initially achieved by 
the alternative splicing of exons encoding a carboxy-terminus portion of IgM/IgD 
from that of a membrane bound form to that of a secreted form. Therefore activated
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B cells initially secrete IgM and IgD antibodies. The cells can then undergo further 
recombination events between sequences known as “switch regions” that are located 
adjacent to other regions of the Ig locus which allows for the production of other 
secreted immunoglobulin isoforms. This process is called “isotype switching” and 
the type of secreted immunoglobulin (either IgG, IgM, IgA, or IgE) that a plasma 
cell secretes depends on the type of cytokines produced by the helper T cell during 
B cell activation (Lorenz et al., 1995; Lorenz and Radbruch, 1996).
B cell memory is a important element in the development of a strong 
humoral response to repeated exposure to antigen. B cells that encounter foreign 
antigen for the first time are likely to have a low affinity to the antigen, however on 
secondary and subsequent exposure to the same antigen, the responding antibodies 
have increased affinities, a process known as affinity maturation (Wagner and 
Neuberger, 1996). During a primary antibody response activated B cells proliferate 
to form a primary focus in the T cell area of lymphoid tissues where they 
differentiate and secrete antibody that helps to localise the antigen on the surface of 
follicular dendritic cells (FDCs). This stimulates the formation of germinal centres 
where B cells that have not undergone terminal differentiation enter a second phase 
of proliferation. At this stage the B cells undergo somatic hypermutation of the Ig V 
regions whereby there is an accumulation of mutations within these regions altering 
the specificity’s of their receptors. Somatic hypermutation results in B cells that 
may have BCRs with higher or lower affinities for the antigen. B cells must have 
their BCR bound to antigen if they are to survive in the germinal centres. Those B 
cells that have the highest affinity after somatic hypermutation compete more 
efficiently for antigen displayed on tiie FDCs and this ensures that only those ceUs 
with increased affinity to the antigen after somatic hypermutation survive. During 
secondary responses, antibody produced during the primary response also 
competes with B cells binding to antigen on FDCs amplifying this effect such that 
secondary responses produce higher antibody affinities than primary responses.
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B cell coreceptor
The B cell coreceptor consists of a complex of four transmembrane 
signalling molecules CD 19, CD21, CD81 and Leu-13 molecules that are closely 
associated with the BCR. The function of these molecules is to modulate the 
responsiveness of B cell signals from the receptor (Doody et al., 1996; Fearon,
1993). B cells from transgenic mice that over-express human CD 19 are found to be 
hyper-responsive to antigen crosslinking (Engel et al., 1995) whilst CD19-deficient 
mice have decreased proliferative responses to mitogens, reduced serum Ig and fail 
to form germinal centres (Engel et al., 1995; Sato et al., 1997). These studies 
indicate a positive role for CD19 in the signal transduction mechanisms during BCR 
stimulation. The CD21 component of the coreceptor is a receptor for iC3b, C3dg 
and C3d firagments of C3 the third component of complement (Sato et al., 1997; 
Tedder et al., 1997). These complement components are involved in the innate 
immunological responses to microbial infection. CD21 is also thought to have a 
positive role in BCR signal transduction and therefore plays an important role 
during B cell encounter with microbial antigens. CD21-deficient, mice have severely 
diminished T-dependent antibody responses consistent with its positive regulatory 
role. CD81 is a ubiquitously expressed cell surface glycoprotein which is a member 
of a family of proteins containing four transmembrane spanning regions (Maecker 
and Levy, 1997). CD81 also appears to play a positive role in regulating the 
thresholds of receptor signalling. Mice deficient in CD81 have a reduced level of 
CD 19 expression and are defective in signal transduction on CD 19 crosslinking 
(Tsitsikov et al., 1997). In conclusion, the role of the coreceptor molecules is to 
regulate the strength of receptor signalling on BCR engagement. The exact roles 
and the contribution that each of these coreceptor molecules make to BCR signal 
transduction during encounter with antigen is not clear (DeFranco, 1996).
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B-1 cells
B cells can be subdivided into B-1 and B-2 cells based on their location and 
the expression of surface markers (Tarakhovsky, 1997). The developmental 
relationship between these B-1 and B-2 cells is not clear though they appear to be 
descended from distinct progenitor populations (Borrello and Phipps, 1996; 
Hamilton et al., 1994). B-1 ceUs are present in lower numbers than B-2 ceUs, 
being only about 1% of the mature B cell population. They reside predominantly in 
the peritoneal and pleural cavities where they are thought to be the primary defence 
against microbial antigens. They can be distinguished from B-2 cells by their 
expression of CD 11b, a marker normally expressed on macrophages. B-1 cells 
also have a higher IgMrlgD ratio than B-2 ceUs and are thought to be the major 
source of serum IgM that is present in the absence of antigenic challenge 
(Tarakhovsky, 1997). B-1 cells can be further subdivided into B-la and B-lb 
subtypes on the basis of their expression of CD5, a marker more commonly 
associated with T development (Forster et al., 1991). B-la cells express CD5 
whilst B-lb cells do not. Whether there are any functional differences between 
these B-1 cell subtypes is hot clear (Tarakhovsky, 1997).
B-2 cell development
B cell precursors in the marrow undergo a series of developmental steps 
prior to maturing to IgMTgD^ peripheral recirculating B cells (Hentges, 1994). All 
B cells can be recognised by antibodies to the B cell specific isoform of CD45 
(B220). When used in conjunction with antibodies that recognise IgM and either 
the IL-2 receptor a chain (CD25) (Rolink et al., 1994) or CD43 (Hardy et al.,
1991), B cell development can be divided into pro-B, pre-B and immature B cell 
populations. B220TgM’CD25CD43^ pro-B cells begin the process of 
immunoglobulin rearrangement of the D and J segments of their heavy chain (D„ 
and J„) (Weaver and Alt, 1997). This is followed by joining V„ to D^J» segments 
to complete V^D^Jh recombination. Successful rearrangement results in expression 
of the p heavy chain which associates with the surrogate light chain components,
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VpreB and X5, to form the pre-BCR (Kitamura et al., 1992). Functional expression 
of the pre-BCR drives the development of these cells into B220^gM CD25^CD43 
pre-B cells. This also stops the rearrangement of heavy chain genes and induces the 
Vl and Jl rearrangement of receptor light chains, k or X. Successful rearrangement 
of these genes results in the production of a light chain which associates with the 
heavy chain to form a functional BCR, leading to in the formation of 
B220‘TgM^CD25^CD43' immature B cells. Immature B cells responsive to
autoantigens are deleted by negative selection at this stage in the bone marrow to 
avoid autoimmunity. Non-autoreactive immature B cells migrate to the red pulp and 
T zones of the spleen where they either die or are induced to mature to IgM^IgD  ^
recirculating B cells and to enter B cell follicles. This final step of B cell maturation 
may involve signals from the BCR which select only a subset of immature B cells 
into the recirculating pool (Torres et al., 1996; Turner et al., 1997). This may 
represent the positive selection of B cells, analogous to the more extensively studied 
T cell process.
B cell developmental checkpoints and allelic exclusion
The ultimate goal of B cell development is to produce B cells expressing a 
BCR of a single unique specificity that does not recognise autoantigens. To achieve 
this, BCR construction occurs in a stepwise fashion with developmental 
checkpoints to monitor the success of each step. As discussed earlier, pro-B cells 
firstly undergo ¥„ D„ rearrangement at one of the Ig heavy chain alleles. Only if 
this rearrangement leads to production of a functional p H chain does it pair with the 
surrogate light chain (SL) components VpreB and A.5 , to form the pre-BCR which 
signals to the cell to suppress further rearrangement at the second Ig HC allele - a 
process known as allelic exclusion (Loffert et al., 1996). Successful H chain 
rearrangement and assembly of the pre-BCR also promotes the differentiation of 
pro-B cells into pre-B cell (and/or their clonal expansion). Only if rearrangement of 
the first allele fails to produce a functional pre-BCR is the second allele rearranged, 
a mechanism that allows the B cell a second chance to make a functional receptor
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(Loffert et al., 1996). Failure to make a functional H chain from this allele results 
in the death of the pro-B cell (Kitamura and Rajewsky, 1992; Kitamura et al.,
1991). The presence of a functional pre-BCR is not only essential for the process 
of allelic exclusion but is required for the further transition of these B cells into the 
pre-B cell conçartment. Mice deficient in (X5'^ ') cannot efficiently form a 
functional pre-BCR and therefore carmot efficiently transit the pro-B/pre-B cell 
developmental checkpoint (Kitamura et al., 1992; Rolink et al., 1993). However, 
some B cells do accumulate in these mice due to either some light chain 
rearrangement occurring before V„ to rearrangements or possibly due to 
VpreB and p forming a pre-BCR in absence of X5.
The Iga and Igp components of the pre-BCR are known to play an 
importarit role in signal transduction from the BCR. These molecules are expressed 
early in B cell development at the pro-B cell compartment prior to 
recombination and are therefore available to complex with the pre-BCR and 
contribute to signal transduction pathways (DeFranco et al., 1995). Interestingly, 
mice deficient in Igp are able to undergo D„ to recombination but fail to rearrange 
their V„ to D^J^ gene segments (Gong and Nussenzweig, 1996). This may suggest 
there is a checkpoint at this point during B cell development (hat requires signal 
transduction events mediated by Igp. Mice expressing only a truncated form of the 
Iga chain that cannot contribute to signal transduction have a partial block in the 
transition firom the immature B cell to the mature recirculating B cell (Torres et al.,
1996). In conclusion, Iga and p subunits inay contribute to signal transduction 
during different B cell developmental stages (Roth and DeFranco, 1996).
Allehc exclusion is not restricted to the H chain genes but also occurs during 
L chain gene rearrangement. Pre-B ceUs first rearrange k L chains which substitute 
for SL to form the BCR (Melchers et al., 1993). Formation of a functional BCR 
acts to suppress further k  chain gene rearrangement as well as rearrangement of X L 
chain genes and allows the transition of the B cells into immature IgNT cells that exit 
the bone marrow (Loffert et al., 1996). Only in the absence of the production of a
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functional rearrangement of k chain genes at this stage of development does X L 
chain rearrangement then occur.
B cells and autoantigens
I have discussed how B cells undergo a series of defined differentiation 
steps on their way to becoming mature antigen-reactive B cells. During this 
development it is necessary to check that not only has a functional BCR. been 
constructed but also that the BCR is non-autoreactive (Goodnow, 1996; Hentges,
1994).
B cells expressing autoreactive Ig receptors are thought to be negated either 
by deletion or inactivation (Goodnow, 1992). Clonal deletion of self-reactive B 
cells has been investigated using transgenic mice expressing BCRs in the presence 
or absence of their cognate ligands (Nemazee et al., 1991). The two best studied 
BCR transgenic mouse models are the 3-83pS mice which have transgenes encoding 
IgM and IgD that bind MHC class I H-2K'' or H-2K’’, and the anti-HEL transgenic 
mice which express IgM and IgD that bind hen egg lysozyme (HEL) (Goodnow,
1992). In botii these models self-reactive B cells that recognise a 
membrane-associated form of the cognate ligand with high affinity in the bone 
marrow are deleted such that no B cells expressing the autoreactive BCR enter the 
periphery of these animals (Nemazee et al., 1991). This deletion is driven by the 
induction of apoptosis leading to the death of these cells in the bone marrow. It is 
unclear whether this deletion is caused by apoptosis-inducing intracellular signals 
from the receptor itself, or whether the presence of autoreactive receptors leads to 
the failure of secondary signals that induce B cell maturation, apoptosis being a 
default pathway (Goodnow, 1996).
It is possible that B cells may not encounter all autoantigens during their 
development in the marrow. To counteract this B cells must have a mechanism that 
allows for the deletion or inactivation of self-reactive cells in the periphery. BCR 
transgenic mice expressing the cognate antigen for the receptor exclusively in
peripheral tissue have been used to investigate this issue. For example 3-83|i6 mice, 
crossed to mice that express the deleting ligand H-2K‘* solely in the liver, delete B 
cells efficiently from the periphery demonstrating that autoreactive B cells are still 
susceptible to negative selection after leaving the marrow (Russell et al., 1991).
Alternatively, B cells can avoid deletion on exposure to autoantigens by 
either altering the specificity of the antigen receptor. Receptor editing is the term 
given to autoantigen-driven alterations in the specificity of a BCR by the 
substitution of the light chains of the receptor (Hertz and Nemazee, 1998; Pelanda et 
al., 1997). This phenomenon has been particularly well studied in transgenic 
mouse models. 3-83p6 transgenic mice in the presence of the deleting H-2K‘" or 
H-2K^ antigen mainly undergo clonal deletion of their B cells. However, a 
proportion of their B cells survive and enter the periphery. These B cells have 
predominantly undergone rearrangement of their endogenous k or 1  genes resulting 
in a light chain which pairs with the heavy chain of the transgene resulting in 
altered, non-autoreactive BCR specificity (Gay et al., 1993; Pelanda et al., 1997; 
Tiegs et al., 1993).
The use of transgenic mice expressing rearranged receptors to autoantigens. 
has also revealed mechanisms other than receptor editing to avoid deletion without 
inducing autoimmunity. For example, anti-HEL transgenic animals do not delete 
their B cells when crossed to mice that secrete small amounts of a soluble form of 
HEL (sHEL) (Goodnow et al., 1989). No autoimmune disease develops in these 
mice although their B cells are able to produce anti-HEL antibodies in response to 
the antigen in vitro (Goodnow et al., 1989). This phenomenon is described as 
clonal ignorance, and is probably due to the low level of receptor stimulation 
provided by the small amounts of cognate antigen present in these animals.
Clonal anergy is another mechanism by which autoimmunity is avoided 
(Goodnow, 1992). This process is characterised by the presence of B cells that 
express BCRs that recognise self-antigen but have become functionally inactivated. 
This process has also been studied using the anti-HEL transgenic mouse model. 
When these mice are crossed to transgenic mice expressing sHEL at higher levels
than those that induce clonal ignorance then clonal anergy occurs (Goodnow et al., 
1988). B cells reach the periphery of these mice in near normal numbers but they 
exhibit a loss of many normal cellular responses such as a reduction in mitogen- 
induced B cell proliferation, Ig secretion and they have a characteristic twenty-fold 
reduction in the level of BCR expression (Cyster et al., 1994; Goodnow, 1992; 
Mason et al., 1992). When the fate of these anti-HEL expressing anergic B cells 
was explored in the context of a polyclonal repertoire where they were mixed with 
non-autoreactive B cells and used to reconstitute lethally irradiated recipients, the 
anergic cells where found to be excluded from migrating into primary follicles and 
died in the outer T cell zone (Cyster and Goodnow, 1995; Cyster et al., 1994). 
This suggests that transition through the outer T cell zone where they compete with 
naive B cells for survival may be an important selection event that prevents the 
accumulation of anergic B cells.
The induction of B cell deletion, ignorance or anergy is probably dependent 
on the signals èhcited from the receptor on engagement. In the model proposed by 
Goodnow (Goodnow, 1996), B cells are essentially “tuned” in their responsiveness 
to antigen and the outcome of encounter with antigen depends on the amount of 
stimulating antigen, the avidity of the receptor recognition, the timing of the 
exposure to the antigen as well as the level of co-stimulation the receptor receives. 
These factors contribute to the strength of signal from the BCR which determines 
the fate of the developing B cell.
Signal transduction from the BCR
Signal transduction from the BCR is essential for B cell responses to foreign 
antigens and for passage through development checkpoints during B cell 
development as discussed above. The immunoglobulin domain of the BCR has 
only a short cytoplasmic tail and relies on the Iga and Igp components of the 
receptor to elicit signalling responses (Cronin et al., 1998; Teh and Neuberger,
1997). One of the earliest events following receptor engagement is a rapid increase
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in Src-family protein tyrosine kinase (PTK) activity (Campbell and Sefton, 1990; 
Gold et al., 1990). The BCR itself does not have any intrinsic kinase activity and 
instead depends on the recruitment of kinases to the receptor. Specifically Lyn, Blk 
and Fyn Src-family kinases have been shown to be associated with the BCR, and to 
become phosphorylated and activated following BCR stimulation (Brown et al., 
1994; Burkhardt et al., 1991; Sefton and Taddie, 1994). Engageinent of the BCR 
by antigen results in the phosphorylation of immunoreceptor tyrosine-based 
activation motifs (ITAMs) with the consensus sequence YXXLg^YXXL (single 
letter amino acids code, X represents any amino acid) within the cytoplasmic 
portion of the Iga and IgP molecules by Src-family members (Thomas, 1995). The 
phosphorylated ITAMs act as docking sites for the SH2 domains of the Syk-family 
kinases. This binding leads to the activation of these kinases and to further 
downstream signalling events such as the activation of the Erk, INK and p38 
mitogen-activated protein (MAP) kinase pathways (Cambier et al., 1994). BCR 
antigen engagement is also associated with a rapid increase in the concentration of 
intracellular Ca^*. This response is driven by the activation of phospholipase C, 
which results in the hydrolysis of phosphoinositide lipids, and the production of the 
second messengers inositol -1,4,5-trisphosphate (IP3) and diacylglycerol (DAG). 
IP3  in turn binds to IP3  receptors in the endoplasmic reticulum leading to the release 
of Ca^^  from intracellular stores into the cytoplasm. In contrast DAG is thought to 
activate the serine/threonine protein kinase C (PKC) (Bazzi and Nelsestuen, 1989). 
The consequence of these signalling events is to ultimately alter the activity of many 
different transcription factors such as NF-AT, NF-kB and AP-1, leading to altered 
gene transcription activity which elicits a B cell response, whether that be activation, 
proliferation or apoptosis (May and Ghosh, 1998).
The signals emerging from the activated BCR are subject to negative 
regulation by ceU-surface proteins which include the IgG constant region receptor 
FcyRUB and the a2,6-sialoglycoprotein binding, immunoglobulin superfamily 
member CD22. These molecules contain tyrosine-based inhibitory motifs (iT'IMs) 
which contain the tyrosine phosphatase SHP-1/2 binding domain consensus 
sequence V/IXYXXL/V (Isakov, 1997; Unkeless and Jin, 1997). Co-aggregation
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of the BCR and FcyRUB inhibits BCR-mediated proliferation and antibody 
responses (D'Ambrosio et al., 1995). Moreover FcyRIIB-deficient mice have 
elevated responses to both T-dependent and T-independent antigens demonstrating 
the negative role of this molecule has on BCR signalling (Takai, 1996; Takai et al., 
1996). CD22 appears to function as a constitutive regulator of B cell function 
without requiring co-ligation with the receptor. CD22-deficient mice are found to 
have elevated serum Ig, enhanced BCR-mediated proliferative responses and 
increased Ca^^mobilisation on receptor stimulation (Nitschke et al., 1997; O'Keefe 
et al., 1996; Otipoby et al., 1996; Sato et al., 1996). The importance of SHP-1 in 
the negative regulation of receptor signalling is evident from the naturally occurring 
motheaten mice which have a defect in SHP-1 and show severe autoimmune disease 
(Tsui et al., 1993). SHP-1 has a negative effect on downstream signalling events 
such as inositol phospholipid hydrolysis and Ca^  ^ flux that occur on receptor 
stimulation, however its in vivo substrates are not known and therefore it is not 
clear how SHP-1 mediates its inhibitory effect (Unkeless and Jin, 1997). 
Coligating FcyRUB with the BCR has been used to study how the inhibitory 
signalling pathways interact with signals from the BCR. These studies demonstrate 
that these pathways integrate through phosphorylation events of CD 19. Receptor 
ligation normally causes the phosphorylation of CD19 and this is reversed by the 
recruitment of Fc^LEB to the receptor (Buhl and Cambier, 1997; Hippen et al., 
1997; Kiener et al., 1993). CD19 phosphorylation causes the association and 
activation of phosphatidylinositol 3- kinase (PI-3K). PI-3K activity results in the 
generation of phosphatidylinositol-3,4,5-trisphosphate (PIP3 ) which ultimately 
gives rise to the enhanced production of U* 3  by Fhe&fba Lipase Cy (PLCy) ^alasca 
et al., 1998; Scharenberg and Kinet, 1998). Thus CD19 dephosphorylation results 
in the termination of IP3  production and Ca^ "^  flux. In addition to the ability of 
Fc^RUB-l to recruit SHP-1 and SHP-2 which function to prevent the production of 
PIP3  it also recruits a PIP3  5*-phosphatase called SHIP whose function is to 
degrade PIP3  and therefore contribute to the inhibition of these signals.
The role of the Src-family members in membrane-proximal signalling events 
has been further analysed in mice deficient in these kinases. Lyn-deficient mice are
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found to have reduced numbers of peripheral B cells and alterations in 
phosphorylation patterns on receptor crosslinking support the proposed role for Lyn 
in receptor-proximal signalling events (Nishizumi et al., 1995). However, these 
mice also appear to have autoimmune responses in that they produce anti-DNA 
antibodies, have elevated serum IgM and IgA and display splenomegaly (Hibbs et 
al., 1995). In addition Lyn-deficient B cells are more sensitive to BCR-driven 
proliferation suggesting a role for Lyn in the negative regulation of signals from the 
BCR (Chan et al., 1997). Recent studies on B cells firom Lyn-deficient mice have 
shown that tyrosine phosphorylation of both FcyRUB and CD22 coreceptors are 
impaired and that this was associated with their failure to recruit SHP- 1  and SHIP 
explaining the hyper-responsiveness of the Lyn-deficient B cells (Chan et al., 1998; 
Nishizumi ct al., 1998). The loss of these negative regulatory functions would lead 
to increased signalling. In contrast to Lyn-deficient mice, Fyn-deficient mice appear 
to be unaffected in terms of BCR signal transduction as they have unaltered tyrosine 
phosphorylation, inositol hydrolysis and Ca^  ^ flux compared to control cells 
(Sillman and Monroe, 1994). This suggests that either Fyn plays a minor role in 
the signalling events firom the BCR or that in the absence of Fyn other protein 
kinases can substitute for Fyn activity. Mice deficient in the Src-family tyrosine 
kinase Blk have not been as yet been reported in the literature.
Briaton’s tyrosine kinase (Btk) is a member of the Tec-family of kinases and 
has been shown to have an important role in B cell signal transduction. Both 
humans with X-linked agammaglobulinemia (XLA) and mice with X-linked 
immunodeficiency {xid) have severe deficiencies in B cell function caused by 
mutations in Btk. The activation of Btk has been shown to require both PT-3K and 
a Src-family kinase (Aoki et al., 1994; Cheng et al., 1994; Kawakami et al., 1997; 
Rawlings et al., 1996; Satterthwaite et al., 1998; Yao et al., 1994) and its activation
results ill the phosphorylation and activation PLCy leading to downstream signalling 
events including calcium flux (Fluckiger et al., 1998; Scharenberg et al., 1998).
Syk-deficient mice die perinatally (Cheng et al., 1995; Turner et al., 1995). 
However, Syk-deficient B cell development has been studied by making radiation
chimeras reconstituted with foetal liver from these mice and has shown that B cell 
development is impaired with a profound block in the transition from immature to 
mature B cells as well as a partial block at the pro- to pre-B cell transition (Turner et 
al., 1997; Turner et al., 1995). These results are consistent with Syk playing a 
crucial role in signalling at both the pre-BCR and BCR during these developmental 
checkpoints.
1.3 T cell development and function
The T cell receptor structure and function
The TCR, like the BCR, is an oligomeric complex consisting of antigen 
binding and signal transduction units. The antigen binding domain of the receptor 
is a heterodimer of two transmembrane glycoproteins a and p (there are also y5 T 
cells which have a distinct function and will not be discussed here). The TCR a 
and p subunits have constant and variable regions that are similar to those of the 
BCR (von Boehmer and Fehling, 1997). The variable region of p subunit 
undergoes RAG-dependent somatic recombination events which join V, D and J 
segments whilst the a subunit is assembled by recombination of V and J segments 
which together generate diversity in TCR antigen specificity. In a similar maimer to 
the BCR, the TCR is also found as a complex with molecules required for 
signalling, namely CD3y, 6 , e chains and  ^and q that allow the T cell to become an 
armed effector cell (Cantrell, 1996).
T cell accessory molecules
T cells, like B cells, have molecules associated with their receptor that 
modulate its activity. The TCR coreceptor molecules are CD4 and CDS. These 
transmembrane glycoproteins aid ligand recognition by interacting with the MHC 
molecules during peptide presentation (Engelhard, 1994). Specifically CD4 binds 
to the p2 domain of MHC class II, whereas CDS binds to the a3 domain of MHC
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class I. CD4 is a single chain molecule composed of four extracellular 
immunoglobulin-like domains and a short intracellular domain involved in 
signalling. The CDS coreceptor is stmcturally very different from the CD4 
molecule. It consists of a disulphide-hnked heterodimer comprising a  and p chains 
which has an extended extracellular structure and a short cytoplasmic tail. The 
presence of either CD4 or CDS increases the sensitivity of a T cell to 
MHC-presented antigens by up to 100-fold (Zamoyska, 199S). These coreceptor 
and MHC interactions are required for T cell development as well as activation on 
encounter with antigen. Nfice deficient in MHC class I and class II have severely 
diminished T cell development (Grusby et al., 1993; 22jlstra et al., 1990), whilst 
mice deficient in either CD4 or CDS molecules are found to have severely deficient 
helper or cytotoxic function, respectively (Fung Leung et al., 1991; Killeen and 
Littman, 1993; RahemtuUa et al., 1993).
ap T cell development
T cell precursors migrate firom the bone marrow to the thymus where they 
develop into mature cells which enter the blood sfream and migrate to the peripheral 
lymphoid organs such as lymph node and spleen. T cell maturation in the thymus is 
distinguished by distinct stages of development characterised by the expression of 
CD4 and CDS (Roth and DeFranco, 1995)). Thymocytes develop from the least 
mature CD4CDS double negative (DN) thymocytes through an intermediate 
CD4^CDS^ double positive (DP) stage before maturing to either CD4* single 
positive (SP) or CDS  ^ SP cells prior to leaving the thymus to become mature 
recirculating T cells. Levels of expression of the adhesion molecule CD44 and 
CD25 on DN cells have been used to further define these immature thymocytes 
(Godfirey and Zlotnik, 1993; Nikolic-Zugic, 1991). The earliest T cell progenitors 
that enter the thymus are CD44^CD25 (DNl) cells. These cells are thought to come 
directly from the bone marrow and are no longer pluripotent but committed to 
lymphoid development. At this stage these cells still have their TCR genes in 
germline configuration. These cells next develop into CD44^CD25^ (DN2) cells
28
which have started transcription of the TCRp chain and rearrangement of D to J 
gene segments (Dudley et al., 1994). T lymphocytes now become CD44'CD25^ 
(DN3) and finally CD44CD25 (DN4) thymocytes prior to leaving the DN 
compartment. DN3 thymocytes have undergone V-D-J recombination at the TCRp 
locus which is expressed on the cell surface with the pre-Ta chain (pTa) to form the 
pre-T cell receptor (pre-TCR) (Saint-Ruf et al., 1994) this provides a signal for the 
cell to start rearrangement of the TCRa chain. In this way pTa is thought to act in a 
similar manner to SL chain in B cell development. The role of CD25 and therefore 
IL-2 during progression through the DN compartment of T cell development is not 
clear as IL-2 deficient mice have normal thymus development (Sadlack et al.,
1993). The IL-2 receptor y chain, however, is shared by a number of cytokine 
receptors (IL-4R, IL-7R, IL-9R and IL-15R) and is usually referred to as the 
common y chain (yc). Mice expressing a truncated yc chain have a profound block 
in T cell development at the DN stage (Crompton et al., 1997; Ohbo et al., 1996). 
Moreover mice deficient in IL-7 expression also display a similar block in 
development (Peschon et al., 1994). This may suggest that IL-7 signalling through 
yc may be an important aspect of T cell development.
The earliest known checkpoint in thymic development occurs in the DN 
thymocyte population at the DN3 stage of development. As described earlier, these 
thymocytes have rearranged on of their TCR p alleles and expressed it on the cell 
surface with the pTa subunit to form the pre-TCR. Normally, formation of a 
functional pre-TCR leads to the prevention of rearrangement of the second TCR p 
chain alleles leading to allelic exclusion in a similar manner to that seen with 
pre-BCR (Aifantis et al„ 1997). Production of a functional pre-TCR is required 
for further T cell development. RAG-1 or 2-deficient mice which are unable to 
rearrange their TCR p alleles, and mice deficient in TCRp fail to make a functional 
pre-TCR and show a block at this stage of development. Mice deficient in pTa also 
show a profound block at the DN3 stage of thymocytes development as well as a 
breakdown in the process of allelic exclusion (Aifantis et al., 1997; Fehling et al.,
1995), again demonstrating a necessity for the production of a functional pre-TCR 
in these processes. In a similar manner to B cell studies, mice deficient in TCR
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coreceptor molecules have been assessed for T cell development and function. 
CD3e-deficient mice are found to have a complete block in T cell development at the 
DN3 stage suggesting this molecule is required for the signal transduction from the 
pre-TCR (Malissen et al., 1995).
Further development from DN thymocytes into DP cells is associated with 
migration of thymocytes to the thymic cortex and rearrangement of the TCRa 
genes. As these DP thymocytes mature, TCRap gene expression increases and 
these cells undergo a positive selection process that only allows further development 
of those thymocytes expressing functional and non-autoreactive receptors into CD4^ 
SP or CD8  ^ SP cells (Jameson et al., 1995; von Boehmer, 1991). Positive 
selection and commitment to the CD4 and CD8  lineage is determined by the affinity 
of interactions between the TCR and peptides presented by MHC class I and class II 
molecules on thymic stromal cells (Ashton-Rickardt and Tonegawa, 1994; Williams 
et al., 1997). This selects those cells that have some affinity for peptide presented 
by self-MHC. As will be discussed later, the affinity of these interactions is 
important in determining the outcome of these selection events. It is thought that 
during this process thymocytes randomly down-regulate either CD4 or CD8  and 
that tills is followed by a step that requires participation by the appropriate 
coreceptor that permits end stage differentiation (Chan et al., 1993; von Boehmer,
1996). Mice deficient in TCRa chain fail to develop CD4^ SP or CD8  ^ SP 
thymocytes demonstrating the necessity for a functional TCR for transition between 
DP and SP stage of thymic development (Fehling et al., 1995; Mombaerts et al.,
1992). This is a developmental checkpoint akin to the need for functional L chain 
rearrangement during B cell development. TCRa chain rearrangement from one 
allele and the production of a functional TCR is thought to suppress recombination 
at the second allele in a similar manner to L chain allelic exclusion in B cells. 
However, it has been found that 30% of mature T cells have two functional 
rearrangements and therefore have two receptors suggesting that TCRa allelic 
exclusion may not be complete (Kisielow and Miazek, 1995; Malissen et al., 1992).
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T cells and autoantigens
T cell development, like B cell development, requires the depletion of those 
cells that recognise self antigen to avoid autoimmune disease. T cells undergo these 
negative selection events predominantly by clonal deletion of immature thymocytes. 
These events have best been studied by the use of TCR transgenic mice. A number 
of transgenic mouse models exist that express either MHC class I- or class IE- 
restricted rearranged TCRs and their cognate ligands. T cell clonal deletion occurs 
in these mice at the DP stage of T cell development by apoptosis (Arnold et al., 
1990; Mamalaki et al., 1993; Nakayama et al., 1992; Page et al., 1993; Shinkai et 
al., 1993). As signalling through the same TCR can drive either positive or 
negative selection at the this stage of development, a model has been proposed to 
explain this process based on the avidity of the receptor for peptide ligands 
presented to the thymocyte by APCs in the thymic stroma (Ashton-Rickardt and 
Tonegawa, 1994). The avidity of the interaction is determined by the affinity of the 
interaction of the receptor and the peptide as well as the concentration of the peptide. 
In the avidity model, thymocytes with TCRs interacting with a low avidity to the 
selecting peptide/MHC (S/M) complex are positively selected and rescued from the 
default fate of death by neglect whilst TCRs that have a strong avidity with the S/M 
complex (because of a high affinity interaction and/or high concentration of 
selecting peptide) are induced to delete. Foetal thymic organ cultures from mice 
expressing a transgenic receptor (P14) with specificity for lymphocytic 
choriomeningitis (LCMV) glycoprotein in association with MHC class I H-2D*’ 
molecule, positively select CD8 * cells when the level of peptide expression is 
relatively low whilst expression at higher density causes negative selection to occur 
(Ashton-Rickardt and Tonegawa, 1994). More recently a transgenic mouse 
expressing a TCR that has different affinities to peptides derived from different 
MHC class I molecules has been studied. Here, peptides with low affinity for the 
receptor could induce negative selection if the ligand was expressed at high 
concentration, supporting the avidity model (Motyka and Teh, 1998). T cells differ 
from B cells in that they must recognise antigenic peptides in the context of MHC
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molecules, and the TCR accessory molecules CD4 and CD8  are crucial in this 
interaction. Both CD4 and CD8 -deficient mice have been found to be defective in 
negative as well as positive selection demonstrating a crucial role for these 
molecules in thymic selection events (Fung-Leung et al., 1991; Wallace et al.,
1992). Moreover transgenic mice expressing MHC class I that has a mutation in the 
CD8  binding domain, bred to express a class I-restricted TCR, fail to undergo 
negative as well as positive selection demonstrating a crucial role for MHC and 
accessory molecule interactions during negative as well as positive selection (Fung- 
Leung et al., 1991).
T cells also undergo clonal deletion in response to superantigens (Simpson 
et al., 1993). There are two categories of superantigens, the viral superantigens 
encoded by the long terminal repeats (LTR) of endogenous mouse mammary 
tumour viruses (MMTV), and the soluble endotoxins produced by gram-positive 
bacteria such as Staphylococcus aureus. TCR recognition of conventional peptides 
involves presentation by MHC molecules and their recognition by the variable 
regions of both the a and p chains of the TCR (Webb and Gascoigne, 1994). 
Superantigen recognition, on the other hand depends primarily on binding to Vp and 
MHC class n  molecules outside the peptide binding domains (Webb and 
Gascoigne, 1994). In this way, expression of superantigens can lead to the 
stimulation of antigen receptors bearing particular Vp chains. Originally called 
minor lymphocyte stimulating (Mis) antigens, different inbred strains of mice are 
known to have different MMTV proviral expression patterns (Webb and Gascoigne,
1994). As these MMTV superantigens are essentially autoantigens in these mice, 
they lead to the negative selection and clonal deletion of particular Vp-expressing 
cells during their development, depending on which Vp a given MMTV 
superantigen binds. For example the BALB/c mouse strain expresses endogenous 
MMTV 6 , 8  and 9, which causes the deletion in the thymus of T cells expressing Vp 
3,5,11 and 12 (Simpson et al., 1993). Bacterial endotoxin superantigens act in a 
similar manner to endogenous proviral superantigens in their interactions with the 
receptor (Marrack and Kappler, 1990). A number of different endotoxin antigens 
exist that differ only slightly in structure but have distinct specificity’s for different
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vp domains. Treatment of mice with these exogenous superantigens results in 
MHC class n-dependent Vp-specific deletion of thymocytes (Marrack and Kappler, 
1990). The deletion of these Vp expressing T cells occurs at the SP stage of 
thymocyte development rather than at the DP stage where T cells are deleted on 
encounter with conventional autoantigens (Marrack and Kappler, 1990).
Like .B cells, mature T cells that encounter autoantigen in the periphery have 
mechanisms to prevent the development of autoimmune disease. Indeed all the 
phenomena associated with B cell encounter with peripheral autoantigen have been 
demonstrated in T cells. Transgenic mice expressing TCRs of known specificity 
crossed to mice expressing cognate ligand under the control of a tissue-specific 
promoter have been used to study this process. Mice expressing a transgenic TCR 
specific for H-2 K^  crossed with mice in which H-2K*’ is expressed exclusively on 
hepatocytes demonstrates that the expression of autoantigen can lead to peripheral 
antigen tolerance of T cells by clonal anergy (Motyka and Teh, 1998). Other 
transgenic mouse models have demonstrated that T cells can develop clonal 
ignorance to the antigen (Berber et al., 1994) or demonstrate clonal deletion of 
autoreactive T cells (Carlow et al., 1992).
Signal transduction from the TCR
Signal transduction events from the TCR to the nucleus are necessary for 
both responses to foreign antigen and for passage through checkpoints during 
thymocyte development (Owen and Venkitaraman, 1996). An early event on TCR 
activation is a rapid increase in tyrosine kinase activily that is essential for 
downstream signalling events (Weiss and Littman, 1994; Zenner et al., 1995). The 
TCR itself does not have any intrinsic enzymatic activity but rather, when activated, 
recruits specific PTKs to the receptor complex via the conserved ITAMs present in 
the CD3 Y, 6  and z subunits and Ç chain of the TCR complex (Qian and Weiss, 
1997). Following TCR activation, Src-family tyrosine kinases Lck and Fyn have 
been shown to phosphorylate the ITAMs present in CD3 and Ç (Zenner et al..
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1995). Once phosphorylated, the ITAMs allow the binding of the Syk-family 
tyrosine kinase ZAP-70, via its tandem SH2 domains to twin phosphorylated 
tyrosines in the  ^chain of the activated receptor. This binding in turn allows for the 
subsequent tyrosine phosphorylation of ZAP-70 by Lck and its activation. In turn 
ZAP-70 may phosphorylate and activate a number of other proteins involved in the 
signalling pathway including Vav, an exchange factor for the Rho-family GTPases 
that has been shown to interact with multiple other components of signal 
transduction pathways (Zhang et al., 1998). Activation of the TCR leads to a 
number of downstream signalling events that are similar to those discussed earlier 
for BCR signalling and include hydrolysis of inositol-containing phospholipids, 
Ca^  ^mobilisation and activation of the Ras/MAPK pathways (Qian and Weiss, 
1997). These pathways ultimately lead to alterations in the activities of transcription 
factors, changes in gene expression patterns and altered cellular function.
The role of the Src-family kinases in membrane-proximal signal 
transduction has been further characterised in mice deficient in these molecules. 
Lck is known to associate with the cytoplasmic domains of both CD4 and CD8  as 
well as the p chain of the IL-2 receptor (Barber et al., 1989). Mice deficient in Lck 
show a deficient in T cell development (van Gers et al., 1996). They have a partial 
block at the DN3 compartment of T cell development, suggesting that Lck 
transduces some of the signals from the pre-TCR. This block is not complete and 
some DP cells develop, however very few SP T cells are detectable in these mice 
suggesting that Lck is also involved in the transduction of signals during the 
positive selection events that lead SP T cell development. Fyn-deficient mice on the 
other hand do not display any defect in T cell development although thymocytes 
from these mice do have signal transduction deficits such as reduced Ca^  ^flux and 
proliferation (Appleby et al., 1992; Stein et al., 1992). This is not the case in 
peripheral mature Fyn-deficient T cells (Appleby et al., 1992) suggesting that a 
different signal transduction mechanism may be used during T cell development 
Mice deficient in both Lck and Fyn show a more profound block than that seen in 
Lck-deficient mice alone (Groves et al., 1996). Here thymocyte development is 
completely blocked at the DN3 con^artmenf of thymocyte development such that
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now the thymus of these mice are identical to RAG-deficient mice (Groves et al., 
1996; van Gers et al., 1996). These results indicate that Lck plays an important role 
in the signal transduction events from the pre-TCR and that Fyn can partially 
substitute for Lck in its absence, but that at least one of these kinases must be 
present in order to generate a pre-TCR signal.
T cell development in mice deficient in ZAP-70 is blocked at the DP stage 
demonstrating a need for ZAP-70 signalling during thymic positive selection of 
CD4^SP and CD8  ^SP but not at earlier stages in development (Gong et al., 1997; 
Negishi et al., 1995). In addition thymocytes from ZAP-70 deficient mice are also 
deficient in negative selection, a result consistent with a role for ZAP-70 in signal 
transduction during both positive and negative selection events (Negishi et al.,
1995). Syk, the other Syk-family member is also expressed in the T cell lineage, 
however Syk-deficient naice show no abnormality in T cell development or fimction 
(Turner et al., 1995). A role for Syk in T cell development has been resolved by 
the analysis of mice deficient in both Syk and ZAP-70 (Cheng et al., 1997). These 
mice have a complete block at the DN3 stage of thymocyte development. Moreover 
over-expression of Syk in ZAP-70 deficient mice restores thymocyte development 
(Gong et al., 1997). Together this suggests that Syk and ZAP-70 have overlapping 
redundant roles in pre-TCR signalling.
T cell development in mice deficient in Vav also demonstrate deficiencies in 
TCR signaUing-dependent thymic selection events (Turner et al., 1997). 
Thymocyte development is partially blocked at the DN3 stage of development and 
there is a more profound block at the transition from DP to CD4^ SP and CD8  ^SP 
cells. Moreover therc is a defect in both positive and negative selection of 
thymocytes. Thus Vav has a role in the signal transduction events from both the 
prerTCR and the TCR that are required during T cell development.
In a similar manner to regulation of signalling through the BCR, TCR 
signalling is also subject to negative regulation. The best studied of this is the 
negative regulation of TCR signalling by cytotoxic T-lymphocyte antigen-4 
(CTLA-4). CTLA-4 shares with CD28 the ligands B7-1 and B7-2, and indeed
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these molecules may compete to bind to these ligands (Linsley et al., 1994; 
Thompson, 1995). CTLA-4 plays an inhibitory role in the signal transduction 
events by recruitment of the SHP-2 phosphatase to the receptor after 
phosphorylation of a conserved YVKM (single-letter amino acid code) SH2 binding 
site (Thompson and Allison, 1997). Mice deficient in CTLA-4 have a 
lymphoproliferative disorder, moreover T cells from these mice have been shown to 
have constituitively active Fyn, Lck and ZAP-70 kinases (Chambers et al., 1997). 
Nevertheless exactly how CTLA-4 mediates its biological effect and its role in the 
control of signal transduction during antigen encounter is still controversial 
(Thompson and Allison, 1997). T cells are also known to express ITIM containing 
transmembrane proteins such as the küler cell inhibitory receptors (KIRs) (Isakov,
1997). In humans these molecules, which belong to the Ig superfamily, are 
expressed on both NK and T cells and bind specifically to MHC class I molecules. 
In a similar manner to the negative regulation of the BCR by FcyRUB-1, KIR 
rriMs become phosphorylated when the KIR is co-ligated with the receptor and this 
leads to the recruitment of the SHP-1 phosphatase. Motheaten mice, which have a 
deficiency in SHP-1, exhibit increased proliferative response to TCR. stimulation, 
and have enhanced and prolonged TCR-induced tyrosine phosphorylation of both 
the TCR complex and cytosolic signalling proteins (Pani et al., 1996), 
demonstrating the importance of this protein in modulating signalling from the 
receptor.
1.4 The role of CD45 in the immune response
CD45 structure: the extracellular domain
CD45 (also called T2(X), B220, Ly-5 or leukocyte common antigen; Figure 
1) is an abundant 180-220kD transmembrane protein tyrosine phosphatase that is 
expressed on all nucleated haemopoietic cells where it can comprise of up to 1 0 % of 
the cell surface membrane (Alexander, 1997). It has an elongated receptor-like
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extracellular domain that is highly glycosylated and sulphated (Giordanengo et al., 
1995; Sato et al., 1993). At least eight different isoforms of CD45 exist due to the 
alternative splicing of three variable exons (exons 4, 5 and 6 ) encoding parts of the 
extracelluar domain of the protein (Chang et al., 1991; Saga et al., 1990). Isoforms 
recognised by monoclonal antibodies specific for epitopes within exons 4, 5 and 6  
arc designated CD45RA, RB and RC respectively (Alexander, 1997). A further 
antibody specificity exists that recognises an epitope in human CD45 that is created 
only m the absence of these three epitopes; the isoform recognised by this antibody 
is called CD45RO. No equivalent antibody exists for mouse CD45. Different 
CD45 isoforms are known to be expressed on different T cell subsets. In mice, for 
example, expression of the CD45RB isoform is associated with previously 
activated/memory T cells whilst the CD45RA isoform is expressed by naive T cells 
(Thomas and Lefrancois, 1988). B cells in contrast only express a high molecular 
weight isoform of CD45 known as B220, which is antigenically distinguishable 
from isoforms expressed on T cells ((Thomas and Lefrancois, 1988). The true 
biological significance of these different isoforms is not understood as, despite its 
resemblance to known receptors, no specific ligands for CD45 isoforms have been 
identified. The only CD45 ligand that has been proposed is the B cell specific 
molecule CD22 which was initially shown to interact specifically with the CD45RO 
isoform (Stamenkovic et al., 1991). Later experiments however, have shown that 
CD22 is a lectin that interacts with a wide range of glycosylated proteins including 
all isoforms of CD45, not just with CD45R0 (Powell et al., 1993; Sgroi et al.,
1993).
One possible role for the extracellular domain of CD45 is that it may interact 
with cell membrane molecules in cis (i.e. on the same cell). There is evidence that 
CD45 interacts with the TCR (Volarevic et al., 1990), the coreceptors CD4 and 
CD8  (Mittler RS, 1991), the B cell receptor (Brown et al., 1994), GDI 6  (Altin et 
al., 1994) and CD26 (Torimoto et al., 1991). However, given the abundance of 
CD45 on the cell surface it is unclear whether these interactions are of physiological 
significance.
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In the absence of a convincing demonstration of a physiological ligand for 
CD45, monoclonal antibodies (mAb) reactive to the extracellular domain of CD45 
have been used to study the consequences of an extracellular stimulus. The results 
of many of these studies have been confusing since the effects of the mAbs are 
epitope specific. For example certain CD45 mAbs that recognise all isoforms of 
CD45 (anti-panCD45 mAb) exert either no effect or a negative effect on TCR 
mediated signalling (Goldman et al., 1992), whilst a monoclonal that recognises a T 
cell specific CD45 isoform can exert a positive effect (Torimoto et al., 1992). 
Moreover, certain anti-panCD45 mAb have been found to exert a positive effect on 
TCR signalling in CD45RA*  ^but not CD45RO‘*‘ cells (Welge et al., 1993), whilst 
other studies have shown CD45 mAbs to have an inhibitoiy effect on CD4^ but not 
CD8  ^T cell lines (Maroun and Julius, 1994). This suggests that responses to these 
mAbs may be different depending on the differentiation and activation state of the T 
cells.
CD45-deficient T cell lines are defective in many receptor-mediated 
signalling events (Alexander, 1997). Transfection of full length CD45 back into T 
cell lines have been shown to restore the signalling capability of these cells 
suggesting CD45 plays a positive role in signal transduction events (Koretzky et al., 
1992; Shiroo et al., 1992). Transfection using mutant forms of CD45 that lack the 
extracellular domain of CD45 was also found to restore receptor-mediated signalling 
suggesting that the extracellular domain of CD45 is not required for its function 
(Desai et al., 1993; Donovan et al., 1994; Hovis et al., 1993; Volarevic et al.,
1993). Moreover when a chimeric molecule was made joining the intracellular 
portion of CD45 to the extracellular domain of the epidermal growth factor receptor 
(EGFR) whose ligand (EGF) is known, addition of the ligand inhibits TCR signal 
transduction (Desai et al., 1993), suggesting that if a physiological ligand for CD45 
exists then its role may be inhibitory. EGFR binding to its ligand causes 
dimérisation of the receptor and its activation. The inhibition of CD45 activity on 
EGF binding is due to steric inhibition of these molecules on ligation. As will be 
discussed later the tertiary structure of the phosphatase domains of CD45 are known 
and this has aided our understanding of the nature of this inhibition (Bilwes et al.,
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1996). Some CD45 has been detected in a dimeric form on the surface of cell lines, 
suggesting that dimérisation may be an important event for CD45 regulation 
(Takeda et al., 1992). Whether or not this is a physiologically important 
mechanism for CD45 regulation will only be solved if a physiological ligand for 
CD45 is identified.
Despite our lack of knowledge of the function of these different isoforms of 
CD45 in extracellular interactions, they clearly play different roles. Expression 
studies in CD45-deficient cell lines have been used to demonstrate that different 
CD45 isoforms can differentially control levels of receptor signalling. One of the 
best studies of this issue used transfection of different CD45 isoforms (CD45RO, 
ÇD45RABC, CD45RBC and CD45RQ together with CD4 and a TCR that 
recognises HEL into a CD4'TCR'CD45 T cell line (Novak et al., 1994). The ability 
of these cell lines to respond to TCR stimulation was evaluated. It was found that 
those isoforms that have the lowest molecular weight (CD45RO and CD45RC) are 
more efficient at promoting antigen recognition via the TCR than higher molecular 
weight isoforms. This is in agreement with a proposed role for the extracellular 
domain of CD45 in the physical interactions of T cells during antigen recognition 
and binding (Shaw and Dustin, 1997). The extracellular domain of CD45 extends 
28-51 nm from the surface of a T cell which is considerably further than the TCR. 
Therefore the physical presence of CD45 would interfere with TCR and 
MHC/peptide interactions and it must therefore be excluded to allow these 
interactions. As will be discussed later this physical exclusion of CD45 during 
TCR interactions has implications on the role of CD45 during TCR signal 
transduction events.
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Figure 1 : Schematic diagram of the CD45 protein. CD45 is a
transmembrane molecule. Tfre extracellular domain is large and highly 
glycosylated. Different isoforms of CD45 exist due to the differential splicing of 
three exons (exons 4, 5 and 6 ) which allows the presence or absence of the 
CD45RA, B or C epitopes (shaded boxes). After the membrane spanning region 
(black box) is the intracellular portion which contains the phosphatase domains of 
which domain 1 (Dl) catalyses the phosphatase reaction whilst domain 2 (D2) is 
important in providing the correct tertiary structure for this reaction.
CD45 structure: th e . intracellular phosphatase domains
The intracellular portion of CD45 is composed of two homologous protein 
tyrosine phosphatase (PTP)-like domains called Domain 1 and 2 (Dl and D2, 
Figure 1) separated by a short spacer region and a C-terminal tail (Alexander,
1997). Dl contains the FTP active site signature motif [V/I]HCXAGXGR[S/T]G 
(single letter amino acid code where X is any amino acid) found to be present in all 
PTPs. It contains a critical cysteine residue (Cys®^ *) necessary for the 
dephosphorylation reaction (Streuli et al., 1990). D2, although sharing much
homology with Dl, does not contain the PTPase active site motif arid does not itself 
have intrinsic phosphatase activity (Johnson et al., 1992; Streuli et al., 1990). 
There is a lot of evidence that argues for a structural requirement of D2 to provide 
the correct structure to allow phosphatase activity from Dl. Firstly, in experiments 
where D2 has been removed, this deletion severely reduces the phosphatase activity
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of CD45 (Streuli et al., 1990). Secondly, mutation of various conserved residues 
in D2 either severely inhibits or completely abrogates CD45 activity (Johnson et al., 
1992). Finally, deletion of the spacer region between the domains ablates CD45 
activity (Ng et al., 1995). Together this suggests the importance of the spatial and 
structural integrity of D2 is required for optimal phosphatase activity of Dl.
Recently the tertiary structure of a dimer of CD45 phosphatase Dl has been 
solved (Bilwes et al., 1996). The structure of this dimer showed that each domain 
formed a wedge-like structure that protruded into the phosphatase catalytic site of 
the other domain. This is particularly interesting as it could explain the inhibition of 
CD45 activity by ligand-driven dimérisation, as seen in the EGFR/CD45 chimera 
studies discussed above. Two acidic residues within the wedge domain are found 
to be highly conserved. A cell line has been created containing an EGFR/CD45 
chimeric molecule with a mutation of one of these conserved residues from a 
glutamate residue at position 624 of CD45 to alanine or arginine (Majeti et al.,
1998). These mutated molecules did not show reduction in phosphatase activity on 
EGF dimérisation. This is presumably due to these mutated molecules having an 
altered tertiary structure that prevents the interaction of the inhibitory wedge with the 
phosphatase domain. This supports the idea of ligand induced inhibition of 
phosphatase activity by dimérisation and could be a general mechanism of 
regulation of all FTP family members.
CD45 genomic structure
CD45 is encoded by a single gene (Cd45) on chromosome 1 in both mouse 
and man. It is composed of 34 exons stretching across approximately 1 lOkb of 
DNA (Saga et al., 1988). Transcription is initiated from either of two exons, la 
and lb which together with exon 2  encode the 5’ untranslated region of the gene. 
The functional significance of the alternative initiation sites is not clear but they are 
not used in a cell-type specific maimer. Exons 3 to 15 encode the extracellular 
domain of CD45 and includes the alternatively-spliced exons 4,5 and 6 . Exons 3-8
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encodes for amino-acid sequences rich in serine, threonine and proline amino acids 
characteristic of 0-linked glycosylation sites. Exon 16 encodes the membrane 
spanning region whilst exons 17-33 encode the cytoplasmic domain and 3’ 
untranslated region.
CD45 and signal transduction in T cells
As discussed earlier, in vitro studies of CD45 mutant cell lines has, in 
general, indicated a positive role for CD45 in TCR signalling. Both CD4^ and 
CD8  ^ CD45-deficient murine T cell clones are defective in both antigen-induced 
proliferation and IL-2 secretion while CD45-expressing revertants regained these 
abilities (Pingel and Thomas, 1989; Weaver et al., 1991). Moreover, 
CD45-deficient leukemic T cell lines have been found to be deficient in TCR- 
induced tyrosine phosphorylation, Ca^ * mobilisation, and PKC activation (Koretzky 
et al., 1992; Koretzky et al., 1990; Shiroo et al., 1992). All these features of signal 
transduction were restored on transfection of a cDNA encoding a phosphatase active 
CD45 (Desai et al., 1993; Hovis et al., 1993; Volarevic et al., 1993). Together 
these results clearly point to an absolute requirement for CD45 to maintain 
functional TCR signal transduction pathways in these cells.
A possible explanation for the regulation of TCR signal transduction by 
CD45 was found by studying the phosphorylation events that control the activity of 
the Src-family tyrosine kinases Lck and Fyn. Lck and Fyn are inactive when 
phosphorylated on a COOH-terminal tyrosine residue (Tyr °^  ^ in Lck and Tyr^^ in 
Fyn) because of an intramolecular binding of this phosphotyrosine to the SH2 
domain of the kinase (Qian and Weiss, 1997). When these negative regulatory 
tyrosines are dephosphorylated, the conformation of the kinases is altered and they 
autophosphorylate another regulatory tyrosine (Tyr^^ for Lck and Tyr' '^  ^ of Fyn) 
leading to the full activation of the kinase activity (Qian and Weiss, 1997). Studies 
in CD45-deficient murine lymphoma as well as human cell lines have demonstrated 
that Lck and Fyn are both hyperphosphorylated at the negative regulatory tyrosine
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residues and therefore could suggest they are inactive (Hurley et al., 1993; 
Ostergaard et al., 1989; Sieh et al., 1993). Thus the failure of TCR signal 
transduction in CD45-deficient T cells could be due to the failure to activate these 
Src family kinases. When the kinase activity of Lck and Fyn has been assayed 
directly from CD45-deficient cell lines and compared to wildtype cells, conflicting 
results have been obtained depending on the cell lines studied. For example, one 
study found no differences in Lck or Fyn activity in a CD45-deficient murine T cell 
lymphoma compared to controls (Hurley et al., 1993), others found either an 
increase in Fyn activity but no change in Lck activity when CD45-deficient 
HPB-ALL cells were transfected with a cDNA for CD45 (Shiroo et al., 1992) and 
finally it has been reported that in a CD45-deficient T-leukaemia cell line (CB-1) 
there are increases in Lck activity without changes in Fyn activity (Biffen et al.,
1994). The reason for this confusion could arise from the fact that there may be 
different pools of these Src-family members, with only those proximal to the 
receptor being responsible for transduction of signals firom it (Biffen et al., 1994). 
Thus the activity of the receptor associated pool of Src-family kinase activity may be 
masked when total cellular activity is measured. As discussed earlier, 
phosphorylation of the negative regulatory tyrosine of Lck and Fyn allows an 
intramolecular interaction between the SH2 domains and this phosphorylated 
residue which inhibits their kinase activity (Sieh et al., 1993). These changes in 
conformation have been utilised to study the activity states of Lck and Fyn by using 
a synthetic peptide that can bind to the SH2 domain of Src family kinases (Sieh et 
al., 1993). The SH2 domain becomes inaccessible to the peptide when these 
kinases are in an inactive conformation as the SH2 domain is bound to the negative 
regulatory phosphotyrosine. This peptide was used to probe the molecular structure 
(and therefore the activity state) of Src family kinases in CD45-deficient cell lines 
and compared to control cells. These studies showed that the amount of active Lck, 
but not Fyn, is dependent on CD45 (Sieh et al., 1993). Another study was 
designed to look at receptor-associated pools of Src family kinase activity (Biffen et 
al., 1994). This study was conducted in a CD45-deficient sub-clone of the CB-1 T 
cell line where the total Lck and Fyn kinase activity were similar or higher than
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control levels. When the activity of Lck and Fyn associated either with the receptor 
or coreceptor was assayed it was considerably reduced compared to controls, 
suggesting that the role of CD45 is to selectively regulate the pools of these kinases 
which are in close proximity to the receptor.
Although most CD45-deficient cell lines cannot undergo receptor-mediated 
signalling, intriguingly there is one example of a CD45-deficient T cell line that is 
still able to signal through its antigen receptor (Chu et al., 1996). This line was 
found to be unusual in that it expressed the PTK Syk, whereas 
signalling-incompetent CD45-deficient lines do not (Chu et al., 1996). Comparison 
of both signalling-competent and incompetent CD45-deficient cell lines found that in 
both of these lines Lck was in an inactive conformation, Csk activity was 
equivalent, as was TCR-Ç chain phosphorylation. Subsequent transfection of Syk 
into the signalling-incorhpetent CD45-deficient cell line restored TCR signalling 
(Chu et al., 1996). This suggests that TCR signalling can proceed in a CD45- and 
Lck-independent manner through Syk.
More recently, a role for CD45 as both a positive and negative regulator of 
Src-family kinase activity has been proposed (Shaw and Dustin, 1997). As 
discussed earlier, the TCR (and indeed the MHC) is a relatively small molecule 
compared to CD45 extending only 15nm from the cell surface compared to CD45 
whose span is 28-51 nm. Removal of CD45 from the vicinity of the receptor could 
therefore be necessary for TCR/MHC interactions to occur. In resting T cells most 
Lck molecules are in fact dephosphorylated at both the negatively regulating residue 
Tyr^^ and the activating residue Tyr^^ (Alexander, 1997). CD45 may be 
responsible for maintaining the dephosphorylated state of Src-family kinases. 
Figure 2 shows this model of Src-family kinase regulation using Lck as an 
example. Dephosphorylation of Lck at Tyr °^  ^ by CD45 allows the kinase to 
autophosphorylate Tyr^^ and become kinase active. CD45 may also be responsible 
for the déphosphorylation of Tyr^^ returning the kinase to a “primed” 
dephosphorylated state. Indeed Csk, has the ability to phosphorylate the negative 
regulatory tyrosine of Lck and therefore to inactivate it. Thus the activity of
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Src-family kinases, and therefore downstream signalling events, could be controlled 
by the relative activities of CD45 and Csk (Okada et al., 1991). Exclusion of CD45 
from the receptor con^lex during antigen recognition would mean that both the 
recruitment of inactivated kinases to an active state and inactivation of kinase in an 
active state would fail to occur (Rodgers and Rose, 1996). As most Lck in a cell is 
in the “primed” state this could favour the accumulation of active Lck
Csk
CD45
CD45?
active 
Lck
,394
Autophosphorylation
505
Figure 2: Proposed model for the regulation of Lck activity. Lck is
inactive when phosphorylated on a negative regulatory tyrosine CD45 can
dephosphorylate this tyrosine residue allowing autophosphorylation on a second 
activating tyrosine (on Y^ ®^ ). Once activated Lck could phosphorylate ITAMs 
present in the TCR/CD3 complex allowing the binding and activation of ZAP-70 
and downstream signal transduction events. CD45 may also be responsible for the 
dephosphorylation of Y^^ such that CD45 is in a primed state whereby the tyrosine 
kinase Csk can phosphorylate Lck on its negative regulatory tyrosine and therefore 
inactivate it. A similar mechanism may apply to other Src-family kinases.
CD45 and signalling in B cells
Less is known about the role of CD45 in BCR signalling compared to T cell 
signalling although some studies have been conducted using CD45-deficient B cell 
lines. In a CD45-deficient subclone of the plasmacytoma cell line J558Lpm3, BCR 
ligation no longer triggered Ca^ * influx, Ras activation, PLC activation and ERK
MAP kinase activation (Justement et al., 1991; Kawauchi et al., 1994), clearly 
demonstrating a positive role for CD45 in these events. In contrast BCR ligation in 
a CD45-deficient WEHI-231 derived immature B cell line resulted in prolonged 
Ca^  ^signalling and increased receptor mediated apoptosis suggesting that in this cell 
line CD45 maybe acts as a negative regulator of BCR signalling (Ogimoto et al.,
1994). These difference may be dependent on the stage of maturation of the B cell 
or reflect peculiarities of transformed ceU lines.
CD45 is thought to play a similar role in B cells in regulating Src-family 
kinases in B ceUs as it does in T cell activation. Of the Src-family tyrosine kinases 
associated with signalling from the BCR, CD45 has been shown to be physically 
associated with Lyn but not Blk or Fyn (Brown et al., 1994). Moreover, Lyn 
activity is dysregulated in CD45-deficient B cell lines (Katagiri et al., 1995), 
suggesting a requirement for CD45 for the functional activity of this Src-family 
kinase. In a similar manner to studies on the phosphorylation patterns of Lck in 
CD45-deficient T cell lines, Lyn has been found to be hyperphosphorylated on both 
the negative regulatory tyrosine and on the autophosphorylated tyrosine associated 
with Lyn activation (Yanagi et al., 1996).
CD45 Associated protein
Most of the CD45 in lymphocytes exists in a complex with a 
lymphocyte-specific protein called CD45 associated protein (CD45-AP). CD45 and 
CD45-AP have been shown to specifically bind each other via their transmembrane 
domains. A role for CD45-AP in signal transduction has been recently revealed by 
the creation of mice deficient in CD45-AP (Matsuda et al., 1998). These mice have 
normal lymphocyte development however they have deficiencies in both 
lymphocyte proliferation and signalling. When the amount of Lck physically 
associated with CD45 was assayed using immunoprécipitation and Western blotting 
using control T cells the Lck/CD45 ratio was found to rise after receptor 
cross-linking. In CD45-AP-deficient T cells the basal Lck/CD45 ratio was much
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lower than in control T cells and it did not increase on receptor stimulation. This has 
lead to the suggestion that CD45-AP directly or indirectly mediates the CD45/Lck 
interaction and it is a defect in this interaction that explains the failure of signal 
transduction events in the absence of CD45-AP. As yet no information has been 
published on the phosphorylation status of the Src-family kinases in these mice.
CD45-deficient mice
The first published CD45-deficient mouse strain created by homologous 
recombination in ES cells was mutated in exon 6  of the Cd45 gene 
(Cû?45” ®'“ ‘^ )(Kishihara et al., 1993). Exon 6  is one of the differentially expressed 
exons of the Cd45 gene encoding for the epitope recognised by anti-CD45RC 
monoclonal antibodies . A mutation in this region of the gene was created with the 
intention of making mice deficient in all isoforms containing this exon but retaining 
all other CD45 isoforms. However in view of the fact that the targeting left behind 
a neo gene within exon 6 , it was not surprising that these mice have virtually no 
expression of CD45 on most lymphocytes except for a subset of around 20% of T 
cells. These cells have levels of expression of all isoforms of CD45 (except those 
containing the targeted CD45RC epitope) equivalent to controls. On the other hand 
B cells within these animals do not express CD45 and therefore these mice have 
been particularly useful in studying CD45-deficient B cell development and 
function. B cell development was found to be normal (Kishihara et al., 1993) and 
in vivo B cells displayed normal T-dependent and T-independent
responses (Bachmann et al., 1997; Kong et al., 1995). However B cell
proliferation after BCR crosslinking in vitro was found to be greatly reduced, 
confirming the earlier studies of CD45-deficient B cell lines which had concluded 
that CD45 is a positive regulator of BCR signalling (Bcnatar et al., 1996; Kishihara 
et al., 1993).
A second CD45-deficient mouse strain has been made using homologous 
recombination to target exon 9 of the Cd45 gene {Cd45^^^'^\ an exon common to
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all isoforms of CD45 (Byth et al., 1996). These mice were found to have no 
expression of any isoform of CD45 in either their B or T cells. Their B ceU 
development was found to be identical to that found in in both cell
surface phenotype and lack of proliferation following BCR crosslinking. 
Cd45^^^ T cell development was found to be deficient particularly in the transition 
from DP to SP CD4* and CD8  ^ thymocytes, a feature similar to that found in 
Cd45^^^ mice, despite the expression of some CD45 in T cells from these mice.
1.5 Aims of the work in this thesis
The aim of the work in this thesis was to gain a greater understanding of the 
role of CD45 in lymphocyte development and in particular to assess its role in the 
receptor-dependent processes of positive and negative selection of lymphocytes. 
This project involved the creation of a mouse strain deficient in CD45 by targeted 
mutation of exon 12 of the Cd45 gene, an exon used in all isoforms of CD45. This 
project was originally started prior to the publication of the Cd45^^^^^  ^ mice 
(Kishihara et al., 1993) and as these mice had expression of CD45 in a proportion 
of their T cells we decided to create mice with a deficiency in a conserved exon of 
the CD45 gene. During the course of this project the second CD45-deficient 
(CD45®’"’'“ ®) mice was reported (Byth et al., 1996). In this thesis I describe the 
generation of mice targeted in exon 12 of Cd45 {Cd45' '^) and present the analysis of 
B and T cell development in the absence of CD45, with particular emphasis on 
developmental checkpoints known to require antigen receptor signals.
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Chapter Two
MATERIALS AND METHODS
2.1 Solutions
TAE: 0.04M Tris-HCl, 0.02M glacial acetic acid, ImM EDTA (pH 8.0).
SSC: 0.15M NaCl, 0.015M tri-sodium citrate (pH 7.2).
TE: lOmM Tris-HCl pH 8.0,0.lmM EDTA.
PBS: 150mM NaCl, 2mM KCl, 8 mM Na^HPO .^
PBS-Tween: PBS containing 0.05% Tween-20.
CAPS: lOmM 3-cyclohexylamino-1 -propanesulphonic acid, pH 11.0.
TNES: lOmM Tris-HCl, pH 8.0, lOOmMNaCl, ImM EDTA, 1%SDS, 0.25mg/ml 
Proteinase K.
Tail Mix: 50mM Tris-HCl, pH 8.0, lOOmM NaCl, lOOmM EDTA, 1% SDS, 
0.25mg/ml Proteinase K.
Hybridisation Mix: 0.2M NaPO^, ImM EDTA, 1% BSA, 7% SDS, 15% 
formamide.
TBS: 25mM Tris-HCl pH 7.4, 140mM NaCl, 5mM KCl.
SDS-PAGE upper buffer: 0.125M Tris-HCl, 0,1% SDS, pH 6 .8 .
SDS-PAGE lower buffer: 0.375M Tris-HCl, 0.1 % SDS, pH 8 .8 .
SDS-PAGE running buffer: 0.025M Tris base, 0.19M glycine, 0.1% SDS.
DNA sample buffer: 3% glycerol and 0.02% bromophenol blue and xylene cyanol 
FF.
Nal solution: 6 M Nal, O.IM Na^SOy 
Denaturing Buffer : 0.5 M NaOH, 1.5M NaCl.
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Stop Buffer: 0.025M EDTA, 1% SDS in TE.
High Salt Buffer: 2x SSC, 0.5% SDS.
Low Salt Buffer: O.lx SSC, 0.5% SDS.
HBS/2-ME: HBS with 7xlO^M p-mercaptoethanol.
NP40 lysis buffer: 1% NP40, 150mM NaCl, 20mM Tris pH 7.0, lOmM 
iodoacetamide and Img/ml of each of the peptide inhibitors chymostatin, leupeptin 
and pepstatin.
Laemmli reducing sançle buffer: 10% glycerol, 3% SDS, 0.5x SDS-PAGE upper 
buffer, 500mM p-mercaptoethanol, 0.005% bromophenol blue.
Na Citrate buffer: 50mM sodium Citrate, pH 5.5.
DNA sample buffer: 20% glycerol, lOOmM EDTA, 0.1% bromophenol blue, 0.1% 
xylene cyanol.
2.2 Tissue Culture Media
ES cell medium: Dulbecco’s Modified Eagles Media (DMEM), 15% foetal calf 
serum, 50 units/ml penicillin, 2mM glutamine, 50jig/ml streptomycin, 5xlO'^M 
p-mercaptoethanol, non-essential amino acids (Gibco BRL) and 1x10 units/ml LIE 
(Gibco BRL).
EF medium: DMEM with 10% Foetal, calf serum (FCS) and 50 units/ml penicillin, 
2mM glutamine, and 50pg/ml streptomycin.
Blastocyst media: Dulbecco’s Modified Eagles Media with 10% FCS and 50 
units/ml penicillin, 2mM glutamine and 50pg/ml streptomycin.
Injection Media: As above but with 20mM Hepes.
Mast cell medium: RPMI 1640, 10% foetal calf serum, 2mM glutamine, ImM 
sodium pyruvate, 50pM p-mercaptoethanol, ImM sodium pyruvate, non-essential 
amino acids (Gibco BRL) and 10% conditioned medium from WEHI-3B ceUs as a 
source of IL-3.
NTOC medium: Iscove’s modified Dulbecco’s medium, 10% FCS, 50p.M
p-mercaptoethanol, 50 units/ml penicillin, 2mM glutamine and 50pg/ml 
streptomycin.
RPMI-COM medium; RPMI1640 (Gibco), 50 units/ml penicillin, 2mM glutamine 
and 50pg/ml streptomycin.
Trypsin solution: 0.25% trypsin (Gibco), 1.4mM EDTA, 120mM NaCl, O.SmM 
Na^PO^, l.SmM KH2 PO4 , 4.0inM KCl, 5.6mM D-glucose, 2.5mM EDTA, 
0.005% Phenol Red, pH 7.6.
2.3 Bacterial Media
Luria broth: Bacto-tryptone lOg/1, Yeast extract 5g/l, NaCl lOg/1 adjusted to pH 
7.2.
Luria agar: as above but with 15g/l Difco agar.
Antibiotics: Ampicillin lOOpg/ml when needed.
2.4 Embryonic Stem Cells
Preparation of Embryonic Fibroblast Feeder Cells
G418-resistant embryonic fibroblast feeder cells (EFneo) were prepared by mating 
homozygous IL3-deficient mice which contain the neo gene (Nishinakamura et al.,
1996) with wildtype female BALB/c mice. Pregnant females were sacrificed at day 
13 of gestation. Soft organs and viscera were dissected from the embryos and the 
remaining carcass minced finely in Trypsin solution (2ml/embryo). The embryos 
were then placed at 30°C for 30min with disruption by pipetting every 5-lOmin. An 
equal volume of EF medium was added, mixed and allowed to settle for l-2min. 
The supernatant was removed and each embryo was plated out into a T175 flask 
which was incubated at 37®C, 5% COg overnight. The following day the medium 
was changed and the cells incubated again until they reached extreme confluency. 
Each flask was then split into five T175 flasks and again grown to extreme 
confluency. These confluent flasks were again split into five T175 flasks. The 
cells were then trypsinised, resuspended in medium and irradiated with 3500 rads
and frozen at 4x10® cells/vial or 20x10® cells/vial in EF medium containing 10% 
DMSO.
Routine Maintenance of ES Cells
All plates for ES cell growth were gelatinised using 0.1% gelatin for one hour at 
room temperature. Irradiated EFneo feeders were thawed out and spun through 
medium and resuspended in ES medium prior to use. EFneo cells were used at the 
following densities: 4x10® cells/lOcm dish, 2x10® cells/6 cm dish, 1.3x10® cells/24 
well plate and 2x10“^ cells/96 well plate. ES cells were fed l-4hr before passage, 
washed with PBS and trypsinised as described elsewhere. ES cells were normally 
fed every day when routinely passaging. Cells were normally split 1/10 every 3 
days onto new plates with feeders.
Electroporation of ES Cells
D3 ES cells (Tybulewicz et al., 1991) were grown to 50-80% confluency on EFneo 
feeders in a 10cm tissue culture plate. The DNA targeting construct, that was 
previously prepared by CsCl^ purification and was linearised by Not! restriction 
digestion, was ethanol precipitated by standard procedures and dissolved in sterile 
TE at 2mg/ml. 10cm plates to receive the electroporation were seeded with 4x10® 
EFneo cells. The ES cells were trypsinised and dismpted to produce a single cell 
suspension and resuspended in HBS/2-ME at 10^  cells/ml with 30-50pg/ml DNA. 
For each electroporation 0.8ml of the cell/DNA suspension was placed in an 
electroporation curvette (0.4cm electrodes, Biorad). Electroporations were carried 
out at 400V and 25pF using a Biorad Gene Puiser. The cells were then 
resuspended in 3.3ml of media and 10% of the cells plated out onto one 6 cm plate 
with G418 alone (to allow the calculation of enrichment) and the remaining cells 
were plated onto four 10cm plates containing G418 and gangcyclovir. G418 was 
used at 300pg/ml and gancyclovir at 2pM, unless otherwise stated, and was added
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to the cells 24hrs after plating out the electroporated cells. Plates were then 
incubated at 37®C for approximately 10 days prior to picking of ES cell colonies.
Picking and Expanding ES Clones
The day before picking of the ES cell colonies, a 96 well plate (Costar) was seeded 
with 2x10^ * irradiated EFneo feeders per well. On the day of picking the colonies a 
further 96 well plate was prepared with 40^d trypsin per well. The 10cm plates 
containing the colonies were washed with PBS and 10ml of PBS was added. The 
colonies were picked under the microscope using a P200 Gilson pipette set to 20pi. 
Individual colonies were then placed in the 96 well plate containing the trypsin. 
After incubation at 37®C for 3min the colonies were disrupted by vigorous 
pipetting. The dispersed clones were then placed into the 96 well plate that 
contained the feeders. The colonies were fed the next day and allowed to grow for 
six days prior to trypsinisation and transfer into 24 well plates containing EFneo 
feeders. Four days later the confluent ES clones were used to make DNA and were 
frozen as described below.
Freezing of ES Clones
After the ES cell clones reached confluence in the 24 well plates, as described 
above, half the cells were frozen and the other half was used to make DNÀ for 
Southern analysis. Each well was washed in PBS and 80pl trypsin was added. 
Plates were incubated at 37°C for 3min and the clones disrupted using a P200. 40pl 
of the cells were added to 400|il of ES medium containing 12% DMSO in a 1.5ml 
freezing vial. These vials were then placed at -70”C overnight prior to placing them 
into liquid nitrogen. The remaining 40pl of cells were used to make DNA as 
described below.
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Preparation of Genomic DNA from ES Ceils
Half the ÉS cell clones grown to confluence in the 24 well dishes were removed for 
freezing as described above, whilst the other half were placed in a 1.5ml microfuge 
tube to make DNA. After addition of 400pl of TNES with 0.5mg/ml proteinase K, 
these cells were incubated at 37°C overnight. Next an equal volume of 
TE-equilibrated phenol was added and the sample extracted by vortexing. The 
sample was spun in a microfuge and the aqueous layer was removed this was 
followed by a further extraction using an equal volume of chloroform. After 
centrifugation the aqueous layer was again removed and thé DNA collected by 
ethanol precipitation (two volumes EtOH:3M NaOAc in a 25:1 mix) and spooling 
out with a sealed Pasteur pipette. The DNA was next washed in 70% ethanol and 
air-dried before being dissolved in 30pl TE. Typically iOpl was used for 
subsequent restriction digestion and Southern blotting.
2.5 Microinjection
Harvesting of Blastocysts for Microinjection
Four days prior to microinjection, B6  females were mated to B6  males and mice 
with vaginal plugs were set aside. On the day of microinjection the female mice 
were sacrificed by cervical dislocation and their uterine horns removed. Fat around 
the uterine horns was dissected away and the horns flushed with 0.5ml Blastocyst 
media into a 35mm Pelii dish. The blastocysts were removed from the debris with 
a pipette tubing flamed and pulled to give a diameter of approximately 2 0 0 |jm which 
was attached to a rubber tube and manipulated by mouth. The recovered blastocysts 
were then placed in a drop of Blastocyst medium, under oil to prevent evaporation 
and placed in a 37“C, 5% COj incubator until required.
Microinjection of Blastocysts
Microinjection was carried out using standard techniques (Robertson). A Nikon 
microscope and Leitz micromanipulators assembled on a hydraulic table were used. 
Injections were conducted in Injection Medium in a solid state cooling chamber at 
10®C (Robertson). Approximately 15 ES cells were injected into each blastocyst 
and the injected blastocysts were stored in a drop of Blastocyst medium under oil in 
a incubator at 37®C, 5% COg until ready to transfer to the foster mothers.
Transfer of Embryos to Foster Mothers
Embryos were transplanted into (C57/BL/6 x CBA) F, psuedopregnant foster 
mothers on the same day of injection. Three days prior to the day of transfer the 
foster mothers were mated to vasectomised males and those females with vaginal 
plugs were set aside for use. Just prior to the transfer the female fosters were 
anaesthetised using 17pl of 2.5% Avertin per gram of body weight. 10-15 embryos 
were transferred into one of the uterine horns of each mouse. Chimaeras that were 
bom were identified by their agouti coat colour chimaerism against the black of the 
host. Male chimaeras were then initially bred to C57/BL6 (B6 ) females. This 
allows the identification of chimaeras that undergo germline transmission of the ES 
cell hne by the presence of agouti pups from these matings. Transmission of the 
mutation was confirmed by Southern blotting of tail DNA firom these pups.
Preparation of genomic DNA from mice
For genotyping, a tail biopsy of approximately 1cm in length was taken from each 
mouse at the time of weaning and placed in 700pl of Tail Mix. The samples were 
rotated at 55®C overnight before being extracted twice with an equal volume of 
phenohchoroform (1:1) and once with chloroform. After the final extraction, 0.6 
volumes of isopropanol was added to the aqueous layer and the sample vortexed to
generate a pellet of DNA, which was then spooled out using a flame-sealed Pasteur 
pipette. After washing in 70% ethanol, the DNA was left to dissolve overnight at 
4®C in lOOpl TE.
2.6 Molecular Biology
Endonuclease Restriction Digestion of DNA
DNAs were digested using restriction enzymes in the buffer recommended by the 
manufacturer (New England Biolabs). Typically l-2pg of plasmid DNA was 
digested in a volume of lOpl for Ihr whilst 10|ig of genomic DNA was digested in a 
25pl volume overnight. In both cases the enzyme constituted no more than 5% of 
the volume of the reaction. Digests were terminated by the addition of 1/10 volume 
of DNA sample buffer.
Agarose Gel Electrophoresis of DNA
For routine analysis, preparative gels and Southern blotting, DNA was separated in 
1% w/v molecular biology grade agarose gels (SeaKemTM, FMC Bioproducts) 
whilst firagments smaller than 0.5kb were analysed using 1% SeaKemTM, 3% 
NuSieveTM (FMC Bioproducts) gels made up in TAE with Ipg/ml ethidium 
bromide (EtBr) added to both gel and buffer to visualise the DNA under ultra-violet 
light (UV). DNA sançle buffer was added to the samples prior to loading. All 
agarose gels were powered in horizontal perspex electrophoresis tanks (Owl 
Scientific). Running buffer was TAE with Ipg/ml EtBr and gels were run at 
lOVcm *. UV analysis was performed using a UVP°^  ^ CHROMATO-VUE^ 
transiUuminator. BffEII digested X DNA was used routinely as size markers 
(NEB).
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Isolation of DNA Fragments from Agarose Gels
Purification of DNA restriction fragments from agarose gels was routinely used 
prior to using these fragments in ligation reactions in cloning experiments. After 
agarose gel electrophoresis the band of interest was cut out using a clean razor 
blade. 2-3 volumes of Nal solution was added to the gel slice and the sample 
incubated at 50®C with occasional vortexing until the gel was completely dissolved 
(around lOmin). Between 2-5pl of a silica/water slurry (1:1) was added and the 
mixture incubated on ice for 17min with occasional vortexing. The glass, to which 
the DNA adheres, was spun out in a microfuge for 15s and the pellet washed once 
with 300^d Nal solution and twice with ice-cold ethanol wash solution (50% 
ethanol, Q.IM NaCl, lOmM Tris pH 7.5). After the last wash, the sample was 
spun briefly in a microfuge and the remaining last drops of ethanol wash solution 
removed with a microcapillary. The glass was then resuspended in the desired 
amount of TB and incubated at 50®C for a further 17min to allow the DNA to elute, 
after which the glass was spun out (15s in a microfuge) and the DNA solution 
recovered from the liquid phase.
Transfer of DNA from Agarose Gels to Membranes
Genomic DNA was digested with the appropriate restriction enzyme as described 
earlier and separated according to size on a 1% agarose gel with lug/ml EtBr in 
TAE. Gels were run at 1-2 Vcm'* for 14-16 hours and photographed. The DNA 
was denatured by twice soaking in Denaturing buffer for 20min with gently 
rocking. The DNA was then transferred to Hybond N+ nylon membrane 
(Amersham) by capillary action using 20x SSC as transfer buffer according to the 
manufacturer’s instractions and the DNA was bound to the membrane by placing 
the filter onto 2 sheets of Whatmann paper soaked in 0.4M NaOH for 20min.
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Labelling of DNA using Random Priming
Labelling of DNA with which to probe Southern blots was achieved using the 
random priming kit from Boehringer and according to their instructions using a-®^ P 
dCTP (~ 6000Ci mmol**, Amersham). Briefly 25-50ng of the probe fragment in a 
volume of 9pl was boiled for 5min to generate single stranded DNA. The reaction 
was then set up according to the manufacturer’s instructions by adding 3pl of 
nucleotide mixture (without dCTP), 2|il of the hexanucleotide reaction mixture and 
5pl of the a-®^ P dCTP. To this reaction 2pl of Klenow enzyme was added, 
vortexed, spun briefly (15s) in a microfuge, and incubated at 37°C for 30min. The 
reaction was stopped by adding lOOpl of Stop Buffer. Unincorporated nucleotides 
were removed using a Sephadex G-50 column (Pharmacia) according to the 
manufacturer’s instructions. The probe was eluted from the column in a 400|il 
volume. 2 pl of the purified labeled probe was removed and the amount of 
radioactivity incorporated was measured in a beta counter (Pharmacia). A typical 
specific activity was around lO^cpm/pg.
Hybridisation of Southern Blots
Filters carrying the target DNA were wetted in 2x SSC and inserted into a 
hybridisation bottle (Hybaid). 10ml of Hybridisation mix was added and the bottle 
rotated in a hybridisation oven at 65®C for a minimum of 15min. After the 
prehybridisation, the probe, along with O.lmg/ml herring sperm DNA, was boiled 
for 5min to denature the DNA and this mix was added to the hybridisation bottle. 
The membranes were then washed to remove non-specifically bound probe. Firstly 
the membranes were washed three times in High Salt Buffer for 20min each wash at 
65®C, followed by two further 20min washes in Low Salt Buffer. After the final 
washes, the membranes were placed between two sheets of Saran Wrap (Dow) and 
exposed to film at -70°C using intensifying screens to strengthen the signal. Probed 
filters could be stripped to remove the probe to allow reprobing with a different
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fragment. This was achieved by adding boiling 0.5% (w/v) SDS to the membrane 
and allowing to cool to room temperature.
Ligation of DNA Fragments
Vector and insert that had been digested with the appropriate restriction enzyme and 
dephosphorylated or blunted as required were purified after gel electrophoresis as 
described previously. Typically 300ng of purified insert DNA was ligated in a 
reaction with a vector to insert ratio of 1:3 moles. Ligations were carried out in a 
volume of lOpl using the protocol and buffer supplied with T4 DNA ligase (New 
England Biolahs). The reaction was routinely incubated at 15°C overnight and 
ligation products used to transform E. coli. Some ligation reactions required the 
filling in of 5’ overhanging DNA termini prior to the ligation reaction. Typically 
lp,g of insert in 20pl of distilled water was incubated with 4 units of Klenow 
fragment in the appropriate buffer supplied with the enzyme (New England 
Biolabs). The reaction was incubated for 20min at room temperature and stopped 
by the addition of EDTA to 5mM, followed by heating to 75°C for lOmin.
Transformation and Culture of E. coli
Competent E. coli (Subcloning Efficiency DH5a) were purchased from Gibco 
BRL and the transformation was carried out according to manufacturer’s 
instructions. E. coli were grown in liquid culture in Luria broth containing 
ampicillin. 2 ml small scale cultures (minipreps) were grown in sterile universals 
and 500ml cultures (maxipreps) were grown in 21 conical flasks, overnight at 37°C 
witli shaking at 225rpm to aerate the media. Long term storage of E. co/i strains 
was by storage at -70®C in 12% sterile glycerol.
Harvesting of Plasmid DNA
Both small scale and large scale cultures were harvested and the plasmid DNAs 
recovered using standard techniques. Plasmid DNA from maxipreps was purified 
by centrifugation in a caesium chloride gradient by standard procedures. All DNA 
preparations were stored in TE at -20°C. Quantification of DNA was accomplished 
by measuring the optical density of a 1  in 2 0 0  dilution of the sample at a wavelength 
of 260nm using a spectrophotometer and assuming that an ODj^ q^  ^ of 1 . 0  
represents a concentration of 50pg/ml.
2.7 Mice
All strains were bred at the National Institute for Medical Research in a conventional 
facility. The B and T cell transgenics have been described previously: BM3.6 
(Sponaas et al., 1994), Al(m-2) (Douek et al., 1996) F5 (Mamalaki et al., 1993) 
and 3-83|i5 (Nemazee et al., 1991). The presence of the transgenes as weU as 
mutations in endogenous genes were screened for by Southern analysis of mouse 
tail DNA using standard techniques described above. AU mice were between 6  and 
16 weeks of age when analysed. The Cd45‘'' BALB/c line was created by 
backcrossing the mutation 10 generations onto BALB/c mice. All other mice were 
outbred being mixtures of 129/Sv, C57BL/6 (B6 ), DBA/2 and CBA. Littermates 
were used as controls in all cases.
2.8 Flow cytometric analysis
Expression of cell surface antigens was determined by cytofiuorometric analysis. 
TypicaUy 1x10® ceUs were stained with biotinylated, FTTC- or PE- conjugated 
mAbs (see below) in PBS containing 0.1% sodium azide and 1% BSA for 45min at 
4°C in the presence of 10% heat-inactivated normal rat serum. Biotinylated 
antibodies were revealed with streptavidin-PE (Biogenesis, Poole),
streptavidin-RED613, or streptavidin-RED670 (Gibco-BRL). Fluorescence was 
acquired and analysed with Cellquest software on a Facs Vantage flurocytometer 
(Becton-Dickinson). Dead cells were excluded on the basis of low forward light 
scatter and only live cells falling within the lymphocyte scatter gate are shown.
Antibodies
The Table below lists the source of monoclonal antibodies used.
Specificity Antibody Species Conjugate Source
3-83 idiotype 54.1 RatIgG BIO and FTTC (Nemazee et al, 
1991)
BM3 clonotype Ti98 Rat IgG BIO and FTTC (Sponaas et al., 
1994)
GDI lb Ml/70 Rat IgG2b BIO Pharmingen
CD19 1D3 Rat IgG2a FTTC Pharmingen
CD3 2C11 Hamster IgG BIO Pharmingen
CD4 H129.19 Rat IgG2a RED613 GibcoBRL
CD4 GK1.5 Rat IgG2b FTTC ATCC
CD44 1M7 RatIgG2b PE Pharmingen
CD5 53-7.3 Rat IgG2a APC Pharmingen
CD69 H1.2F3 Hamster BIO Pharmingen
CDS 53-6.7 Rat IgG2a APC Pharmingen
CDS YTS169vF FTTC (Cobbold, 1984)
HSA Ml/69 RatIgG2b PE Pharmingen
IgD 1.19 Rat IgG2a BIO Pharmingen
IgM b-7-6 RatlgGl FTTC ATCC
L-Selectin MEL-14 Rat IgG2a FTTC Pharmingen
pan-VpS F23.1 Mouse IgG2a BIO (Staerz, 1985)
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TCRap H57-597 Hamster IgG FTTC Pharmingen
VB-ll RR-3-15 Rat IgG2b BIO Pharmingen
Vp3 KJ25 Hamster IgG BIO Pharmingen
Vp5 MR9-4 Mouse IgGl BIO Pharmingen
Vp8.2 F23.2 Mouse IgG2a BIO (Staerz, 1985)
Intracellular calcium analysis
Thymocytes were incubated with Indo-1 acetoxy-methyl ester (Indo-1; ImM; 
Calbiochem) for 45min at 37°C in RPMI1640 (Gibco), 1% bovine serum albumin, 
washed and stained with anti-CDS-FTTC, anti-CD4-PE and anti-CD3. Four colour 
cytometric analysis was performed on a FACSVantagc dual laser flow cytonaeter 
(Becton-Dickinson). FTTC and PE were excited by an argon ion laser (488nm, 
IQOmW) and Indo-1 by a UV argon ion laser (320nm, 50mW). Indo-1 emission 
was detected using 405/40nm (violet) and 495/20nm (blue) bandpass filters. To 
determine relative calcium concentration, cells were warmed to 37°C, analysed for 
30-45s to establish baseline calcium levels and CD3 was crosslinked by the addition 
of up to lOOpg/ml goat anti-hamster-IgG (Jackson Immunoresearch). Acquisition 
was continued in real time for up to six minutes.
2.9 B cell Purification and Proliferation Assay
Spleens were dissected out asceptically and cells disrupted using a sterile cell 
strainer (Falcon) and resuspended in 1.8ml of RPMI COM/ABS medium (Gibco). 
To remove T cells rat anti-mouse Thy-1 antibody (NIMR-1) was added at 1/900 
final concentration with 1/9 dilution of guinea pig complement pre-absorbed with 
agarose (Harlan Seralab). Cells were incubated for 30-45min at 37°C. CeUs were 
spun at 2000rpm for 5min to remove ceU debris. The supernatant was discarded 
and the ceUs resuspended in 500ml of RPMI-COM and added to a PercoU gradient. 
The PercoU gradient was a three step gradient with 85% PercoU as the bottom layer, 
75% in the middle, and 50% PercoU at the top. The ceUs were carefuUy layered on
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top of the gradient and the cells spun for 20min at 2,500rpm. Small resting B cells 
which form the a layer between the 85% and 75% PercoU gradient were removed 
and washed in media to remove any PercoU. CeUs were then seeded into a 96 weU 
flat bottom dish (Falcon) at 10® ceUs per weU in lOOpl. The b-7-6 anti-mouse IgM 
antibody was then added at the stated concentrations in media with or without IL-4 
(lOOU/ml) and the plates incubated at 37°C, 5% CO  ^for two days. Next 0.5p.Ci 
(5.0Ci/mmol, Amersham) ®H-thymidine was added per weU and the plate incubated 
for 4hrs. Supernatants were harvested on a Wallac Betaplate ceU harvester and 
incorporation of ®H-thymidine was measured using a betaplate counter.
2.10 Culture of Mast Cells
Mast ceU cultures were generated by culturing 2x10® bone marrow ceUs from 6  
week old Cd45^* or Cd45'^ ' mice in Mast ceU medium as described previously 
(CosteUo et al, 1997). After 7 days in culture the adherent ceUs were scraped off 
and combined with the suspension ceUs and reseeded at 2x10®. This was repeated 
every week. After 4 weeks of culture when the ceUs were predominately mast ceUs, 
only the suspension cells were propagated.
2.11 Western blotting
Total Cell Lysates
2x10® primary murine ceUs or cultured mast ceUs were peUeted at 1200rpm for 3min 
in a benchtop centrifuge and washed twice with PBS. 50pi of NP40 lysis buffer 
was added and the samples rotated at 4°C for 15min. After the lysis the samples 
were spun in a microcentrifuge for 15min at 4®C to remove the nuclei and 
membranous debris. The supernatants were transferred to a fresh tube and an equal 
volume of Laemmli reducing sample buffer was added. The samples were then 
heated to 100°C for 5min prior to loading on to the gel.
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Immunoprécipitation
1 0  ^ cells were pelleted, washed and lysed in 1 ml of lysis buffer as described for 
total cell lysates. After spinning out the nuclei, 3^ 1 of antibody specific for the 
cytoplasmic domain of CD45 was added and the samples incubated rotating for Ihr 
at 4®C. The antibody and protein were precipitated by adding 20|il of 
Protein-A-Sepharose beads (Pharmacia) and the samples were incubated rotating for 
a further 2hr at 4®C. Protein was recovered by spinning samples in a microfuge for 
15s to pellet the beads and the supernatant was removed by aspiration. Some of the 
samples were used to confirm by Western analysis that the immunoprécipitation 
was successful. In these samples the beads were washed 4 times in 1ml of lysis 
buffer before being resuspended in lOOpl of Laemmli sample buffer, boiled for 
5min, centrifuged, and the supernatant used to run on a polyacrylamide gel as 
described below. For samples that were to be used for tyrosine phosphatase assay, 
the precipitated beads were washed three times in 1 ml of lysis buffer, followed by 
three washes in 1ml Na Citrate buffer and resuspended in lOOpl of Na Citrate buffer 
ready for the tyrosine phosphatase assay. The immunoprecipation of Lyn, used as 
a control in these experiments, was conducted using anti-Lyn antibodies previously 
coupled to beads which were a gift firom Dr. C. Cunningham. 20pl of these packed 
beads were added to the total cell lysates and the samples were then treated the same 
as those containing anti-CD45 antibodies.
SDS-Polyacrylamide gel electrophoresis (PAGE)
40ml gels were poured using 10ml of Protogel (National Diagnostics), which 
results in a 10% acrylamide gel, in SDS-PAGE lower buffer. lOOpl of 25% 
ammonium persulphate and 20pl of TEMED were added to polymerise the gel. 
Stacking gels (4% acrylamide) were cast using SDS-PAGE upper buffer. Gels 
were run in SDS-PAGE running buffer for either 4 hours at 200V or overnight at
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50V. Pre-stained molecular weight protein markers (16kD-175kP) were run 
alongside the samples (New England Biolabs).
Immunoblotting/ECL
Proteins separated by SDS-PAGE were immobilised on polyvinylidene 
flouride (PVDF) membrane (Millipore) for immunoblotting. The PVDF membrane 
was soaked in methanol to pre-wet it before being immersed in CAPS. Transfers 
were carried out at pH 11.0 as proteins are negatively charged at this pH and this 
increases the efficiency of the transfer. The blot was then assembled in the transfer 
tank cassette using filter papers soaked in CAPS and with the gel nefffcst the 
cathode of the tank. The tank was filled with CAPS and the buffer lecircul^ed 
throughout the tank during transfer. Blotting was carried out at lOOV and 300mA 
constant current for between 6-12hr at 4°C. The PVDF membrane was then placed 
in blocking solution (PBS-Tween with 5% Marvel) for Ihr prior to antibody 
staining.
After vigorous washing of the blot in PBS-Tween for lOmin the blot was 
firstly stained with rabbit polyclonal antibodies to the intracellular portion of CD45 
(gifts of Dr. M Thomas or Dr. P Johnson) diluted a thousand fold in PBS-Tween 
with 2% Marvel and incubated at room temperature for Ihr. After washing 4 times 
in PBS-Tween the anti-CD45 antibodies were detected by using horseradish 
peroxidase (HRP)-protein A (Amersham) for 30min at room temperature at the 
concentration recommended by the manufacturer. The blots were then washed 6  
times for 5min with PBS-Tween to remove any unbound secondary reagent. CD45 
was detected on immunoblots using enhanced chemiluminescence (ECL™) reagents 
(Amersham). This method utilises the oxidation of luminol by horseradish 
peroxidase, an enzymatic reaction which generates light which is detected by film. 
10ml of the ECL reagent was added to the blot for Imin with gentle rocking. 
Finally the blot was sandwiched between two sheets of Saran Wrap and the excess 
ECL solution removed using a roller. The blot was placed in a cassette with
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X-ograph XB-200 high definition film for approximately 15-60s or until the correct 
exposure time was achieved.
Membrane stripping
Blots were stripped by incubating in a solution of lOmM p-mercaptoethanol, 
2%SDS and 6.25mM Tris-HCl pH 6.7 at 50®C for 30min. After washing 4 times 
in PBS-Tween for lOmin per wash in a fume hood, the blot was re-blocked in 5% 
Marvel for up to 12 hours prior to reuse.
2.12 Tyrosine phosphatase assay
Tyrosine phosphatase activity was assessed using a kit from Promega and was 
conducted as described in the instructions for the kit. Total cell lysates were 
prepared and immunopreciptations conducted as described earlier. Assays were 
performed using a mixture of both the tyrosine phosphorylated peptides provided. 
with the kit in Na Citrate buffer. Assays were conducted in the presence of a 
standard curve using dilution’s of a l.OmM KH^PO  ^phosphate standard provided 
with the kit. Reactions were incubated at 37°C for I5min and the reaction stopped 
by the addition of the Molybate Dye/Additive mix as described in the instructions. 
Plates were then read at 630nm using a Titertek Multiscan MCC/340 Elisa plate 
reader.
2.13 Neonatal thymic organ cultures
Neonatal (day of birth) thymus lobes were obtained from matings of Cd45*'* or 
Cd45‘‘' mice that were also Rag-1''' and carried the F5 TCR transgene. Mature CD4^ 
single positive thymocytes were generated in neonatal thymic organ cultures 
(NTOCs) as previously described (Basson et al., 1998; Bommhardt et al., 1997) in
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the presence of a genetically engineered bispecific F(ab* ) 2  reagent recognising both 
CD3e and CD4 (Kostelny et al., 1992). Lobes were cultured for three days in 
culture medium containing antibody, transferred to fresh filters in mediuni without 
antibody and cultured for an extra day prior to FACS analysis. Single ceU 
suspensions prepared from the lobes were stained with directly conjugated 
antibodies to CD4 (APC-conjugated RM4-5, Pharmingen), CD8 a (PE-conjugated 
53-6.7, Sigma), V ^ l l  (FTTC-conjugated KT11.5) and biotinylated PNA (Oxford 
Glycosystems), followed by streptavidin-RED613 (Life Technologies). Live cells 
were gated on forward/side scatter profiles and numbers of mature 
(Vp-11*"/PNA*°), CD4^ cells that differentiated were calculated from three individual 
lobes for each concentration of anti-CD3/CD4.
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Chapter Three
RESULTS
3.1 Creation of CD45-deficient mice
Construction of the Cd45 targeting vector
To create the Cd45‘'' mice I used the tecMque of gene targeting by 
homologous recombination to insert a neomycin {neo) gene cassette into a BamYil 
site in exon 12 of the Cd45 gene in 129/Sv-derived embryonic stem (ES) cells 
(Figure 3). This exon is located 3' to the differentially spliced Cd45 exons 4-6 and 
5' to the transmembrane domain exon 16. I chose to target exon 12 of the Cd45 
gene as it encodes part of the extracellular domain and thus targeting this exon 
would separate the signal sequence of CD45 from the phosphatase domain; either 
part of the Cd45 gene, 5’ or 3* of exon 12 is utüikely to be able to generate a 
membrane localised tyrosine phosphatase; workk in CD45-deficient cell lines 
demonstrated that in order to function, CD45 needs to be membrane associated. 
Furthermore, exon 12 is not known to be subject to alternative splicing and is thus 
common to all CD45 isoforms. Hence I anticipated that mice targeted in exon 12 of 
Cd45 would be deficient in all isofonns. My colleague Edmund Siu had previously 
isolated overlapping X, bacteriophage clones containing Cd45 genomic sequences by 
screening a 129/Sv library with an 806 bp EcoRWIHindSi firagment from the mouse 
Cd45 cDNA (Chang et al., 1991) extending from exon 7 to exon 13. He isolated 
four phage containing overlapping genomic fragments that spanned 16 kb of the 
1 0 0  kb genomic sequence. In collaboration with Dr.V. Tybulewicz, from one of 
these bacteriophage I subcloned a 6.7 kb EamHI Segment extending from intron 8  
to exon 1 2  and a 3.1 kb Ea/nHI fragment extending from exon 12 to intron 12 into
the Xho\ and EcoRI sites respectively of pPNT (Tybulewicz et al., 1991) to create 
the targeting vector ^Cd45-1 (Figure 3). To check for the integrity of the completed 
targeting construct and its intermediates I conducted extensive restriction enzyme 
mapping and confirmed the presence of fragments of predicted size and checked the 
DNA sequence across the junctions between the Cd45 genomic DNA and the neo 
gene (not shown).
CD45
15.2 kb
= 128 ?  9 Bwild-type 
C(t45 gene
7 10 11
4.5 kb
Figure 3: Targeted disruption of the Cd45 gene. Schematic diagram of 
the targeting strategy used to create the Cd45'^ ' mice. The Cd45 gene (top line) was 
dismpted by the insertion of the neomycin resistance gene (neo-shaded box) at a 
BamWi site (B) located in exon 12 of the gene (exons are black boxes). A gene 
replacement targeting vector pCd^5-T was constmcted to contain 9.8 kb of isogenic 
genomic DNA cloned as BamHl fragments into the EcoRl and Xhol sites of pPNT 
(Tybulewicz et al., 1991) (dotted lines) such that the neomycin gene was located in 
exon 12. Neomycin-resistant ES cell lines were initially screened using a probe 3’ 
to the region of homolo^ called ES750 (hatched box). Integrity of tiie targeting 
event was confirmed using a probe homologous to the neo gene (shaded box) 
isolated as a Pstl fragment from pPNT and a 236 bp FcoRV/XÏal fragment of the 
Cd45 cDNA. Restriction enzyme site are marked; B for BamHI and S for Sad.
Electroporation of the Cd45 targeting construct
The D3 embryonic stem (ES) cell line, which is derived from 129/Sv mice, 
was electroporated with linearised pCd^J-T plasmid and plated the cells into G418-
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and gancyclovir-containing medium to select for cells that had stable integration of 
the neo gene into their genomes, but had lost the hsv-r^ gene. Homologous 
recombinants were identified by the restriction length polymorphism generated by 
the presence of a novel Sad  site in the 5’ UTR of the neo gene on integration of the 
vector (Figure 3 and data not shown). This produces a diagnostic 4.5 kb band 
which is distinguishable from the endogenous 15.2 kb band by Southern blotting of 
5flcl-digested genomic DNA probed with the ES750 probe (Figure 3). This probe 
was constructed by sub-cloning an EcoRUSad fragment from one of the 
bacteriophage clones into the pUC19 cloning vector. This probe contains 
sequences 3* to the targeted region of the Cd45 gene and I used this probe for both 
the initial screening of colonies for homozygous recombinants and for genotyping 
of mice (Figure 3 and 4). Two other probes were used in restriction site mapping 
experiments to confirm the integrity of the targeting event in recombinant clones. 
These probes were a neo gene specific probe and a probe specific for sequences 5’ 
of the targeted region (Figure 3 and not shown). Three independent 
electroporations were conducted. Cells from the first electroporation were selected 
at 300pg/ml G418 and from the 480 colonies screened no homologous 
recombinants were isolated. This protocol was repeated a second time and only one 
putative recombinant was isolated after screening 356 colonies. This clone was 
further mapped by restriction digestion and Southern blotting and was found to 
have a duplicated insertion of the construct and thus the structure of the targeted 
Cd45 locus was incorrect (not shown). To overcome the lack of homologous 
recombinants we decided to decrease the G418 concentration during selection on the 
basis that the particular site into which the neo gene was being targeted may hinder 
its expression. A third electroporation was conducted and selected in 250pg/ml 
G418. 456 colonies were screened for homologous recombination by Southern 
Blotting using the ES750 probe and 16 homologous recombinant cell lines were 
isolated.
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Generation of Cd45 mice
To generate chimaeras I microinjected three of these homologous 
recombinant ES cell lines into C57 Bl/ 6  (B6 ) mouse blastocysts. All three lines 
generated chimaeric mice with varying degrees of coat colour chimaerism. Initially 
these chimaeras were bred to (B6xDBA/2)F; mice to determine whether the ES cell 
line had populated the germline of the mice. Germline transmission from the 
chimaeras can be determined by the presence of agouti offspring. In addition, these 
F, mice make better mothers and have larger litters than mice from inbred strains. 
Germline transmission was achieved from one of the three recombinant cell lines 
injected. To confirmed germline transmission of the mutation, genomic DNA from 
mouse tail biopsies from the agouti pups was digested with Saciy Southern blotted 
and probed with the ES750 probe. This identified mice heterozygous for the Cd45 
exon 12 mutation Cd45^'). Homozygous mutant mice {Cd45'^ ') were
generated by intercrossing heterozygous mutants (Figure 4) and were further 
intercrossed to generate a colony of Cd45'^ ' mice on a mixed genetic background 
(B6  and DBA/2 and 129/Sv) which I will refer to as the “outbred” line. To generate 
Cd45'^ ' mice on a 129/Sv background I bred the chimaeras directly to 129/Sv mice. 
and screened all progeny for the presence of the mutation. As the chimaeras were 
generated from an ES cell line of 129/Sv origin this allowed the creation of an 
inbred line in one generation. To generate inbred Cd45'^ ' BALB/c backgrounds I 
backcrossed the mice sequentially for 10 generations against wildtype BALB/c mice 
and finally intercrossed heterozygous mutants to generate the inbred homozygous 
mutants.
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Figure 4: Southern blot analysis of the Cd45 mutation from mouse 
taU DNA. Southern blots of Sacl-digested tail biopsy DNA from mice whose 
parents were known to be heterozygous for the Cd45 mutation. The wildtype aUele 
(15.25 kb) can be distinguished from the mutant allele (4.5 kb). The genotype of 
the mice is shown at the top of each lane. Note the absence of the 15.25 kb band in 
mice.
Strain-specinc lethality of 129/Sv Cd45''' mice
Initial attempts to derive an inbred 129/Sv Cd45'^ ' mouse strain were 
thwarted due to lethality in this strain. As can be seen in Figure 5, a small minority- 
of Cd45'^ ' mice reach adulthood, however greater than 75% of the mice die within 
one month of birth. This lethality was characterised by juvenile diarrhoea, 
malnutrition and eventual death. This lethality was not seen in Cd45*^  ^ or Cd45*'' 
littermate controls (Figure 5). Increased mortality was also hot observed in Cd45'^ ' 
outbred mice or mice on the BALB/c genetic background (not shown), suggesting 
strain specificity of this lethality. I also observed a strain-specific phenotype in 
inbred Cd45'^ ' BALB/c mice; Although superficially these mice appear healthy, 
post-mortem examination revealed splenomegaly. Spleens from Cd45 mice were 
found to be 3-5 times heavier that Cd45*'* controls mice (not shown) This 
enlargement of the spleen is not observed in Cd45* ‘^ BALB/c mice, in Cd45'^ ' 
outbred or 129/Sv mice (not shown).
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Figure 5: Lethality of the Cd45 mutation on a 129/Sv genetic 
background. Line diagram of percentage survival of mice genotyped by Southern 
blotting of tail DNA to be either Cd45'^ * (solid line), Cd45^' (dash and dotted line) 
or Cd45'^ ' (dashed line) plotted from birth in days. All mice are littermates generated 
from Cd4y '  mating pairs.
Cd45 mice do not express any isoforms of CD45
To confirm the absence of cell surface expression of the CD45 protein in 
homozygous animals, flow cytometric analysis was conducted with a panel of 
monoclonal antibodies to all the different CD45 isoforms (A,B,C and B220) (not 
shown) and a pan-CD45 antibody that recognises all CD45 isoforms (Figure 6 ). 
Using this technique I could not detect any expression of any isoform of CD45 on 
thymus, lymph node, spleen, and bone marrow cells, and on cultured primary mast 
cells (Figure 6  and data not shown). Cd45^' splenocytes were found to have 
reduced levels of CD45 on their cell surface (Figure 6 ) as compared to Cd45*^*‘ 
cells, consistent with the disruption of expression from one of the Cd45 alleles.
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Figure 6: Flow cytometric analysis of CD45-deficient splenocytes.
CD45 expression levels on splenic lymphocytes from outbred Cd45* * (thin line), 
Cd45^'' (dotted line) and Cd45'^  ^ (bold line) mice revealed with a pan-C<i45 
antibody. Staining with an isotype-matched control antibody of irrelevant 
specificity (rat IgG2a) (shaded) is indistinguishable from staining of Cd45'^ ' cells.
Western analysis of Cd45''' cells
I used Western blotting to determine if there was any expression of any 
truncated form of the protein 3’ of the mutation. Figure 7 shows the result of 
Western blotting of primary mast cell extracts with two independently 
derived-polyclonal antisera raised against the cytoplasmic domain of CD45. Both 
of these antisera detect CD45 in cell lines, as seen as a smeared band of 180-220 kD 
in the Cd45*^* lanes. One of the antisera (A) failed to detect any additional bands 
present in the Cd45'^ ' cells that could have been a truncated form of CD45. 
However, this antiserum had a number of background bands that could have 
masked the presence of such a band. Thus I reprobed this Western blot with a 
second cytoplasmic tail-specific polyclonal antiserum which gave fewer background 
bands (B). This antiserum revealed the presence of a crossreacting truncated 
protein that was not present in the Cd45*^ '^  cells. Densitometry showed this protein 
to be present at approximately 5% of the level of the endogenous protein (not
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shown). Additional experiments showed that this truncated protein was also 
present in thymocytes and splenocytes from Cd45 '^ mice and was present at similar 
levels to those found in mast cells (not shown).
180-220
Figure 7: Western blotting reveals a truncated form of the CD45 
protein. Western blot analysis was conducted on cell lysates prepared from mast 
cell lines derived from Cd45*'* and Cd45'^ ' mice. Blots were probed with two 
different polyclonal rabbit anti-mouse antisera specific for the intracellular domain 
of the CCM5 protein. Blots probed with antiserum supplied by Dr. M. Thomas (A) 
and antiserum supplied by Dr.P Johnson (B) were visualised using EGL. The 
arrow in B identifies a truncated form of CD45 in the targeted cells.
The truncated form of Cd45 has phosphatase activity
To determine if the observed truncated form of the protein had any tyrosine 
phosphatase activity I used the polyclonal antiserum obtained from Dr. P Johnson 
(B in Figure 7) to immunoprecipitate this CD45 fragment and assayed its activity in 
a tyrosine phosphatase assay. This assay measures the ability of tyrosine 
phosphatases to liberate free phosphate from tyrosine-phosphorylated synthetic 
peptides. This free phosphate is detected by a colorimetric assay. Figure 8  shows 
the results obtained from cell lysates that were prepared from cultured mast cells
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from Cd45*^* and Cd45'^ ' mice. Protein was immunoprecipitated with either 
antiserum to the cytoplasmic domain of CD45 (antiserum B) or as a control, with an 
antiserum against the tyrosine kinase Lyn. As expected, Cd45*'* cells were found 
to have a high level of tyrosine phosphatase activity in protein immunoprecipitated 
using the CD45-specific antiserum. Protein immunoprecipitated with antiserum 
from Cd45'^ ' mast cells was found to have low but detectable levels of tyrosine 
phosphatase activity which are approximately 3% of the levels in Cd45*^* cells. 
Protein precipitated using an antiserum to the irrelevant protein, Lyn, did not give 
any detectable tyrosine phosphatase activity over background suggesting that the 
observed tyrosine kinase activity in Cd45''‘ mast cells is not an artefact of the 
immunoprécipitation protocol. It is not possible to determine the specific activity of 
the immunoprecipitated protein as protein concentrations could not be calculated due 
to the presence of antibody in the immunoprécipitations. For this reason the results 
are displayed as pM free phosphate detected per 15min reaction.
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Figure 8 : The truncated isoform of CD45 tyrosine phosphatase 
activity. Phosphatase activity as measured by the liberation of free phosphate 
from synthetic, peptides was assessed by the protein immunoprecipitated fi*om total 
cell lysates from mast cells from either Cd45*'* and Cd45'^ ' mice using either 
antisera to the cytoplasmic domain of CD45 (antiserum B) or an irrelevant antiserum 
(against the Lyn kinase).
Summary
I have created mice which are homozygous for a targeted mutation of exon 
12 of the Cd45 gène. There is a strain specific lethality of the mutation on the 
129/Sv genetic background. Cd45''' mice do not express ^ y  isoform that is 
recognisable by antibodies to the extracellular domain of CD45. A smaU amount of 
a truncated form of CD45 (approximatley 5% of wildtype levels) is detected in 
Cd45 ‘^ cells and tissues by antiserum to the intracellular domain of CD45 . This 
truncated protein has tyrosine phosphatase activity.
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3.2 B cell development in CD45-deficient mice
B cell development in the bone marrow
CD45 has been implicated as both a positive and negative regulator of signal 
transduction from the BCR in the small number of studies conducted using 
CD45-deficient B cell lines (Alexander, 1997). I therefore decided to determine the 
effect of this mutation on the development of B cells within Cd45'' mice with 
particular emphasis on those developmental transitions where antigen receptor 
mediated signalling has been implicated.
Early B cell development occurs in the bone marrow and is characterised by 
cell surface expression of distinct markers associated with defined developmental 
steps. These developmental stages are normally characterised by flow cytometric 
analysis of the expression of B220 and other cell surface markers (Hardy et al., 
1983). As B220 is a B cell specific isoform of CD45, this molecule is not 
expressed on the surface of Cd45'^ ' mice and another marker must be used for this 
analysis. CD 19 is a B cell-specific marker that can be used as a substitute for B220 
ill this analysis since it is expressed throughout B cell development from the earliest 
pro-B cell compartment (Rolink et al., 1996). B cell development proceeds from 
the pro-B (CD19^IgM'CD25CD43*) through the pre-B cell 
(CD 19^gM'CD25^CD43 ) and then to the immature B ceU (CD19^gM^IgD ) stage, 
finally generating mature (CD19'^IgMTgD^) B cells found in splenic and lymph 
node follicles. As described in the introduction, the developmental transition from 
pro-B cell to pre-B cells is known to require signalling events through the pre-B cell 
receptor (pre-BCR). To assay the role of CD45 in this transition I used antibody 
staining to analyse these populations by flow cytometric analysis. Figure 9A shows 
a typical flow cytometric an^ysis of bone marrow from Cd45'^ ' mice compared to 
bone marrow from Cd45*'* mice stained with anti-CD 19 and anti-IgM antibodies. 
It can be seen that there is a small but consistent reduction in the numbers of B cells 
that are CD19TgM" in Cd45'^ ' bone marrow (24%) compared to Cd45*^* bone 
marrow (30%). This suggests that there is a partial block at an early stage of B cell
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development. To determine if this block is at the pro-B to pre-B cell transition, 
anti-CD25 and anti-CD43 markers were included in this analysis. By gating on 
cells that are CD19^gM* and displaying the level of CD25 or CD43 expression as 
histograms (Figure 9B) Cd45'^ ' bone marrow was found to have a reduction in both 
CD43' and CD25^ cells within the CD19^IgM' compartment (ie. pre-B cells) 
indicative of a block in B cell development at the pro-B cell to pre-B cell stage. This 
is a partial developmental block as Cd45^' cells develop into CD19^gM^ immature 
cells although at reduced levels (9% compared to 16% in Cd45*^* marrow - Figure 
9A). Total cellulaiity of the bone marrow is no different between mutants and 
controls.
These results demonstrate that CD45 is required for the efficient 
development firom pro-B cells to pre-B cells, a transition that is associated with 
signal transduction from the pre-BCR. This suggests that in the absence of CD45, 
the efficiency of pre-BCR signalling is reduced. There is not an absolute 
requirement for CD45 during this transition suggesting that CD45 is only partially 
required for signalling from the pre-BCR or that in its absence other molecules can 
substitute for its activity.
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Figure 9: There is a partial developmental block in the transition from 
pro- to pre-B cells in Cd4S^' mice. Bone marrow from Cd45'^ ' and Cd45^* 
outbred mice were stained with CD 19, IgM and CD25 or CD43 as three colour 
stains. (A) Typical flow cytometric analysis displayed as dot plots showing bone 
marrow staining for IgM and CD 19 of 6  wk old outbred female Cd45'^ ' mice and 
Cd45^^ * litter mate control. The two boxed regions represent the CD19^gM' ceUs 
consisting of the pro- and pre-B cell cornpartments and CD19^IgM^ ceUs consisting 
of the immature and mature B cell compartments and the percentages of cells within 
these boxes are displayed above them. B) Cd45'' (shaded) and Cd45*'* (broad 
line) CD19^gM cells were gated on shown in (A) and overlay histograms of CD25 
or CD43 expression within these gates are displayed with the percentage of ceUs 
that are CD25^ or CD43 pre-B celk calculated and displayed.
Cd45^' B cells have unusual levels of cell surface markers
B cell development from IgM^IgD’® B cells to the most mature IgM‘®IgD*“ 
cells is characterised by changes in the expression levels of a number of makers, 
As CD45 was found to have a role in the pro-B cell to pre-B cell development I 
decided to assess die role of CD45 in this B cell transition as signal transduction 
from the BCR has been implicated in this developmental checkpoint (Torres et al., 
1996; Turner et al., 1997). The presence and maturity of B cells in the spleen of
80
Cd45 '^ mice was analysed using antibody staining and flow cytometry. Figure 10 
shows dot plot analysis of typical staining from Cd45^* and Cd45'^ ' splenocytes 
stained with anti-IgM and anti-IgD antibodies. Splenic B cells from Cd45*^* mice 
show the expected IgM/IgD staining patterns with a majority of the B cells having 
the mature phenotype of a high ratio of IgD to IgM (IgM‘®IgD“). In Cd45'^ ' mice, B 
cells are present in equivalent numbers to controls although they are unusual in that 
they have high expression levels of both IgM and IgD (IgM^TgD"" ) compared to 
controls (Figure 10). This suggests that the QMS-deficient B cells are less mature 
than controls as they do not have the most mature population of IgM'®IgD  ^ cells. 
To study this further, I analysed the expression of various markers that alter their 
expression levels during B cell maturation. I stained splenocytes with multiple 
antibodies and chsplayed the level of expression of these markers on B cells, by 
gating on IgM*IgD  ^ cells. Figure 10 shows that there are moderately increased 
levels of expression of the B cell coreceptor molecule CD 19, MHC class II, and 
complement receptor 1 and 2 (CRl/2), all of which are molecules whose 
expression increases during B cell maturation. This increase in expression was not 
due to an increase in cell size as measured by forward and side scatter analysis (not 
shown). There was not a general increase in the levels of all cytoplasmic membrane 
proteins, as expression of the CD22 was not increased. CD23 is another marker of 
B ceU maturity which increases in expression during B ceU maturation. Cd45 '' B 
ceUs express higher levels of this marker than controls suggesting that these cells 
are immature. HSA expression decreases as B cells mature and as Cd45''' B cells 
express lower levels of this marker this would suggest they are immature. In 
conclusion QMS-deficient B cells are unusual in that there is a contradiction 
between the level of expression of HSA, CD23 and IgM/IgD suggesting these cells 
are immature, however the expression of other developmental markers suggest 
more advanced maturation. It is difficult to reconcile these observations if these 
markers are only representing the developmental stage of the B cells in 
QMS-deficient mice. In addition to looking at the maturity of QMS-deficient B 
Cells I also analysed the levels of expression of the QD28 ligand, B7.2. Increased 
B7.2 expression is associated with 3  cell activation (Lenschow et al., 1994). The
increased levels of expression of this marker on C!D45-deficieht B cells suggests 
that these cells have an activated phenotype. This could be explained if CD45 is a 
negative regulator of BCR signalling and thus CD45-deficient B cells are more 
susceptible to activation on encounter with antigens.
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Figure 10: B cell surface marker egression. Representative flow 
cytometric analysis of splenocytes from Cd45 and Cd45'^ ' animals stained with 
anti-IgM and anti-IgD (dot plots-top left hand side). IgM^gD^ cells were gated and 
the percentages of gated lymphocytes displayed. Total B cell numbers are shown at 
the top of the dot plots. The levels of expression of cellular maturity and activation 
markers CD 19, CRl/2, MHC class H, CD23, HSA, B7.2 and CD22 from gated 
cells were obtained by three or four colour analysis and are displayed as histograms
(CûW5+/+-Shaded and Cd45~^'-hio2jl black lines).
Cd45^' B-1 cells are greatly reduced in number
As described in the introduction, the major B cell population consists of so- 
called B-2 cells, however another population of B cells called B-1 cells exist which 
reside predominantly in the peritoneal cavity of mice (Tarakhovsky, 1997). Mice 
deficient in positive regulators of signal transduction, such as CD 19, have reduced 
numbers of B-1 cells, whilst mice defective in negative regulators of signal
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transduction, such as CD22, have more B-1 cells. This suggests that the 
development or maintenance of this population of B cells require signal transduction 
from the BCR and that the strength of this signal determines the numbers of B-1 
cells present in the mouse. To determine whether CD45 maybe involved in this 
process, flow cytometric analysis was performed using markers of this population 
on cells flushed from the peritoneal cavity of CD45-deficient mice. B-1 cells can be 
subdivided into two distinct populations, B-1 a and B-lb cells. Both B-1 a and B-lb 
cells can be identified on the basis of their expression of IgM and CD 11b, whilst 
B-la cells can be specifically identified as IgM^CDS  ^cells. The peritoneal cavities 
of Cd45'^ * and Cd45'^ ' littermates were flushed and the presence of B-1 cells 
determined by their expression of these markers (Figure 11-boxed areas). Total 
numbers of B-1 cells (IgM^CDllb^ were greatly reduced in Cd45^' animals 
compared to Cd45*^* controls as seen by the reduction in IgM^CDllb^ cells (4.6- 
fold reduction-Figure 11). Moreover, the B-la cell population (IgM^CDS^) is 
reduced four-fold (Figure 11). Since the development or maintenance of B-1 cells 
requires signal transduction from the BCR, this suggests that CD45 is a positive 
regulator of signal transduction from the BCR on B-1 ceUs.
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Figure 11: CD45-deficient mice have a reduced number of B-1 ceils.
B-1 cells obtained by flushing the peritoneal cavity of mice were stained with 
anti-IgM and either anti-CD5 or anti-CD 11b. Boxed areas show percentages of 
IgM^CDllb^ total B-1 cells (upper panels) and the IgM^CD5^ B-la sub-population 
(lower panels). All plots are representative of the analysis of multiple mice.
Cd45*^ 'B ceils fail to proliferate on antigen stimulation
CD45-deficient B ceU lines have been shown to be defective in their 
proliferative responses to antigen receptor cross linking (Justement, 1997). To 
determine whether this is also true for mature re-circulating B cells derived from 
Cd45'^ ' mice, I purified splenic B cells using a negative selection protocol and 
stimulated them to proliferate in vitro by incubation with an anti-IgM antibody that 
crosslinks the BCR. This was conducted in the presence of IL-4 which enhances 
the proliferative response of the B cells to receptor cross-linking. This stimulation 
causes the proliferation of Cd45*^ * B cells, as measured by the incorporation of 
^H-thymidine, and the level of proliferation was dependent on the concentration of
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the anti-IgM antibody added (Figure 12). In contrast only a very low level of 
response in Cd45'^ ' B cells was detected at the highest doses of anti-IgM used, 
suggesting a severe deficiency in proliferative responses in Cd45'^ ' B cells. Cd45'^ ' 
B cells were, however, are able to proliferate in the presence of LPS or 
PMA+Ionomycin and in response to crosslinking of CD40, suggesting that this 
deficiency was specific to the BCR and not to other receptors (not shown). In 
conclusion, CD45-deficient mature B cells are defective in receptor-mediated 
proliferation suggesting that CD45 is a positive regulator of signal transduction 
from the BCR.
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Figure 12: CD45-defîcient B cells fail to proliferate on receptor 
stimulation. Purified splenic B cells were stimulated with anti-IgM (b-7-6) at the 
concentrations shown in the presence of IL4 (lOu/ml) for 3 days and proliferation 
was measured by ^H-thymidme incorporation in counts per min (CPM). Results 
shown are the mean of triplicate samples and error bars show standard deviation. 
Similar results were obtained using a polyclonal goat anti-mouse anti-serum (not 
shown).
Cd45^''B cells expressing a transgenic receptor can be efficiently 
deleted
B cells firom Cd4S'~ mice fail to proliferate when stimulated by crosslinking 
of their BCR and this suggests that CD45 is required as a positive regulator of 
signal transduction in these cells. To examine the effects of this mutation on
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another BCR-mediated phenomenon, that of the negative selection of B cells on 
encounter with autoantigen, I bred Cd45'^ ' mice with mice carrying the 3-83|x5 
(3-83) transgene. 3-83 transgenic mice express IgM and IgD specific for H-2K'' 
and H-2K*’, but which do not bind H-2K‘*. In the absence of aiitoantigen, B cell 
development can occur with the majority of B cells expressing the 3-83 receptor. In 
the presence of H-2K"^  or H-2K*’, B cells in 3-83 transgenic mice are deleted in 
response to autoantigen. Figure 13 shows flow cytometric analysis of bone 
marrow from Cd45'^ ' and Cd45*^ * imce expressing the 3-83 receptor in the presence 
or absence of the negatively selecting ligand H-2K*’. Cd45^' B cells expressing the 
3-83 transgene were found to be efficiently produced in the marrow of both Cd45^* 
and Cd45^' animals on the non-deleting 11-2** genetic background (top panels). In 
the presence of H-2K*’, the negatively selecting hgand, B cells expressing the 3-83 
transgene are efficiently eliminated in the bone marrow of both Cd45^* and Cd45'^ ' 
mice (Figure 13-lower panels) and no 3-83-expressing B ceUs were found in the 
lymph node or spleen of these mice (data not shown). Thus although Cd45'^ ' B 
cells are deficient in antigen receptor-mediated proliferative responses to receptor 
crosslinking in vitro, CD45 does not appear to be necessary for BCR mediated 
negative selection events in vivo.
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Figure 13: B cell development in the bone marrow Cd45"^"and Cd45*^ * 
mice expressing the 3-83 transgenic B cell receptor. Flow cytometric 
dot plots of bone marrow of Cd45*^ '*' or Cd45'^ ' mice carrying the 3- 83| l i ô  transgene 
stained with anti-CD 19 and an anti-idiotypic antibody specific for the 3-83 BCR 
(anti-3-83) in the presence (lower panels, H-2*^ ‘‘) or absence (upper panels, H-2‘*^‘*) 
of the deleting ligand MHC class I H-2K^. Cells expressing these markers have 
been gated (box) and their percentages calculated.
This transgenic mouse model can also be used to assess the role of CD45 in 
allelic exclusion of both Ig heavy and light chains. As discussed in the 
introduction, allelic exclusion is a mechanism that requires signalling events from 
antigen receptors. The transgenic 3-83 receptor is of the IgM® allotype so by 
breeding these mice to have endogenous heavy chains of the IgM** allotype it was 
possible to assess by flow cytometry allelic exclusion of endogenous heavy chain 
gene rearrangement by the transgenic receptor. Figure 14 shows flow cytometric 
analysis of splenic B cells stained for the presence of the 3-83 receptor and for the 
endogenous IgM*' allotype. In the absence of the deleting ligand the transgene was 
found to efficiently prevent the expression of endogenous receptors in Cd45'^ ‘ B 
cells as seen as an absence of IgM*' expressing B cells (Figure 14-top panels). Only 
in the presence of the cognate ligand for the 3-83 receptor do we find a small
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number of B cells in both Cd45*^ * and Cd45 '^ mice that now express IgM*' (Figure
14-bottom panels). It is likely that these result from a small population of cells in 
which 3-83 expression has been suppressed by some epigenetic means allowing 
endogenous heavy chain rearrangement and thus escape from deletion. However in 
both Cd45^‘* and Cd4S '^' mice there is no evidence of a population of cells 
expressing both the transgenic IgM* and endogenous IgM*' heavy chains which 
would be indicative of a failure of heavy chain allelic exclusion. This data suggests 
that not only is CD45 not required for negative selection but also that heavy chain 
allelic exclusion does not require CD45.
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Figure 14: Heavy chain allelic exclusion in Cd45“^“ and Cd45^* mice
expressing the 3-83 transgenic B cell receptor. Flow cytometric dot plots 
of bone marrow of Cd45 or Cd45'^ ' mice carrying the 3-83p6 transgene stained 
with anti-IgM*' and an anti-idiotypic antibody specific for the 3-83 BCR toti-3-83) 
in the presence (lower panels, H-2*'^ )^ or absence (upper panels, H-2 )^ of the 
deleting ligand MHC . class I H-2K-. Cells expressing these markers have been 
gated ^ox) and their percentages calculated.
88
The 3-83 transgene uses a k  light chain thus it is also possible to assess 
light chain allelic exclusion using this mouse model by staining for endogenous X 
light chain rearrangement. Figure 15 shows flow cytometric analysis of splenic B 
cells from Cd45*'* and Cd45'^ ' mice that express the 3-83 transgene. In the absence 
of H-2K*’ both Cd45*^ '^  and Cd45'^ ' mice contain very few cells that express X light 
chain suggesting that the 3-83 transgene drives efficient light chain allelic exclusion 
in the mutant mice (Figure 15-top panels). In the presence of H-2K*’, both Cd45^* 
and Cd45^' mice have B cells that express endogenous X light chain (Figure
15-bottom panels). By this rearrangement these cells alter the specificity of their 
antigen receptor and thus avoid negative selection by altering the specificity of their 
antigen receptor - a process called receptor editing (Hertz and Nemazee, 1998).
In conclusion, although CD45-deficient B cells fail to undergo proliferation 
on receptor crosslinking, the processes of negative selection and both heavy and 
light chain allelic exclusion do not require CD45 and suggest that different signal 
transduction pathways are used in these receptor mediated events.
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Figure 15: Light chain allelic exclusion and receptor editing in
Cd45“^“ and Cd4S*^ * mice expressing the 3-83 transgenic B cell 
receptor. Flow cytometric dot plots of bone marrow of Cd45"^* or Cd45'^ ' mice 
carrying the 3-83p5 transgene stained with anti-IgM* and antibody specific for X 
light chain {X) in the presence (lower panels, H-2 *'^ '*) or absence (upper panels, 
H-2‘*'‘*) of the deleting ligand MHC class I H-2K\ Cells expressing these markers 
have been gated (box) and their percentages calculated.
Cd45^' B cells expressing a transgenic receptor have unusual levels of 
the receptor.
B cell development in the bone marrow of Cd45'^ ' mice expressing the 
3-83p5 transgene was found to occur normally (Figure 13-top panels), I therefore 
examined whether these cells were present in the peripheral lymphoid organs. I 
performed flow cytometric analysis on splenic cells from these mice stained with 
anti-IgM and anti-IgD antibodies to assess the maturity of these cells and compared 
them to controls. B cells firom both Cd45*^^  and transgenic mice expressing
the 3-83 BCR accumulate in the spleen in high numbers on the non-deleting H-2‘*
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genetic background (Figure 16- top panels). These Cd45'^ ' B cells expressing the 
3-83 transgene have an altered level of expression of IgM and IgD being IgM*"IgD*° 
cells compared to the IgM*“IgD*“ phenotype seen in non-transgenic Cd45''' B cells 
(compare Figure 16-top panels and Figure 10). The failure of these cells to increase 
expression of IgD could suggest that the B cells are less mature that those cells seen 
in the absence of the transgenic BCR. In the presence of the deleting MHC ligand, 
H-2*’, the majority of B cells are eliminated from the spleen of both Cd45*^* and 
mice. Some B cells accumulate in the spleen (Figure 16-lower panels) and 
lymph node (not shown) of both 3-83 transgenic Cd4^ *^ * and Cd45'^ ' mice. These B 
cells accumulate due to rearrangement of endogenous heavy and light chains which 
alter the receptor specificity of the BCR allowing these B cells to evade deletion. 
Due to this alteration of receptor specificity these cells are not recognised by the 
anti-idotypic antibody (data not shown). CD45-deficient B cells that accumulate in 
this fashion have a IgM*" IgD*" phenotype similar to CD45-deficient B cells that 
develop in the absence of the 3-83 receptor. In conclusion, the expression of the 
rearranged BCR in transgenic mice appears to alter the level of receptor expression 
and possibly the maturity of non-transgenic CD45-deficient B cells when compared 
to CD45-deficient B cells expressing endogenous receptors.
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Figure 16: CD45-defîcient B cells expressing the 3-83 transgene
have unusual receptor levels. Flow cytometric analysis of splenic B cells
from 8  wk-old female Cd45*^* and Cd45'^ ~ mice expressing the 3-83p6 BCR
transgene in the presence (top panels) or the absence (lower panels) of the 
negatively selecting ligand H-2K*’, stained with antibodies to IgM and IgD.
CddS"'' B cells fall to mobilise calcium correctly following antigen 
receptor stimulation
The defective proliferative response of Cd45'^ ' B cells in vitro is suggestive 
of a failure of signal transduction events from the BCR. One of the hallmarks of 
BCR-induced signalling is an increase in intracellular calcium (Ca^ )^ concentration. 
Initially this occurs by a rapid and transient release of Ca^ * from intracellular stores 
and is followed by a slower influx of Ca^^  from extracellular sources. Figure 17 
shows the results of Ca^  ^mobilisation studies performed by flow cytometry. Here
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T cells are excluded from the analysis by staining for CD4 and CDS and gating on 
those cells negative for these markers (Figure 17-boxed area on dot plot), these are 
predominately B cells (not shown). CeUs were stimulated by the addition of 
anti-IgM and intraceUular Ca^  ^concentrations monitored by the changes in the ratio 
of violet/blue fluorescence of a Ca^  ^binding dye Indo-1. Both Cd45^' and Cd45*^ * 
B ceUs are able to mobilise Ca^  ^from intraceUular stores as seen by the initial peak 
in dye fluorescence ratio seen shortly after the addition of the antibody (Figure 17 - 
after broad arrow). The influx of Ca^  ^from extraceUular stores occurs shortly after 
the mtraceUular release of Ca^^  and is seen as a prolonged but shadow increase in 
ratio of the dye fluorescence in the cells (Figure 17A-bracketed area). The addition 
of the chelating agent EGTA to the medium prevents the influx of extraceUular Ca^^  
and ceUs do not appear in this area (Figure 17B-bracketed area), this can be 
reversed by the addition of excess Ca^  ^to the ceUs (Figure 17B-fine arrow). Cd45 '' 
B ceUs are defective in their abiUty to mobiUse Ca^ "'" from extraceUular sources as 
they faU to demonstrate the prolonged increase in [Ca^ *] (Figure 17C). In 
conclusion, these results indicate that CD45 is a positive regulator for signal 
transduction pathways leading from the BCR to extraceUuar but not intraceUular 
Ca^ '’ mobilisation pathways.
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Figure 17: Defective Ca^ flux in Cd45^' B cells. Representative 
experiment on splenic B cells from 6  wk old female and Cd45'^ ' mice
pre-loaded with Indo-1 and stimulated with anti-IgM antibody (b-7-6). (A) Left 
hand side dot plots show wildtype cells stained with CD4 and CDS. Cells were 
gated (boxed area) on cells expressing neither CD4 or CDS and the percentage of 
cells within this gate displayed. Intracellular calcium concentration in B cells (the 
predominant cell type gated in the CD4/CDS plot) is shown as a ratio of Indo-1 
violet/blue fluorescence (Ratio: calcium bound dye/ calcium free dye) versus time. 
Each channel on the time axis corresponds to 500ms. CeUs were stimulated with 
50pg/ml a n ti- I^  at the time indicated by the broad arrow. This results in an initial 
peak representing intraceUular Ca^ ''’ release foUowed by a shaUow broad peak due to 
extraceUular Ca  ^ flux (bracketed area). (B) As above but in the presence of the 
chelating reagent EGTA which prevents extraceUular Ca^  ^ flux as indicated by a 
faUure to see ceUs within the bracketed area. Addition of excess Ca^^  to the cells 
(fine arrow) restores the extraceUular Ca^  ^ flux and cells return to the bracketed 
area. (C) As for Cd4S^* ceUs. Note the absence of ceUs in the bracketed area after 
the initial peak due to intraceUular Ca^  ^flux.
Summary
Cd45^' mice produce equivalent numbers of B ceUs compared to/control 
animals. These B cells are unusual in that they have altered levels of ceU surface 
markers. In apparent contradiction, these ceUs appear immature on the basis of their
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expression levels of IgM and IgD and yet have increased expression of other 
markers that are associated with increasing B cell maturation. In addition, 
CD45-deficient B cells have increased expression of B7.2, suggesting that these 
cells are activated and therefore that the absence of CD45 has made the BCR more 
susceptible to activation. In contrast, on BCR stimulation in vitro these B ceUs 
have a diminished BCR-mediated proliferation response. B-1 ceU populations are 
greatly reduced in these mice suggesting that CD45 is also a positive regulator of 
BCR signalling B-1 cells.
The use of the 3-83 transgenic BCR demonstrates that 3-S3/Cd45''' B cells 
can be produced however these cells express unusual levels of IgM and IgD, 
suggesting that they are less mature than CD45-deficient B cells that develop in the 
absence of the transgene. Cd45'^ ' B cells are deleted normally in the presence of the 
negatively selecting ligand for the transgenic receptor and undergo both Ig heavy 
and light chain allelic exclusion normally suggesting that CD45 is not required for 
these processes. Finally Cd45 '' B cells have a diminished but not absent Ca^  ^ flux 
on receptor stimulation that could explain the abolition of some BCR-mediated 
responses.
3.3 T cell development in Cd45''' mice
Cd45^' T cells have a partial block in early T cell development
CD45 has been implicated as a positive regulator of signal transduction from 
the TCR in the majority of studies conducted on CD45-deficient T cell lines in vitro. 
I therefore decided to assess the effect of CD45 deficiency on the development of T 
cells in Cd45'^ ' mice with particular, emphasis of those developmental checkpoints 
that require signal transduction from the receptor.
To assess the effect of CD45 deficiency on the development of T cells in 
Cd45^' mice, flow cytometric analysis was performed using antibodies specific for 
markers of early T cell development. T cells develop in the thymus from CD4 CD8
double negative (DN) thymocytes through an intermediate double positive (DP) 
stage where thymocytes express both the CD4 and CD8  coreceptor molecules, to 
single positive (SP) mature CD4^ or CD8  ^ T cells. The DN stage of T cell 
development can be further subdivided into distinct developmental steps based on 
their cell surface expression of CD25 and CD44 molecules. DN thymocytes 
develop from CD44^CD25* (DNl) cells into CD44^CD25^ (DN2) cells, next into 
CD44CD25^ (DN3) and finally into CD44CD25 (DN4) thymocytes prior to 
leaving the DN compartment (Godfrey and Zlotnik, 1993; Nikolic-Zugic, 1991). 
Figure 18A shows a typical flow cytometric analysis using these markers and 
Figure 18B shows the enumerated results of three mutant and control mice. Cells 
were stained with antibodies to CD4, CD8 , CD44 and CD25 and analysed using 
four colour flow cytometry. * -  s  t o  be
~ > , IbesK is a greater than 5-fbld
accumulation of DN cells that are CD44'CD25^ (DN3) cells in Cd45^' mice 
compared to Cd45*^ '^  controls. A block at this stage of T cell development has been 
reported in mice mutant for Rag-\, TCRp and pTo, suggesting that this block is 
associated with pre-T cell receptor signalling (Fehling et al., 1995; Levelt et al., 
1993; Mombaerts et al., 1992). This deficiency in T cell development in Cd45'^ ' 
mice is a partial block as cells can develop into CD44 CD25 T cells and leave the 
DN T cell compartment to become DP thymocytes. This shows that CD45 is 
required for the efficient progression through the DN3 stage of thymocyte 
development and suggests that CD45 is a positive regulator of signal transduction 
fi-om the pre-T cell receptor.
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Figure 18: Early T cell development Is impaired in Cd45^' mice. (A) 
Typical flow cytometric analysis of CD44 and CD25 expression on DN thymocytes 
from 6  wk old female outbred mice with the percentages shown for the least mature 
CD44+CD25' (DNl) fraction, the CD44+CD25+ (DN2) fraction, the CD44CD25 
(DN3) fraction and the most mature CD44 CD25' (DN4) fraction ^  DN 
thymocytes. (B) Bar graph showing mean numbers of DN thymocytes f r ^  3 
control {Cd4T*) and 3 mutant {Cd4T') outbred mice (female; 6  weeks old). Error 
bars represent standard error of mean (s.e.m.). Numbers are shown for the DNl, 
DN2, DN3 cells and the most mature DN4 thymocytes. Note the five-fold increase 
in DN3 cells in Cd45 ‘' mice.
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The development of single positive thymocytes is blocked in Cd45^' mice
T cells develop from the DP stage of thymic development into CD4^ or 
CD8  ^SP thymocytes that exit the thymus and enter the periphery. As described in 
the introduction, the positive and negative selection of thymocytes at the DP stage of 
T cell development relies on the strength of signal from the TCR. To determine the 
role of Cd45 in these developmental steps, flow cytometry was performed on 
Cd45'^ ' thymi using antibodies to CD4 and CD8  and the absolute numbers of cells 
were calculated. Thymic cellulaiity in Cd45'^ ' mice is typically half that of control 
mice. This reduction can almost entirely be accounted for by a reduction in the 
number of DP thymocytes present in Cd45'^ ' mice (Figure 19). This reduction is 
likely to be to the reduced efficiency of transit into the DP stage of thymocyte 
development due to the earlier block at the DN3 stage of T cell development. There 
is also a dramatic 7-13-fold reduction in the number CD4^ and CDS* SP cells in the 
thymus of Cd45'^ ' mice. A similar decrease was also seen in the numbers of CD4^ 
and CD8  ^peripheral T cells in the spleen and lymph nodes of the mutant mice (not 
shown). This is suggestive of a block in positive selection events. As seen with 
the earlier block at the DN stage of T cell development, this is not a complete block 
as some thymocytes develop into CD4^ SP and CD8  ^SP cells. This suggests that 
CD45 may be required for the efficient signal transduction from the TCR during 
positive selection.
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Figure 19: Cd45''' thymic deveiopment is impaired. Bar graph showing 
mean numbers of thymoc)4es from 6  control {Cd45*'*) and 6  mutant (Cd45'') mice 
(female; 7-8 weeks old) inbred on a BALB/c background. Error bars represent 
standard error of mean (s.e.m.). Numbers are shown for the least mature double 
negative (DN) fraction of thymocytes expressing neither CD4 nor CD8  (CD4 CD8 ’), 
the double positive (DP) friction expressing both (CD4^CD8^ or the most mature 
single positive (SP) fractions expressing ei&er C!D4 or CD8  alone (CD4^CD8‘ and 
CE)4'CD8^). Œ45-deficient thymocytes show a 2.6-fold reduction in the number 
of DP and a 7 to 13-fold reduction in the number of SP cells. Note the logarithmic 
scale.
Thymocytes from Cd4S^' mice express altered levels of cell surface 
markers
A number of cellular markers can be used to assess maturation of T cells 
during their development. Flow cytometric analysis was performed to assess the 
expression of these markers during T cell development in Cd45'^ ' mice. A hallmark 
of DP thymocytes undergoing positive selection is an increase in CD3 expression 
from intennediate to high levels and the induction of CD69 expression. Figure 2 0  
shows flow cytometric analysis of Cd45'^ ' thymocytes using these markers in 
multicolour analysis. Cells were stained with antibodies to CD4 and CD8  and 
gating was used to display as histograms the levels of expression of these maturity 
markers in DP cells. Firstly it can be seen that Cd45'^ ' DP thymocytes contain cells
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that express very high levels of the CD4 and CD8  coreceptor molecules compared to 
controls. In addition Cd45'^ ' DP thymocytes contain very few cells that are CDS'", a 
characteristic of cells undergoing positive selection. Instead Cd45'^ ' mice have many 
DP cells with intermediate levels of expression of CD3 suggestive of a block at this 
point in development. Cd45'^ ' DP thymocytes also contain fewer CD69"^  cells a 
further characteristic of a failure of positive selection (Swat et al., 1993; Wang et 
al., 1995; Yamashita et al., 1993). CD45-deficient DP thymocytes also fail to 
up-regulate the expression of CD5 (Figure 20) a marker that normally increases in 
expression during the transition from DN to DP cells (Dutz et al., 1995; Sheard et 
al., 1996). The few SP thymocytes and peripheral T cells that do develop in Cd45 '' 
mice are unusual in that they express higher levels of expression of CD69 and HS A 
than control cells (not shown) suggesting that a lack of CD45 has had a profound 
effect on the biology of these cells.
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Figure 20: Thymic development in Cd45^' mice. Typical flow cytometric
analysis of Cd45'^ ^'^  and Cd45~ '^ thymocytes stained with anti-CD4 and anti-CD8 . . 
The dot plots at the top show flow cytometric analysis of a Cd45*'* and Cd45 '^ 
thymus stained for CD4 and CD8 . Levels of expression of cellular maturity and 
activation markers in the DP population are displayed in the histogram plots (gated 
as shown) and was achieved by three or four colour flow cytometric andysis
(GW5+/+ -shaded; Cd45'^ “ thick black line)
CddS"^ ' T cells have a “previously activated” phenotype
Lymphocytes on encounter with antigen become activated, and these cells 
can be distinguished by their expression of the cell surface markers CD44 and 
L-selectin (Barrat et al., 1995; Gerberick et al., 1997; Khan et al., 1996; Tietz and 
Hamann, 1997). Those ceUs which are activated are typically CD44*" and 
L-selectin*® whilst naive T cells have CD44'® L-selectin*" phenotype. As CD45 is 
thought to be a positive regulator of signal transduction from the TCR I decided to 
assess Cd4S '^ mice to see if this mutation prevented the activation of CD45-deflcient 
T cells. Figure 21 shows flow cytometric analysis of lymph node T cells from 
Cd45'^ ' mice compared to Cd45*^ * mice, assessed for the expression of these 
activation markers. It can be seen that in Cd45*^^  mice, both CD4^ and CD8  ^ T
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cells are mainly naive (CD44'°L-selectin*"). In contrast, most Cd45'^ ' CD4^ and 
CDS* SP T cells have a “previously activated” phenotype (CD44*"L-selectin'°), This 
is surprising if CD45 is a positive regulator of TCR signalling, since the mutation 
would be expected to prevent these cells becoming activated. These results suggest 
that CD45 may be a negative regulator of TCR signalling and that these cells are 
more susceptible to activation on encounter with antigen.
CD44
Cd45 +/+
"if 1 0’ if if
Cd45 - / -
• ••
•
■ " " ■ â• •• y : . ' - 2 6 %
Jo " if  10
2 ;
■ f e .
6 0%
”21
4%
■1 0»
CD4+
CD8+
L-selecün
Figure 21: Flow cytometric analysis of lymph node cells for 
activation markers. Lymph node cells stained with anti-CD4 and anti-CD8  
together anti-CD44 (IM7) and anti-L-selectin (Mel 14). CD4* or CD8 * T cells were 
gated and the levels of CD44 and L-selectin expression was then displayed as dot 
plots by four colour analysis. The gated region represents naive L-selectm*"CD44'° 
cells and the percentages of these cells are displayed.
Positive selection of the F5 Class ! restricted transgene is inhibited in 
Cd45^' mice
The reduction of the number of CD4* and CD8 * T cells present in the 
periphery of Cd45'^ ' mice is suggestive of a block in positive selection. DP
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thymocytes undergoing positive selection increase their levels of TCR and induce 
the expression of CD69, whilst there is a concomitant decrease in HSA and CD5 
expression (Dutz et al., 1995; Sheard et al., 1996). Alterations in the level of 
expression of these markers and the failure to accumulate normal numbers of 
peripheral T cells is consistent with a failure of positive selection of T cells within 
these mice. However CD45 is expressed on all nucleated haemopoietic cells and it 
is possible that a defect in cells, other than the thymocytes themselves, is 
responsible for this failure of selection. To address this, I reconstituted lethally 
irradiated mice with mixtures of Cd45*'* and Cd45'^ ' hon<& marrow. Flow 
cytometric analysis of these chimeric animals demonstrated that marrow gave 
rise to both B and T cells with identical phenotypic properties to those found in 
non-chimeric Cd45'^ ' mice (data not shown) suggesting that these developmental 
blocks and phenotypic dterations are cell-autonomous, ie. that CD45 is required 
within the B or T cells themselves for normal development.
To test the requirement for CD45 in more detail, transgenic TCRs were 
introduced onto the Cd45'^ ' genetic background. The transgenic TCR recognises an 
influenza nuclear protein peptide in the context of H-2D*’ and is positively selected. 
on the H-2*’ haplotype (Mamalaki et al., 1993). F5/Cd45' '^ mice were further bred 
to Rag-l'^' mice to make F5/Cd45^'/Rag-l '' mice. The absence of Rag-l gene 
expression prevents endogenous TCR rearrangements and allows the study of the 
selection of the transgenic receptor in the absence of endogenous TCRs. Flow 
cytometric analysis was performed on the thymi of these mice and compared to 
Cd45*'* controls (Figure 22). The transgenic TCR was identified by an 
anti-Vp-11.0 antibody (the Vp used by the transgenic receptor). Firstly it can be 
seen that there are similar numbers of CD4*CD8* DP cells in both Cd45*^* and 
Cd45'^ ' mice. However, only Cd45*'*'D? cells are able to express high levels of the 
transgenic receptor, Cd45'^ ' DP cells being either negative or having intermediate 
levels of the receptor suggesting a deficiency in positive selection in these mice. 
Consistent with this observation is the profound lack of CD8 * SP thymocytes in 
Cd45'^ ' mice. The small number of CD4 CD8 * cells found in the mutant thymi are 
likely to be transitional cells from the DN to DP stage of thymocyte development
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that express low levels of CD8  during this transition. In contrast to control mice, 
no CD8  ^cells are found in the spleen or lymph node of ¥5ICd45'^'IRag-\'‘' mice (not 
shown). Thus CD45 is absolutely required for the positive selection of thymocytes 
bearing the F5 TCR.
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Figure 22: Failure of positive selection in Cd45'^ ' thymocytes 
expressing the F5 transgenic TCR . Control (Cd45*^*) and mutant mice 
{Cd45'^ ') ( 6  week old) expressing the transgenic F5 TCR on the positively selecting 
H-2*’ background in the absence of Rag~\ gene expression. Expression of the 
transgenic TCR on DP cells (gated as shown in dot plots) was eviuated using an 
anti-Vp-11 antibody and displayed as histograms (bottom). Percentage of Vp-11*“ 
cells is indicated. All plots are representative of multiple experiments.
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Positive selection of the BM3.6 Class ! restricted TCR is inhibited in 
0/45^" mice
To confirm the deficiency of positive selection of thymocytes found in the 
F5 expressing transgenic mice the Cd45'^ ' mice were bred to express a second class 
I-restricted transgene, BM3.6. BM3.6 is a class I-restricted anti-H-lK** TCR which
is positively selected on an H-2 ^ haplotype (Sponaas et al., 1994). These 
experiments were conducted in the presence of Rag-1 and Rag-2 gene expression, 
so endogenous gene rearrangements can still occur. However the transgenic TCR 
can be distinguished from endogenously rearranged receptors by the use of an 
anti-clonotypic antibody which specifically recognises the BM3.6 TCR. Flow 
cytometric analysis of thymocytes from control animals {Cd45*'^ ) expressing the
positively selecting ligand H-2K^ was conducted by staining with anti-CD4 and 
anti-CD8  antibodies (Figure 23). Many CD8  ^SP cells accumulate in the thymus of 
Cd45*^ * mice (Figure 23) and these cells express high levels of the transgene (not 
shown). These develop into peripheral CD8  ^T cells which express high levels of 
the BM3.6 TCR and are mature as determined by cell surface markers (Figure 23- 
histograms). Cd45^\ BM3.6 mice develop equivalent numbers of DP thymocytes 
as Cd45^* mice (Figure 23). However, very few cells develop from these DP cells 
to become CD8 ^SP cells, demonstrating a failure of positive selection of this 
transgene in the absence of CD45 (Figure 23). The small number of cells found in 
area gating the CD8 ^SP cells in mutant thymi are likely to be transitional cells from 
the DN to DP, as despite expressing the transgene they do not have the low levels 
of expression of CD4 characteristic of CD8  ^SP thymocytes and in addition CD8  ^T 
cells in the spleen or lymph node do not express the transgenic receptor but express 
TCRs derived from endogenous gene rearrangements (Figure 23-hisotgrams). This 
demonstrates an absolute requirement for CD45 in the positive selection of a second 
class-I-restricted TCR.
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Figure 23: Failure of positive selection in Cd45^' thymocytes 
expressing the BM3.6 transgenic TCR. Cd45"'^ * and Cd45'^ ' mice were bred 
to contain the BM3.6 transgene and express the positively selecting ligand MHC 
class I Flow cytometric analysis was performed on thymocytes stained with 
anti-CD4 and anti-CD8  together with an anti-clonotypic antibody. Histograms 
(bottom) show expression of the BM3.6 TCR gated on CD8  ^ splenic T cells (top). 
Percentages of cells within the gated regions are displayed. All plots are 
representative of multiple experiments.
Positive selection of the A1 Class-II restricted TCR is inhibited in 
Cd45^' mice
To determine whether the positive selection of class Il-restricted thymocytes 
requires CD45, the Cd45'^ ' mice were bred to express the A1 transgenic TCR (to 
make Al/Cd45^ mice). The A1 transgene recognises a peptide from the male 
specific H-Y antigen presented by MHC class III-E^ and is positively selected on
the H-2^ haplotype (Douek et al., 1996). These experiments were conducted in the 
presence of endogenous Rag-l and Rag-2 gene expression, so the mice are able to
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rearrange endogenous TCRs. No-clonotype specific antibody exists for the A1 
TCR however the transgenic receptor can be distinguished by its expression of 
Vp8.2. Figure 24 shows a typical flow cytometric analysis of K\ICd45'^ ' and 
A\ICD45^* female mice (where the negative selecting H-Y ligand is absent) on the
positively selecting H-2^ genetic background. Thymocytes were stained with 
anti-CD4 and anti-CD8  antibodies and the expression of Vp8.2 on CD4  ^ SP cells 
displayed as histograms. Firstly it can be seen that there are equivalent numbers of 
DP cells in both Cd45*^^  and Cd45~^ ' mice (Figure 24). In contrast to control mice, 
very few DP thymocytes develop into CD4  ^SP cells in AHCd45'^ ' mice and those 
that do develop express predominately endogenously rearranged receptors. In 
addition no Al-expressing T cells are found in the periphery of these mice. These 
observations demonstrate an absolute requirement for CD45 for. the efficient 
positive selection of the A1 class-II restricted TCR.
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Figure 24: Thymocyte development in Cd45“/' and Cd45+/+ mice 
carrj^g the A1 transgenic TCR. Cd45^'\ and Cd45''' mice were bred to 
contain the A1 transgene and express the positively selecting hgand MHC class H 
I-E . Thymocytes were stained with anti-CD4 and anti-CD8  together with an 
anti-Vp8.2 antibody. Histograms (bottom) show expression of the Vp8.2 
expression on CD4^ SP cells gated as shown in the dot plot (top). Percentages of 
cells in gated regions are displayed. Percentages on histograms show fraction of 
cells that are Vp-8.2\ All plots are representative of multiple experiments.
Cd45^' thymocytes have a reduced sensitivity to a positively selecting 
ligand
To further investigate the lack of positive selection of Cd45'^ ' thymocytes, a 
bi-specific antibody that co-crosslinks the CD3 and CD4 molecules was used to 
induce thymocytes to develop into SP cells in neonatal thymic organ cultures 
(NTOC) in vitro in a dose-dependent manner (Basson et al., 1998; Bommhardt et 
al., 1997). This reagent allows the determination of whether CD45-deficient
108
thymocytes can be positively selected by increasing doses of stimulus. Figure 25 
shows a graphical representation of total CD4  ^SP cells generated from Cd45*'* and 
Cd45'^ ’ neonatal thymi stimulated in vitro with increasing concentrations of the 
anti-CD3/CD4 bi-specific antibody as assessed by fiow cytometric analysis. It can 
be seen that at very high concentrations of the crosslinking antibody both Cd45'^ ''^  
and Cd45'^ ' thymocytes are induced to develop into C!D4^  SP cells in equivalent 
numbers. However, at lower concentrations of this antibody, many fewer CD4^ SP 
cells developed in Cd45'' thymi. These results are consistent with the idea that 
Cd45^' thymocytes require a greater level of receptor stimulation to induce positive 
selection than controls and suggests an altered threshold for antigen receptor 
signalling in Cd45'^ ' thymocytes during positive selection.
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Figure 25: Cd45 '^‘ thymocytes have a reduced sensitivity to a
positively selecting ligand. Graph of total numbers of CD4^SP cells 
generated on stimulation of neonatal thymic cultures from Y’SICd45'*'IRag-Ÿ' mice 
stimulated with a bi-specific anti-CD3/CD4 antibody at the indicated concentrations. 
CD4  ^SP cells were assessed by flow cytometric analysis and total cell numbers 
calculated. Error bars are standard error of mean.
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Cd4S^' thymocytes can undergo negative selection
To examine the requirement for QD45 in the negative selection of 
thymocytes Cd45'^ ' mice were bred to express the BM3.6 TCR on the negatively 
selecting H-2K*’ background. Figure 26 shows the result of flow cytometric 
analysis of thymi from mutant and control mice expressing the transgene on the 
negatively selecting background. Thymocytes were stained with anti-CD4 and 
anti-CD8  and the level of expression of the transgene expressed on CD8  ^SP cells 
displayed as histograms. Firstly it can be seen that there is a dramatic deletion of 
both Cd45*^ * and Cd45'^ ' DP thymocytes in the presence of the negatively selecting 
ligand H-2K*’ (Figure 26). This deletion is associated with a decrease in thymic 
cellularity within these mice (approximately 30 fold - compare cellularity in Figures 
23 and 26). A small number of CD4^SP and CD8  ^SP thymocytes are present in the 
thymus of both Cd45*^* and Cd45'^ ' mice. These cells are predominantly 
clonotype-negative in both Cd45*'* and Cd45^' mice and are present due to 
endogenous TCR gene rearrangements, since these mice were Rag-\, -2*. 
Furthermore, no BM3.6 -expressing cells are found in the spleen or lymph node of 
control or mutant mice (not shown). These results demonstrate that negative 
selection of the BM3.6 TCR occurs normally in Cd4S''' mice and thus CD45 is not 
required for the TCR signalling that drives this selection event.
110
Cd45+/+ Cd45
3.0 X 10 3.3 X 10
CD4
Counts
CDS
410
BM3.6
Figure 26: CD45-deficient thymocytes can undergo negative
selection. Flow cytometric analysis of thymi from control {Cd45'^  and mutant 
(Cd45^') mice (8-10 week old) expressing the BM3.6 transgenic TCR on a deleting 
H-2'’ background. These mice are Rag-l'^*, so some endogenous TCR genes are 
expressed. The total number of thymocytes is shown above each plot. The 
histograms show expression of the transgene in CDS^SP cells.
Cd45^' mice have an altered sensitivity to the negative selection of 
lymphocytes induced by endogenous superantigens
To further characterise negative selection of thymocytes, deletion in 
response to endogenous superantigens was studied. As described in the 
introduction, superantigens are presented by MHC molecules outside the peptide 
binding groove and are likely therefore to provide a weaker stimulus than 
conventional antigens. BALB/c mice present proteins encoded by endogenous 
mouse mammary tumour proviruses (M/v loci) in association with the MHC class II
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molecule I-E^ and this results in the specific deletion of CD4* SP cells expressing 
Vp 3, 5 and 11 (Simpson et al., 1993). In contrast, Vp8 -expressing SP cells do not 
undergo Afrv-mediated deletion in the BALB/c strain and are used as a control in 
these experiments. B6  mice which have a deletion in I-E are unable to present these 
Mtv superantigens and cannot delete the relevant Vp-expressing cells. Figure 27 
shows the result of flow cytometric analysis of Cd45'^ ' BALB/c mice and Cd45*'* 
BALB/c controls compared to B6  mice for their ability to delete T cells expressing 
particular Vp genes. Cd45'^ * mice are found to have many fewer Vp 3, 5 and 11 
CD4  ^T cells compared to the control B6  mice due to the negative selection of these 
cells in the presence of the deleting superantigen. In contrast Cd45'^ ' mice clearly 
have more CD4* T cells which express Vp 3, 5 and 11 though the numbers of these 
cells are reduced in comparison to the B 6  mice suggesting that there is a partial 
block in the negative selection of these cells. As expected all three mouse strains 
were found to contain Vp8.2^ cells, since TCRs expressing this Vp do not bind to 
the Mtv superantigen. This demonstrates at least a partial requirement for CD45 in 
the deletion of superantigen-specific T cells. In an additional experiment Cd45* '^i 
mice were found to delete Vp 3, 5 and 11-expressing T cells in a similar maimer to 
Cd45*^ * mice (not shown).
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Figure 27: Mtv superantigen deletion of CD4* lymph node T ceils 
expressing particular Vp genes. Bar graph representing the mean percentage 
of CD4^ T cells expressing Vp3, 5, 8.2 or 11 in lymph nodes taken from three 
Cd45'^ ' mice backcrossed onto BALB/c {Cd45'^ ') and from three Cd45^* littermates 
{Cd45*^*). Errors bars show standard error of mean. Percentages of CD4* T cells 
expressing the same Vp genes in an age-matched C57B1/6 (B6 ) mouse are shown 
for comparisoii, B6  mice do not express MHC class II I-E molecules and are thus 
unresponsive to Mtv superantigens. Error bars represent s.e.m.
Cd45^ T cells respond poorly to exogenous superantigen deletion
To further examine the altered sensitivity of Cd45'^ ' thymocytes to negative 
selection, I analysed the deletion of thymocytes by Staphylococcus enterotoxin B 
(SEB) in these mice. This system has the advantage that the deleting stimulus can 
be titrated by using increasing concentrations of SEB. SEB binds to class II 
molecules and to Vp3, 7, 8  and 17 (Marrack and Kappler, 1990), leading to the 
selective elimination of T cells expressing these Vps. SEB deletion of thymocytes 
occurs specifically at the SP stage of thymic development (Marrack and Kappler, 
1990). Figure 28 shows the result of flow cytometric analysis of Vp8 -expressing 
CD4^ SP thymocytes in Cd45 '^ BALB/c mice and Cd45^^ BALB/c mice injected 
with increasing concentrations of SEB. Control animals show a gradual increase in 
the percentage deletion of Vp8^CD4  ^ SP cells within the thymus with increasing 
concentrations of SEB. In contrast, there is clearly a substantial deficiency in 
SEB-induced deletion in Cd45'^ ' mice. At the highest SEB concentration used,
113
Cd45*^* mice delete around 60% of all Vp8 -expressing CD4^ SP thymocytes whilst 
this concentration has only a minor effect on CD4* thymocytes in Cd45'^ ' mice. 
These results therefore support a positive role for GD45 in the negative selection of 
T cells in superantigen deletion and suggest that in the absence of CD45 the 
threshold of TCR signalling for negative selection is increased.
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Figure 28: Defective negative selection of thymocytes to exogenous 
superantigen. Staphylococcus enterotoxin B (SEB)-induced deletion of 
Vp8^CD4^SP thymocytes. CD45-deficient (Cd45^') or control {Cd45*^*) mice 
which have been backcrossed to the BALB/c background were injected three times 
every other day with the dose of SEB shown. Mice were analysed the day after the 
third injection. Graph shows the percentage deletion of Vp8^CD4^SP within these 
mice as determined by flow cytometric analysis.
Cd4S^' T cells show defective Ca^ mobilisation following TCR 
stimulation
The deficiency of Cd45'^ ' thymocytes in response to both positive and 
negative selection stimuli could be due to a failure of signal transduction events 
fiom the TCR. One of the hallmarks of this signal transduction is the mobilisation 
of Ca^  ^on antigen stimulation which results in a transient increase in intracellular 
Ca^ * concentrations. Thymocytes from Cd45*^ * and Cd45'^ ' mice were assessed for 
their ability to flux calcium in response to receptor crosslinking using four colour
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flow cytometry. Thymocytes loaded with the Ca^ * sensitive dye Indo-1 were 
stained with anti CD4 and anti-CD8 , to allow gating, and an anti-CD3 hamster 
antibody. TCR stimulation was achieved by the crosslinking of CD3 using an 
anti-hamster antibody and changes in fluorescence of the Indo-1 dye was measured 
over a six minute time course. In initial experiments increasing doses of crosslinker 
were used to stimulate the cells and Cd45*^* cells were found to be sensitive to 
receptor-induced Ca^^  flux with as little as 1 0  |ig/ml cross-linker (not shown). 
Figure 29 shows the results of stimulation of thymocytes with 100 ng/ml 
cross-linker. As expected Cd45*^ * thymocytes respond strongly to this high level 
of receptor crosslinking. In contrast Cd45'^ ' thymocytes only respond very poorly 
to this level of receptor stimulation in any of their thymocyte sub-populations. 
Although Cd45’^ ' thymocytes have lower levels of TCR on their CD4^ SP and CD8  ^
SP thymocytes, since these cells fail to respond even to very high levels of 
crosslinking antibody this suggests that CD45 is required for the coupling of the 
TCR to Ca^  ^signalling pathways.
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Figure 29: Greatly reduced TCR-driven intracellular calcium flux in 
CD45-defîcient thymocytes. Flow cytometric analysis showing CD4 and 
CD8  staining of Cd4^* or Cd45^’ thymocytes preloaded with Indo-1 and stained 
with anti-CD3. Intracellular [Ca^T in either the C!D4^CD8' SP, CD4 CD8  ^ SP or 
CD4^CD8* DP thymocytes (gated as shown in the CD4/CD8 plots) is shown as a 
ratio of Indo-1 violet/blue fluorescence (Ratio; calcium bound dye/cicium free dye) 
versus time. Cells were stimulated with IWpig/ml goat ^ti-hamster antibody to 
crosslink the anti-CD3 at the time indicated by the break in the calcium trace (about 
60s after start of data collection). The percentage of cells responding is indicated on 
each plot, defined as the percentage of cells exceeding a ratio of 600 between 140s 
and 360s after the start of the experiment. All plots are representative of multiple 
experiments.
Summary
Cd45'^ ' mice have been shown to have a severe deficiency in T cell development. 
There are two distinct developmental blocks. Firstly there is a block at the 
CD44 CD25* DN3 stage of CD4 CD8  DN thymocyte development, suggesting that 
CD45 plays a role in signalling from the pre-TCR. The second developmental 
block is at the DP stage in thymocyte development which is associated with the 
positive and negative selection events of T cell selection. Some Cd45'^ ' T cells are 
able to reach the periphery, albeit in greatly reduced numbers. These cells are 
unusual in that they have both an immature (CD3'®/HSA*") and yet an activated 
phenotype (CD44*“/L-selectin‘°) as assessed by expression of cell surface markers. 
To determine the role of CD45 during positive selection of thymocytes both class I 
and class II transgenic TCR receptors were used. Cd45'^ ' mice were found to 
display a profound block in the development of mature T cells expressing the
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transgenic TCRs suggesting an important role for CD45 in the positive selection of 
these receptors. Moreover, this deficiency appears to be due to altered thresholds of 
TCR signalling as assessed using bi-specific antibodies to induce positive selection 
events in a dose dependent manner. The use of a transgenic TCR to investigate T 
cell negative selection events demonstrates that Cd45'*' thymocytes can undergo 
negative selection events induced by the cognate ligand. However, negative 
selection induced by endogenous (Afrv) and exogenous (SEB) superantigens are 
deficient in Cd45^' thymocytes. In addition Cd45'^ ' T cells are found to have a 
profound block in their ability to mobilise Ca^  ^ in response to antigen receptor 
stimulation.
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Chapter Four
DISCUSSION
4.1 Creation of the Cd45'^ ' mice
The aim of this project was to create a mouse strain deficient in CD45 by 
genetic targeting using homologous recombination in ES cells and to characterise 
lymphocyte development in these mice with particular emphasis on the positive and 
negative selection events that occur during development. In this discussion I will 
examine the results of these studies in the context of what is known about the role 
of CD45 in signal transduction and compare and contrast these results with 
published data using other CD45-deficient mouse strains.
The first published CD45-deficient mice were created by genetic
targeting of exon 6  of the Cd45 gene, which is one of the differentially expressed 
exons. These mice were found to have some Cd45 expression on around 20% of 
their T cells although no expression on B cells (Kishihara et al., 1993). More 
recently C d45^‘^  mice have been published which have a targeted disruption of an 
exon used in aU isoforms of CD45 (Byth et al., 1996). These mice do not express 
any isoforms of CD45 on any lymphocytes studied and do not produce any 
truncated form of the protein. Here I describe the construction and characterisation 
of mice with a targeted disruption of exon 12 of the Cd45 gene {Cd45-' \  an exon 
also in all isoforms of CD45. Like the C d45^‘^  mice, no isoforms of CD45 can 
be detected on the surface of the lymphocytes of these mice. In these mice a small 
amount of a truncated protein appears to be produced from the targeted allele. 
Further analysis of this truncated protein has been performed by 
immunoprécipitation studies and has confirmed it has phosphatase activity 
consistent with it being derived from CD45. Despite the presence of this truncated
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protein these Cd45'^ ' mice demonstrate the same deficiencies in T and B cell 
development as described for mice where no truncated form of CD45 is present (see 
later and Byth et al., 1996). This is best explained by the fact that the mutation of 
exon 1 2  was engineered in such a way that if any truncated form of the protein 
containing the phosphatase domain was to be produced, it would lack the necessary 
signal sequences that allow it to be located in the membrane. Studies using 
truncated forms of CD45 in transfection studies have shown that membrane 
localisation is a prerequisite for the contribution of CD45 to signal transduction 
(Alexander, 1997).
The Cd45''' mice were found to have strain-specific phenotypes. The 
mutation was found be lethal on the 129/Sv mouse strain whilst Cd45'^ ' BALB/c 
mice display splenomegaly. Strain-specific differences in phenotype, as well as in 
the severity of the phenotype, have been noted previously in other gene targeted 
mice (Sibilia and Wagner, 1995; Threadgill et al., 1995). Cd45'^ ' mice inbred on a 
129/Sv genetic background suffer from chronic diarrhoea which leads to a 
progressive wasting disease and death. This particular phenotype is reminiscent of 
the symptoms seen in other immunodeficient mice. Mice deficient in the cytokines 
IL-2 and IL-10 both suffer from chronic enterocolitis and develop similar symptoms 
to 129/Sv Cd45 '^ mice (Kuhn et al., 1993; Sadlack et al., 1993). Moreover 
spontaneous inflammatory bowel disease is associated TCRo, TCRp and TCRp and 
6  double knockout mice (Mombaerts et al., 1993). The reason these mice develop 
these symptoms is not clear however it has been suggested that this may be due to 
autoimmune disease caused by an inappropriate immune response to the normally 
non pathogenic microbial flora of the gut (Sadlack et al., 1995). Furthermore, 
splenomegaly similar to that seen in Cd45'^ \ BALB/c mice is also associated with 
autoimmune disease in mice deficient in the Lyn Src-family kinase (Hibbs et al., 
1995; Nishizumi et al., 1995). Thus it appears that Cd45 '^ mice have 
autoimmune-like diseases, although much further work would have to be done, to 
fully characterise these phenotypes. If these symptoms are those of autoim m unity 
then this would suggest that genetic background of the mouse is important in the 
presentation of the disease. Currently I am attempting to analyse anti-DNA
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antibodies in Cd45'^ ' BALB/c mice. The production of this type of antibody and its 
deposition in the kidneys of Lyn-deficient mice is characteristic of their autoimmune 
disease. Preliminary data suggest that older Cd45'^ ' BALB/c mice develop kidney 
pathology however initial attempts to analyse anti-DNA antibodies have been 
unsuccessful.
4.2 B lymphocyte development in Cd45'^ ' mice
To examine the effects of the Cd45 mutation on B cell development, flow 
cytometric analysis was performed using antibodies specific for markers of B cell 
maturation and activation. Analysis of bone marrow from Cd45'^ ' mice has revealed 
a developmental block that has not been reported previously in the other 
CD45-deficient mouse strains. Cd45'^ ' B cell development in the bone marrow is 
seen to be partially defective at the transition from pro- to pre-B cell. This transition 
is associated with signal transduction from the pre-BCR. Failure to transit from the 
pro- to pre-B cell compartment is seen in mice that cannot form a functional 
pre-BCR, such as in RAG 1/2-deficient mice (Mombaerts et al., 1992; Shinkai et 
al., 1992; Weaver and Alt, 1997), X5-deficient mice (Kitamura et al., 1992; Rolink 
et al., 1993), or in mice that do not have Igp molecules (Gong and Nussenzweig,
1996) which are necessary to couple the receptor to the signal transduction 
pathwayis in the cell. This partial block in pro- to pre-B cell transition seen in 
CD45-deficient mice would suggest a need for CD45 in the signalling events from 
the pre-BCR. This requirement is not absolute as many B cells can still make this 
transition.
Despite the partial block in early B cell development, Cd45^' B cells 
accumulate in the spleen in similar numbers to controls. Normally B cell 
development progresses fi'om the most immature peripheral IgM*“IgD‘“ cells to 
IgM’°IgD*" cells (Rajewsky, 1992). Cd45'^ ' B cells are IgM*”IgD“ and this failure to 
down-regulate IgM could mean that these B cells are blocked in their development.
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HSA is another maturity marker that is normally down-regulated during B cell 
development. Cd45'^ ' B cells are seen to have higher levels of this marker, again 
suggesting an immature B cell phenotype. In contrast, Cd45'^ ' B cells also have 
altered levels of expression of other markers that are associated with increasing B 
cell maturation. The levels of expression of both MHC class II and CRl/2 normally 
increase during the transition from IgM*"IgD'° cells to the most mature IgM' I^gD*” 
cells and yet Cd45'^ ' mice have levels of these markers higher than those seen in 
Cd45*'* mice. This B cell phenotype has been reported for both the other published 
CD45-deficient mouse strains (Byth et al., 1996; Kishihara et al., 1993), Given the 
conflicting results on the expression of these development markers of B maturity it 
is therefore difficult to conclude if the B cells in these mice are more or less mature 
than controls. Interestingly, Cd45“^ ‘^  mice crossed to mice deficient in SHP-1 
show an apparent maturation of the B cell phenotype to IgD'^IgM’” cells suggesting 
that mutations in these two phosphatase cancel each other, consistent with CD45 
and SHP-1 being positive and negative regulators of BCR signalling respectively 
(Pani et al., 1997).
Cd45'^ ' B cells also express the co-regulatory molecule CD 19 at higher levels 
than controls. As CD 19 is thought to be a positive regulator of receptor signalling, 
this increase in expression would suggest than Cd45'^ ' B cells may have a lower 
threshold for activation than control cells. This could however be counteracted if 
there was a general increase in. all cell surface molecules including negative 
regulators. CD22 is a major negative regulator of BCR signalling and this is not 
elevated in Cd45'^ ' B cells. Other negative regulators of signalling exist and it is 
possible that they conq)ensate for CD19 over-expression. If Cd45'^ ' B cells are 
more sensitive to BCR stimulation due to CD 19 over-expression, then the B cells 
within these mice would be more likely to become activated by autoantigens and this 
could explain the splenomegaly seen in Cd45'^ ' mice. However, although B cells 
from transgenic mice overexpressing CD 19 are hyper-responsive to receptor 
stimulation, no autoimmunity has been reported in these animals.
121
The elevation of the surface level of expression of B7.2 on Cd45'^ ' B cells is 
interesting as this molecule is generally considered as a marker of B cell activation 
(Lenschow et al., 1994). Studies from all the CD45-deficient mice strains 
analysed, including those presented in this thesis, show that in vitro CD45-deficient 
B cells fail to proliferate following BCR crosslinking, suggesting a decrease in 
signal transduction. Moreover, signal transduction through the BCR in Cd45'^ ' B 
cells also appears to be defective as judged by the greatly reduced intracellular Ca^* 
flux in response to crosslinking of the receptor in agreement with studies performed 
on the C d45^“  ^mice (Benatar et al., 1996). This means there is a contradiction in 
that CD45-deficient mice appear to have an activated B cell phenotype and yet these 
B cells fail to signal properly from the receptor. Could this be explained if Cd45'^ ' B 
cells were anergic? Anergic cells are those that develop in the presence of 
autoantigen but fail to respond to it. If CD45 is a negative regulator of BCR 
signalling then this would mean that the BCR of CD45-defrcient B cells would be 
more likely to result in B cell activation during receptor mediated selection events. 
To avoid autoimmune disease these activated Cd45'^ ' B cells must subsequently 
become unresponsive to antigen receptor stimulation i.e. they become anergic. As 
discussed in the introduction, B cell ancrgy has been studied extensively in the 
anti-HEL transgenic mice bred to express sHEL. Anergic B cells within these mice 
share some characteristic with Cd45^' B cells in that they fail to proliferate in 
response to antigen crosslinking and have reduced Ca^  ^ flux. However anergic B 
cells have a characteristic very low level of expression of IgM such that these B 
cells are IgM’°'TgD*“ which is not seen with CD45-deficient B cells (Cyster • and 
Goodnow, 1995; Goodnow et al., 1991).
When the CD45 '^ mice were bred to transgenic mice expressing the 3-83p0 
BCR, in the absence of the cognate ligand for this receptor (H-2 K**), 3-^3/Cd45'^ ' 
mice develop large numbers of B cells that display a IgM“lgD‘° phenotype, i.e. 
they resemble immature rather than anergic cells. This suggests that CD45 is 
required for the developmental up-regulation of IgD on B cells expressing the 3-83 
BCR. A similar experiment has been conducted using the Cd45‘^ ‘^  mice bred to 
the anti-HEL transgenic mice (Cyster et al., 1996). These mice have the advantage
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that cognate ligand for this receptor can be expressed in mice in soluble form 
(sHEL) which acts as a weak ligand, or a membrane bound form (mHEL) that can 
act as a strong highly crosslinking ligand. When this group made radiation 
chimeras from the bone marrow of Cd45“^ ‘^  anti-HEL mice in the absence of the 
cognate ligand they found that the Cd45"^‘^  B cells also display this IgM'“IgD‘° 
phenotype, again suggesting a reduction in the maturity of CD45-deficient B cells. 
When bone marrow from anti-HEL/sHEL mice is mixed with wildtype bone 
marrow and used to reconstitute lethally irradiated mice to form chimaeras, then the 
anergic cells die by negative selection due to competition by the wildtype cells for 
entry into the follicles (Cyster et al., 1994). When similar radiation chimaeras were 
made with bone marrow from anti-HEL transgenic mice in the absence
of sIŒL, these were found to be behave in a similar manner to wildtype anergic B 
cells in that they had a reduced capacity to compete with wildtype cells to populate 
the spleen and lymph nodes of reconstituted mice (Cyster et al., 1996). However 
when anti-HEL transgenic C d 4 ^^^  mice were bred to express sHEL then a 
surprising result was obtained. B cells from these mice now appear to behave like 
naive wildtype cells having an increased capacity to compete with wildtype bone 
marrow than those CD45-deficient B cells that developed without exposure to sHEL 
(Cyster et al., 1996). In addition they appear to have increased in their maturity to 
become IgM'“*IgD“ cells. This result is more consistent with CD45-deficient B cells 
having a reduced signalling capability. In the absence of CD45 there is insufficient 
signal for this transition to occur. When sHEL is present this autoantigen acts to 
stimulate the receptor further to allow for efficient B cell development. If the 
CD45-deficient B cells were truly anergic then they would be expected to be 
unresponsive to further stimulus through their antigen receptor. In summary CD45- 
deficient B cells are less responsive to BCR stimulation, and when expressing a 
transgene BCR they are arrested in their development at an immature IgM‘“IgD^ ° 
stage. However it is difficult to reconcile this with increased expression of certain 
activation markers.
When 3-%3!Cd45'^  mice were bred to express the negatively selecting 
cognate ligand, H-2K\ the B cells expressing the 3-83 receptor were efiBciently
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deleted. A similar result was obtained with mHEL mice. However
some B cells were found in the 3-^3ICd45 '', H-2‘* mice but these developed by 
rearranging endogenous receptor chains and using these to alter the specificity of the 
receptor such that they no longer recognise H-2K^. The B cells that developed in 
this manner had the IgM‘"IgD‘“ phenotype found in non-transgenic Cd45'^ ' mice. B 
cells expressing rearranged endogenous receptors or B cells expressing a rearranged 
transgenic receptor in the presence of a weak cognate ligand (sHEL), also 
up-regulate IgD and become IgM‘"*IgD'”. One model to explain this is that B cells 
developing from IgM'“IgD’° cells require a weak signal from an as yet unknown 
ligand. GD45-deficient B cells expressing rearranged endogenous receptors will 
have a variety of different receptor affinities and this could mean that those cells 
which have a high enough affinity to this putative ligand can overcome the 
deficiency in CD45 and develop into IgM*“IgD*“ cells. This is presumably 
mimicked by the addition of soluble HEL in the Cd45‘^ ‘^  anti-HEL transgenic 
mice. This process could be regarded as the B cell equivalent of the positive 
selection of T cells (Thompson and Allison, 1997). Indeed both Syk-deficient 
(Turner et al., 1997) and Iga-deficient mice (Torres et al., 1996) have a block in B 
cell development at this stage suggesting that BCR signalling is required for this 
transition.
The numbers of B-1 cells within Cd45'^ ' mice are greatly reduced. Mice 
deficient in each of the BCR coreceptor components CD 19, CD21 and CD81 also 
have a reduction in the numbers of B-1 cells (Maecker and Levy, 1997; Rickert et 
al., 1995; Tsitsikov et al., 1997). This is thought to be due to the reduced levels of 
BCR signalling in the absence of these molecules being insufficient to allow the 
development of this population. Similarly, Btk- and PKCp-deficient mice have very 
much reduced levels of B-1 cells and it has been suggested that these molecules are 
required for signalling from the receptor during B-1 cell development (Khan et al., 
1995; Leitges et al., 1996). In contrast CD22-deficient mice and mice deficient in 
SHP-1 have increased numbers of B-1 cells (O'Keefe et al., 1996). These 
molecules play an important role in the negative regulation of the BCR signalling 
and it is thought that the absence of these molecules increases the sensitivity of the
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receptor leading to increased B-1 cell development. Thus B-1 cell development or 
maintenance is sensitive to the levels of signals being transduced from the receptor. 
Those mutations which reduce BCR signaUing have lower numbers of B-1 cells 
whilst those with increased BCR signalling have more B-1 cells. As Cd45'*' mice 
have reduced numbers of B-1 cells this would suggest that CD45 is require for the 
efficient transmission of signals from the B-1 receptor.
In conclusion, most of the data from all three CD45-deficient mouse lines 
suggests that CD45 is a positive regulator of BCR signalling, and that in its absence 
there are several blocks in B cell development at checkpoints requiring pre-BCR or 
BCR signals..
4.3 T lymphocyte development in Cd45''' mice
To investigate the role of CD45 in T cell development I used flow cytometric 
analysis of T cell markers of maturity and activation. T cell development is severely 
affected in Cd45'^ ' mice. Firstly, there is a partial block at the DN stage of 
thymocyte development at the transition from CD44'CD25^ to CD44CD25' cell 
populations. A similar partial block at this transition has also been reported for the 
mice (Byth et al., 1996). Thymocyte development is also blocked at this 
developmental stage in mice unable to make a functional pre-TCR, such as pTa- 
and RAG-deficient mice (Fehling et al., 1995), or TCRp-deficient mice (Jacobs et 
al., 1996; Levelt et al., 1993; Mombaerts et al., 1992) and mice that do not have 
CD3e molecules which are necessary to couple the pre-TCR to signal transduction 
pathways (Malissen et al., 1995). The block in this transition in the Cd45’' mice 
would suggest that CD45 is a positive regulator of signal transduction firom the 
pre-TCR in a similar manner to its role in signal transduction firom the pre-BCR. 
Again there is not an absolute requirement for CD45 in this transition as many cells 
develop into DP thymocytes.
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The most dramatic block in thymocyte development in Cd45'^ ’ mice is at the 
DP to SP transition resulting in greatly reduced numbers of CD4^ and CD8 * SP 
cells and a concurrent decrease in CD4^ and CD8  ^peripheral T cells. This stage of 
development is associated with positive and negative selection events that are 
governed by interactions between the TCR and MHC/peptide complexes on thymic 
stromal cells. Cd45’'' mice have a deficiency in DP thymocytes that are CDS**' 
CD69^ which are thought to be cells that are being positively selected (Swat et al., 
1993; Wang et al., 1995; Yamashita et al., 1993). The reduced levels of cells 
undergoing positive selection suggests that CD45 may be important in this process. 
To address whether this deficiency in positive selection was T cell-autonomous or 
due to deficiencies in other cell types such as thymic stromal cells, I made radiation 
chimaeras with mixtures of increasing proportions of bone marrow from CddS"^ ' 
mice mixed with bone marrow firom wildtype mice (not shown). The results of 
these studies suggested that the T cell phenotype in Cd45'^ ' mice was intrinsic to the 
T cells and coiild not be overcome in the presence of wildtype cells.
Cd45'^ ' DP thymocytes have lower levels of expression of CD5 than 
controls. In wildtype mice, CD5 expression is induced as thymocytes transit from - 
the DN to DP compartments. CD5 is thought to be a negative regulator of TCR 
signalling (Tarakhovsky et al., 1995; Tarakhovsky et al., 1994) and as such, its 
down regulation m. Cd45'^ ' mice during DP development may be a mechanism to 
compensate for the lower levels of signals passing through the pre-TCR in the 
absence of CD45. In contrast the levels of CD5 expressed on SP T cells and 
peripheral T cells in Cd45'^ ' mice are equivalent to wildtype levels.
To investigate the role of CD45 in T cell selection events, Cd45'^ ' mice were 
bred to transgenic mice expressing class I- and class Il-restricted rearranged 
receptors. With all three different receptors studied, in the absence of CD45 no T 
cells developed that expressed the transgenic receptor, confirming that CD45 is 
required for their positive selection. A similar defect in the positive selection of 
transgenic mice carrying a rearranged receptor has also been described in the 
€445“^"^ mice (Wallace et al., 1997). To study whether efficient Cd45'^ ' T cell
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development could be induced by increasing the signal to the TCR, a protocol using 
neonatal thymic organ cultures (NTOQ was used. Bi-fiinctional antibodies that 
aggregate CD4 with CD3 can be used to efficiently induce CD4^ SP thymocyte 
development in control thymi in vitro (Basson et al., 1998; Bommhardt et al., 
1997). This system can therefore be used for the titration of this stimulus by 
altering the concentration of the bi-specific anti-CD4/anti-CD3 reagent. In this way 
we have shown that Cd45'^ ' CD4^ SP T cell development can be induced to levels 
equivalent to those in controls when high concentrations of bi-specific reagent were 
used. At lower concentrations of the bi-specific reagent, the development of Cd45'^ ' 
CD4^ SP cells was much less efficient than in control NTOCs. When a greater dose 
of bi-specific antibody is used a stronger signal is provided which overcomes the 
deficiency in the CD45-deficient T cells allowing for efficient positive selection. 
Together this suggests that TCR signalling in Cd45'^ ' T cells is lower than in control 
cells and that CD45 is a positive regulator of TCR signalling in thymocytes.
In the case of Cd45'^ ' mice expressing the BM3 and A1 transgenes, some 
Cd45'^ ' SP thymocytes develop but these express endogenously rearranged TCRs 
rather than the transgenic TCRs. Thus, positive selection can occur with randomly 
generated endogenous TCRs but there is no positive selection of Cd45^' thymocytes 
expressing transgenic TCRs. One explanation for this is based on the idea there is a 
particular level of TCR signalling required during the DP to SP transition. During 
positive selection, thymocytes interact with the thymic stromal cells which present 
S/M and drive their development. This involves a signal firom the newly rearranged 
TCR and the strength of that signal determines the fate of the developing cells. 
Tliosc cells that fail to receive a high enough signal die at the DP stage of 
development by neglect, those with too high a signal die by negative selection with 
only those cells given with the correct levels of signalling developing in SP 
thymocytes. As discussed above, in Cd45'^ ' thymocytes the TCR signalling is 
reduced. Because of this, in thymocytes expressing a defined transgenic TCR those 
signals that would be normally elicited through the TCR on interaction with S/M are 
now not sufficient to drive positive selection and the cells die of neglect. 
Rearrangement of endogenous receptors allows the development of cells with a
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wide variety of specificity’s. There is likely to be a spectrum of affinities of S/M 
and TCR interactions. In this way, those cells which receive levels of signalling 
during this interaction that are of sufficient strength to overcome the signalling 
deficiency in the absence of CD45 are positively selected.
4.4 T cell negative selection in Cd45'^ 'voice.
As there is a reduced sensitivity of Cd45'^ ' thymocytes for positive selection 
it is possible that these ceUs would also have an altered sensitivity to negative 
selection. Analysis of negative selection in Cd45'^ ' mice expressing the BM3.6 
transgene shows that deletion of autoreactive thymocytes occurred efficiently in the 
absence of CD45 in a similar manner to wildtype mice. The deleting ligand for the 
receptor, H-2K’’ is expressed at high levels in the thymus in these transgenic mice 
and therefore is likely to provide a strong negative selection stimulus. To see if 
there is any difference in the efficiency of CD45-deficient mice to negatively select 
thymocytes, I studied the effects of a weaker stimulus.
Cd4y' BALB/c mice were used to investigate superantigen induced deletion 
of Vp expressing T cell subsets. Superantigen presentetion differs from the 
presentation of conventional antigens in that superantigens bind, without 
processing, directly to the lateral surface of the MHC class II molecules rather than 
in the peptide binding groove. ' It is likely that this provides a weaker TCR signal 
than conventional peptide antigens (Simpson et al., 1993). Cd45'^ ' thymocytes cells 
expressing Vp 3, 5 and 11 were not deleted as efficiently as wildtype thymocytes in 
the presence of endogenous MMTV-encoded superantigens. This result is in direct 
contrast to observations on the Cd45‘^ ‘^  mice where Vp deletion was reported to 
occur normally (Kishihara et al., 1993). Cd45“^ ^  mice are known to have CD45 
expression on a proportion of their thymocytes and T cells which may explain the 
contradictory results.
128
To further analyse this deficiency in negative selection, I injected varying 
doses of the bacterial endotoxin superantigen SEE into mutant and control mice and 
measured specific Vp deletion. These studies demonstrate that Cd45'^ ' mice have a 
reduced level of negative selection compared to controls. Failure of superantigen 
deletion of thymocytes firom mice treated in vitro with SEE has recently
been reported (Conroy et al., 1996). Thus in conclusion, Cd45'^ ' thymocytes can 
undergo negative selection when exposed to a negatively selecting hgand expressed 
at high concentrations. The use of weaker negatively selecting ligands has revealed 
a deficiency in negative selection of Cd45'^ ' thymocytes at least in response to 
superantigens. Together this suggests that CD45-deficiency leads to reduced TCR 
signalling during negative selection whereby strong signals still work but weaker 
signals do not.
4.5 Peripheral T cells in Cd45'^ ' mice
The expression levels of the adhesion molecules CD44 and L-selectin can 
been used to distinguish cells that have a previously activated/memory phenotype 
(Barrat et al., 1995; Gerberick et al., 1997; Khan et al., 1996; Tietz and Hamann, 
1997). CD45-deficient mature CD4^ and CD8  ^ peripheral T cells have a 
predominantly CD44*"L-selectin‘® phenotype characteristic of activated T cells. 
Despite this activated phenotype, Cd45'^ ', T cells have major deficiencies in Ca^  ^
mobilisation following crosslinking of their antigen receptors (not shown). The 
accumulation of T cells with a previously activated phenotype that are unresponsive 
to receptor stimulation is akin to the observations described earlier for B cells. 
Could Cd45'^ ' peripheral T cells be anergic? Studies of anergic T cells show that 
these cells have low TCR levels, fail to proliferate, flux Ca^  ^ or to produce IL- 2  
following TCR stimulation (Fields et al., 1996; Gallichio et al., 1994; QuiU, 1996; 
Schwartz, 1996; Sloan-Lancaster et al., 1994) AU of these features have been 
reported in CD45-deficient T ceUs suggesting they too may be anergic (Alexander,
1997) . These observations seem paradoxical in view of the reduced TCR
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signalling seen in Cd45'^ ' thymocytes. It may be that whilst CD45 is a positive 
regulator of TCR signalling in thymocytes, it is less important or unnecessary for 
TCR signalling in peripheral T cells. Since, as I have argued earlier, these cells are 
likely to have been selected for a higher affinity for autoantigens, it may be that 
since they have exited into the periphery they become autoreactive and as a 
consequence assume an anergic phenotype. This may also explain the autoimmune- 
like enteritis seen in Cd45'^ ' 129/Sv mice.
4.6 Signalling
Thymocytes from Cd45'^ ' mice have a deficiency in both positive and 
negative selection events. Many other signals have been imphcated in the regulation 
of positive and negative selection during thymocyte development. Inactivation of 
Lck, ZAP-70 and Vav profoundly affects both positive and negative selection of T 
cells (Molina et al., 1992; Negishi et al., 1995; Turner et al., 1997). On the other 
hand the Ras/RafiMEK/ERK pathway has been shown to be required for positive 
but not negative selection (Aberola-Ha et al., 1996), whilst CD40 hgand and Jak3 
have been shown to play a role in negative but not positive selection. I have 
demonstrated that CD45-deficient thymocytes have a defect in Ca^  ^ mobihsation 
following receptor stimulation. This could explain the failure of positive selection, 
as a role for calcium fluxes in thymocyte selection events has been suggested by a 
number of studies. A combination of calcium ionophore and phorbol esters can 
replace the TCR signals that lead to positive selection (Takahama and Nakauchi, 
1996), whilst the use of intracellular calcium chelators to block calcium fluxes, 
interferes with negative selection (Kane and Hedrick, 1996). Moreover the use of 
inhibitors to abrogate the function of the calcium-activated phosphatase calcineurin 
inhibits positive selection and negative selection by weakly deleting hgands (Wang 
et al., 1995). Together these results clearly demonstrate an important role for 
calcium mobilisation in regulating thymocyte selection events and thus its inhibition 
in CD45-deficient thymocytes could explain the failure of these processes.
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How does CD45 regulate calcium mobilisation in thymocytes? Studies have 
been conducted using lymphocytes derived from the Cd45‘^ ‘^  mice into the 
phosphorylation status and activity of many of the proteins associated with proximal 
signalling from the TCR (Stone et al., 1997; Stone et al., 1997). This study found 
that Cd45‘^ ‘^  thymocytes demonstrated hyperphosphorylation of Lck and Fyn 
with Lck in an inactive conformation. This was associated with reduced 
phosphorylation of TCR-Ç and CD3-e and a concurrent failure to recruit ZAP-70 to 
the TCR. The signalling in these cells, although decreased, was not totally ablated 
supporting the idea that CD45 controls the levels of TCR signal transduction. 
These observations support the hypothesis that a major function of CD45 is to 
activate Lck and Fyn following TCR engagement which leads to the subsequent 
phosphorylation of FT AMs in the TCR-associated chains by these kinases. This in 
turn allows for the recruitment of ZAP-70 and further downstream signalling (Chan 
et al., 1994). The absence of CD45 in cell lines has been associated with the 
disengagement of the TCR from the ability to generate second messengers such as 
inositol-1,4,5-trisphosphate (IP3 ) which is responsible for the mobihsation of 
calcium from intracellular stores (Koretzky et al., 1990). TCR engagement leads to 
the activation of phosphohpase C yl (PLCyl) which metabohses 
phosphtidyloinositol 4,5-bisphosphate (PIP2 ) to generate IP3 . How receptor 
activation leads to PLCyl activation is not clear. It appears unlikely that CD45 
directly regulates PLCyl activity as cell lines deficient in CD45 that fail to generate 
IP3  in response to TCR stimulation can still do so when stimulated through other 
classes of receptor (Alexander, 1997). ZAP-70 has been shown to be associated 
with PLCyl following TCR engagement (Nel et al., 1995) suggesting that CD45 
regulation of ZAP-70 activation (via the Src-family kinases) may in turn regulate 
PLCyl activity by direct phosphorylation. An even more complex pathway could 
be via ZAP-70 interactions with Vav. Vav is an exchange factor for Rho family 
members which have been imphcated in the activation of phosphatidylinositol 
4-phosphate 5-kinase (PIP5K). PIP5K activation leads to the production of PIP2  
(Chong et al., 1994; Ren et al., 1996; Toh^ et al., 1995) which in turn is a
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substrate for PLCy, whose activation, on TCR stimulation, leads to production of 
IP3  (O'Rourke et al., 1998; Turner et al., 1997).
Cd45'^ ' B cells have a partial deficiency in calcium mobilisation such that on 
receptor stimulation the initial peak of intracellular calcium concentration due to 
mobilisation of intracellular Ca^  ^ stores occurs normally whilst influx from 
extracellular stores was abrogated. Cd45‘^ ‘^  mice also display this defect (Benatar 
et al., 1996). How does CD45 regulate Ca^^  mobilisation in B cells? The current 
model for the role of CD45 in BCR signalling is thought to be through the 
regulation of the activation status of Src-family kinases such as Lyn or Fyn by 
dephosphorylation of a negative regulatory tyrosine at the carboxy-terminal end of 
these proteins. BCR stimulation results in the activation of these Src-family kinases 
and the subsequent phosphorylation of TTAMs in the Iga and IgP molecules of the 
receptor. This leads to the recruitment of Syk, its activation and further 
downstream signal transduction events. If this model was correct then Cd45'^ ' mice 
would have a B cell phenotype similar to mice deficient in these Src-family kinases. 
Studies of Lyn-deficient mice suggest that B cells firom these mice are 
hyper-responsive to BCR stimulation rather than hyporesponsive as seen in Cd45 '' 
m ice (Chan et al., 1998; Wang et al., 1996). Furthermore B cell development and 
signalling in Fyn-deficient mice is seen to be unperturbed, including having normal 
receptor-mediated Ca^^  flux (Sillman and Monroe, 1994). Syk-deficient {Syk^') 
mice fail to develop mature B cells (Cheng et al., 1995; Turner et al., 1995) and 
Syk-deficient DT40 cells fail to flux calcium (Takata et al., 1994) demonstrating the 
importance of Syk in signalling events from the BCR. Defects in Syk activity are 
however unlikely to explain the defects in Ca^ "^  seen in CD45-deficient B cells. 
Proximal signal transduction pathways in B cells, which demonstrated
that the BCR-induced phosphorylation of Iga and IgP is apparently normal as is 
Syk activation suggesting that this is not the means by which CD45 signals into the 
calcium mobilisation pathway.
In summary, it is not clear how CD45 regulates antigen receptor-mediated 
Ca^  ^fluxes. The most likely route is by regulation of the activation state of Src-
132
family kinases. The observation that no single Src-family kinase knockout mimics 
the defective Ca^ + flux in Cd45 -^ B or T cells may reflect redundancy among 
multiple Src-family kinases expressed in lymphocytes.
4.7 Concluding remarks
There is a striking similarity between B and T cells from Cd45''' mice in that 
they both display profound developmental blocks at stages of development that 
require signal transduction from the receptors of their cells. In addition those B and 
T cells within the periphery look immature and yet have increased expression of 
markers that are associated with having an activated phenotype. Much interest has 
focused recently on the topology of TCR and S/M interactions and the physical 
exclusion of proteins from the site of interaction, and recently it has been proposed 
that CD45 exclusion may play an important role in signal transduction events. The 
deficiency in both positive and negative selection of thymocytes in Cd45'' mice 
clearly points to a positive role for CD45 in these phenomena. However, the 
activated phenotype of both B and T cells within the periphery of these mice could 
suggest a negative role for CD45 in signal transduction from the receptors of these 
cells. This could be explained if CD45 plays different roles at different stages of 
development. Clearly much work needs to be done to fully understand the role of 
CD45 in signal transduction events.
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